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Major advances have been made in treatment of neurological and neuropsychiatric 
disorders; they have however still significant limitations. A vast body of evidence 
shows a dysregulation or disruption of neuroplasticity in mental and brain disorders. 
Here, non-invasive brain stimulation techniques come into play, which modulate 
brain plasticity without disrupting the integrity of the skull. One of those, transcranial 
direct current stimulation (tDCS), has shown promising results in several pilot 
clinical studies to improve symptoms of central nervous system disorders; but, in 
general, effects are often moderate, show nonlinear dosage-dependency, and 
interindividual variability. For improving the efficacy of this tool, more sustained, 
and homogeneous effects are required. This requires novel, improved intervention 
strategies. In addition, neuromodulatory effects of tDCS over the primary motor 
cortex were largely taken as a template so far for the use of this intervention over 
other brain regions, whereas a direct exploration of the physiological effects of tDCS 
on non-motor regions is largely missing.  
The thesis aims to address these challenges, by utilizing advanced 
neurophysiological and computational techniques, aiming to improve the efficacy of 
cathodal tDCS over the primary motor cortex, but also to explore the transferability 
of the results to the prefrontal cortex. To this end, we at the first step systematically 
titrated cathodal tDCS parameters for the human motor cortex model with different 
intensities (1, 2, and 3mA) and durations (15, 20 and 30 min). The results revealed 
intensity-dependent nonlinear effects, in which stimulation with 1 mA induced a 
significant motor evoked potentials (MEP) amplitude diminution, while stimulation 
with 2 mA resulted in a significant corticospinal excitability enhancement. Protocols 
with higher stimulation intensity (specifically stimulation with 3 mA) induced again 
a significant excitability diminution lasting for about one and half hour after 
stimulation, and thus were more efficient than the other protocols. At the second 
step, we explored if repeated tDCS protocols with different intervals can prolong the 
after-effects. We compared the impact of single interventions of conventional (1mA 
for 15min) and optimized cathodal tDCS (3mA for 20min) with the effects of 
repeated application with intervals of 20 min and 24 hours on primary motor cortex 
excitability, based on the assumption derived from animal models that short, but not 
long intervals induce late phase plasticity. The results revealed that the duration of 
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after-effects of repeated conventional and optimized protocols with short intervals 
remained nearly unchanged, as compared to the respective single intervention 
protocols. For the long interval (24 h), stimulation with the conventional protocol 
did not significantly alter respective after-effects, while it reduced the efficacy of the 
optimized protocol, as compared with respective single interventions.  
One important outcome of the first study were the observed nonlinear intensity-
dependent effects of tDCS, which might be an explanation for sometimes 
heterogeneous outcomes of cathodal stimulation, and are not well explained at the 
neurophysiological level. At the third step we therefore explored the underlaying 
mechanisms of this nonlinearity. Since tDCS generates NMDA receptor-dependent 
neuroplasticity, which has calcium channel properties, such non-linearity can likely 
be explained by different levels of calcium concentration induced by the 
intervention, which control for the directionality of plasticity. We therefore 
administrated the calcium channel blocker flunarizine in low (2.5 mg), medium (5 
mg) or high (10 mg) dosages before cathodal motor cortex tDCS of 3mA for 20min. 
The results revealed that the inhibitory after-effects induced by high intensity 
cathodal tDCS were unchanged, diminished, or converted to excitability 
enhancement with low, medium and high dosages of a calcium blocker, respectively, 
which confirms the calcium-dependent directionality of tDCS-induced 
neuroplasticity.  
The outcome of the first and second studies showed also relevant inter-individual 
variability of tDCS effects, which could be another source of limited efficacy of this 
intervention. Recent human in-vivo experiments and computational studies indicated 
that the tDCS-induced electrical field (EF) depends strongly on individual brain 
anatomy and tissue conductivity properties. EF variability might thus be an 
important factor for heterogeneous outcomes of tDCS. At the fourth step, based on 
neurophysiological data obtained in former studies of our group, which explored 
tDCS-altered MEP (induced by transcranial magnetic stimulation (TMS)) and 
cerebral blood flow (CBF; measured by functional magnetic resonance imaging 
(MRI) via arterial spin labeling), we investigated the association between individual 
anatomical factors and tDCS-induced EF, and the respective physiological outcomes 
at the level of the individual. To this end, for each participant, a MRI-based realistic 
head model was designed to 1) calculate anatomical factors and 2) simulate the 
tDCS- and TMS-induced electrical fields (EF). We then investigated at the regional 
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level which individual anatomical factors explain the simulated EFs. Finally, we 
explored which specific anatomical and/or EF factors predicted the 
neurophysiological outcomes of tDCS. The results indicated that, of the included 
anatomical factors, higher EF values were associated with lower electrode to cortex 
distance (ECD), and cerebrospinal fluid (CSF) thickness. In addition, CSF thickness, 
and ECD were negatively correlated, whereas EFs were positively correlated with 
tDCS-induced physiological changes.  
Finally, at the fifth step, we explored the transferability of cathodal tDCS-induced 
neuroplasticity from the motor to the prefrontal cortex. Neurophysiological effects 
of tDCS have been extensively studied over the primary motor cortex. Much less is 
however known for its effects over non-motor areas, such as the prefrontal cortex, 
which is the neuronal foundation for many high-level cognitive functions, and 
involved in neuropsychiatric disorders. To this end, cathodal tDCS was applied with 
low, medium, and high dosages, or as sham stimulation, and applied over the primary 
motor and dorsolateral prefrontal cortex. After-effects of tDCS were evaluated via 
TMS-electroencephalography (EEG), and TMS-MEP at the regional level, for the 
outcome parameters TMS-evoked potentials (TEP), TMS-evoked oscillations, and 
MEP amplitude alterations. The results indicated a dosage-dependent nonlinear 
neurophysiological effect of motor cortex tDCS, which was not one-to-one 
transferable to the results of prefrontal tDCS. Low and high dosages of motor cortex 
tDCS reduced early positive TEP peaks, and MEP amplitudes, while an enhancement 
was observed for medium dosage motor cortex tDCS (early positive TEP peak and 
MEP amplitudes). In contrast, prefrontal low, medium and high dosage tDCS 
uniformly reduced the early positive TEP peak amplitudes. Furthermore, for both 
cortical areas, tDCS-induced neuromodulatory effects were not observed for late 
TEP peaks (with the exception of low-dosage prefrontal tDCS), nor TMS-evoked 
oscillations.  
Taken together, using advanced neurophysiological, computational and 
neuroimaging techniques, this thesis has addressed important challenges regarding 
tDCS-induced neuroplastic effects, and thus provides new insight for future 





















Die Behandlungsmöglichkeiten neurologischer und neuropsychiatrischer 
Erkrankungen haben sich in den letzten Jahrzehnten deutlich verbessert, sind aber 
immer noch eingeschränkt. Eine Dysregulation oder Störung der Neuroplastizität ist 
bei vielen psychischen und Hirnfunktionsstörungen beteiligt. Hier sind nicht-
invasive Hirnstimulationstechniken relevant, die die Plastizität des Gehirns 
modulieren, ohne die physische Integrität des Schädels zu beeinträchtigen. Eine 
davon, die transkranielle Gleichstromstimulation (tDCS), hat in mehreren klinischen 
Pilotstudien vielversprechende Ergebnisse zur Verminderung von Symptomen auf 
der Grundlage von Störungen des Zentralnervensystems gezeigt. Diese Effekte sind 
jedoch häufig moderat, zeigen eine nichtlineare Dosisabhängigkeit und eine 
interindividuelle Variabilität. Um die Wirksamkeit dieses Verfahrens zu verbessern, 
sind länger anhaltende und homogenere Effekte erforderlich. Dies erfordert 
neuartige, verbesserte Interventionsstrategien. Darüber hinaus wurden die 
neuromodulatorischen Wirkungen von tDCS auf den primären motorischen Kortex 
bisher weitgehend als Grundlage für die Anwendung dieser Intervention auf andere 
Hirnregionen herangezogen, während eine direkte Untersuchung der 
physiologischen Wirkungen von tDCS auf nichtmotorische Regionen weitgehend 
fehlt. 
Die Arbeit zielt darauf ab, diese Herausforderungen durch den Einsatz innovativer 
neurophysiologischer und mathematischer Techniken anzugehen, um die 
Wirksamkeit des kathodalen tDCS über dem primären motorischen Kortex zu 
verbessern, aber auch die Übertragbarkeit der Ergebnisse auf den präfrontalen 
Kortex zu untersuchen. Zu diesem Zweck titrierten wir im ersten Schritt 
systematisch kathodale tDCS-Parameter für das humane motorische Kortexmodell 
mit unterschiedlichen Intensitäten (1, 2 und 3 mA) und Stimulationsdauern (15, 20 
und 30 min). Die Ergebnisse zeigten intensitätsabhängige nichtlineare Effekte, bei 
denen die Stimulation mit 1 mA eine signifikante Verringerung der Amplitude der 
motorisch evozierten Potentiale (MEP) induzierte, während die Stimulation mit 2 
mA zu einer signifikanten Erhöhung der kortikospinalen Erregbarkeit führte. 
Protokolle mit höherer Stimulationsintensität (insbesondere Stimulation mit 3 mA) 
induzierten erneut eine signifikante Verringerung der Erregbarkeit, die etwa 
eineinhalb Stunden nach der Stimulation andauerte, und waren daher effizienter als 
die anderen Protokolle. Im zweiten Schritt haben wir untersucht, ob wiederholte 
tDCS-Protokolle mit unterschiedlichen Intervallen die Nacheffekte verlängern 
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können. Wir verglichen die Auswirkungen von Einzelinterventionen mit 
konventioneller (1 mA für 15 Minuten) und optimierter kathodaler tDCS (3 mA für 
20 Minuten) mit den Auswirkungen einer wiederholten Anwendung in Intervallen 
von 20 Minuten und 24 Stunden auf die Erregbarkeit des primären motorischen 
Kortex, basierend auf tierexperimentellen Befunden, dass kurze, aber nicht lange 
Intervalle zwischen einzelnen Interventionen eine langanhaltende Plastizität 
erzeugen.  Die Ergebnisse zeigten, dass die Dauer der Nacheffekte wiederholter 
konventioneller und optimierter Protokolle mit kurzen Intervallen im Vergleich zu 
den jeweiligen Einzelinterventionsprotokollen nahezu unverändert blieb. Für das 
lange Intervall (24 h) veränderte die Stimulation mit dem herkömmlichen Protokoll 
die jeweiligen Nachwirkungen nicht signifikant, während sie die Wirksamkeit des 
optimierten Protokolls im Vergleich zu den jeweiligen Einzelinterventionen 
verringerte. 
Ein wichtiges Ergebnis der ersten Studie waren die beobachteten nichtlinearen 
intensitätsabhängigen Effekte von tDCS, die eine Erklärung für teilweise heterogene 
Ergebnisse der kathodalen Stimulation bieten können, allerdings hinsichtlich ihrer 
neurophysiologischen Grundlagen bisher nur unzureichend untersucht waren. Im 
dritten Schritt haben wir daher die zugrunde liegenden Mechanismen dieser 
nonlinearen Effekte untersucht. Da tDCS eine NMDA-Rezeptor-abhängige 
Neuroplastizität erzeugt, die Kalzium-abhängig ist, kann eine solche Nichtlinearität 
möglicherweise durch unterschiedliche durch die Intervention induzierte 
Kalziumkonzentrationen erklärt werden, die die Richtung der Plastizität steuern. Wir 
verabreichten daher den Kalziumkanalblocker Flunarizin in niedrigen (2,5 mg), 
mittleren (5 mg) oder hohen (10 mg) Dosierungen vor der kathodalen tDCS des 
motorischen Kortex mit 3 mA für 20 Minuten. Die Ergebnisse zeigten, dass die durch 
kathodale tDCS hoher Intensität induzierten inhibitorischen Nachwirkungen bei 
niedrigen, mittleren bzw. hohen Dosierungen eines Kalziumblockers nicht 
verändert, verringert oder in eine Erregbarkeitserhöhung modifiziert wurden, was 
die Kalzium-abhängige Direktionalität von tDCS-induzierter Neuroplastizität 
bestätigt. 
Das Ergebnis der ersten und zweiten Studie zeigten eine relevante interindividuelle 
Variabilität der tDCS-Effekte, die eine weitere Quelle für die begrenzte Wirksamkeit 
dieser Intervention sein könnte. Jüngste In-vivo-Experimente und Computerstudien 
am Menschen zeigten, dass das tDCS-induzierte elektrische Feld (EF) stark von der 
individuellen Anatomie des Gehirns und den Leitfähigkeitseigenschaften des 
Gewebes abhängt. Die EF-Variabilität könnte daher ein wichtiger Faktor für 
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heterogene Ergebnisse der tDCS sein. Im vierten Schritt, basierend auf 
neurophysiologischen Daten, die in früheren Studien unserer Gruppe erhoben 
wurden, die tDCS-induzierte MEP- (induziert durch transkranielle 
Magnetstimulation (TMS)) und zerebrale Blutfluss-Veränderungen (CBF; gemessen 
durch funktionelle Magnetresonanztomographie (MRT) über arterielles Spin-
Labelling) erfaßten, untersuchten wir den Zusammenhang zwischen einzelnen 
anatomischen Faktoren, tDCS-induziertem EF und den jeweiligen physiologischen 
Parametern auf der Ebene des Individuums. Zu diesem Zweck wurde für jeden 
Teilnehmer ein MRT-basiertes realistisches Kopfmodell entworfen, um 1) 
anatomische Faktoren zu berechnen und 2) die tDCS- und TMS-induzierten 
elektrischen Felder (EF) zu simulieren. Anschließend untersuchten wir auf 
regionaler Ebene, welche einzelnen anatomischen Faktoren die simulierten EFs 
erklären. Schließlich untersuchten wir, welche spezifischen anatomischen und / oder 
EF-Faktoren die neurophysiologischen Ergebnisse der tDCS vorhersagten. Die 
Ergebnisse zeigten, dass von den untersuchten anatomischen Faktoren höhere EF-
Werte mit einem geringeren Abstand zwischen Elektrode und Kortex (ECD) und 
einer geringeren Dicke des Liquor cerebrospinalis (CSF) verbunden waren. 
Zusätzlich waren CSF-Dicke und ECD negativ korreliert, während EFs positiv mit 
tDCS-induzierten physiologischen Veränderungen korreliert waren. 
Schließlich untersuchten wir im fünften Schritt die Übertragbarkeit der durch 
kathodale tDCS induzierten Neuroplastizität vom motorischen auf den präfrontalen 
Kortex. Die neurophysiologischen Wirkungen von tDCS auf den primärmotorischen 
Kortex wurden bereits in einer vielzahl von Studien untersucht. Viel weniger ist 
jedoch hinsichtlich physiologischer Effekte der tDCS auf nichtmotorische Bereiche 
wie den präfrontalen Kortex bekannt, der eine wichtige Basis für vielfältige 
kognitive Funktionen darstellt und dessen Dysfunktionen an neuropsychiatrischen 
Störungen beteiligt sind. Zu diesem Zweck wurde kathodale tDCS mit niedrigen, 
mittleren und hohen Dosierungen oder eine Placebo-Stimulation über dem 
primärmotorischen und dorsolateralen präfrontalen Kortex appliziert. Die 
Nacheffekte der tDCS wurden mittels TMS-Elektroenzephalographie (EEG) und 
TMS-MEP auf regionaler Ebene für die Ergebnisparameter TMS-evozierte 
Potentiale (TEP), TMS-evozierte Oszillationen und MEP-Amplitudenänderungen 
bewertet. Die Ergebnisse zeigten eine dosisabhängige nichtlineare 
neurophysiologische Wirkung der tDCS über dem motorischen Kortex, die nicht 
vollständig auf die Ergebnisse der tDCS über dem präfrontalen tDCS übertragbar 
war. Niedrige und hohe Dosierungen der tDCS über dem motorischen Kortex 
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reduzierten frühe positive TEP-Peaks und MEP-Amplituden, während eine 
Erhöhung der Amplituden dieser Potentiale für primärmotorische tDCS mit mittlerer 
Dosierung beobachtet wurde. Im Gegensatz dazu reduzierte präfrontale tDCS mit 
niedriger, mittlerer und hoher Dosierung die frühen positiven TEP-Amplituden 
gleichermaßen. Darüber hinaus wurden für beide kortikalen Bereiche keine tDCS-
induzierten neuromodulatorischen Effekte auf späte TEP-Amplituden (mit 
Ausnahme präfrontaler tDCS mit niedriger Dosierung) oder TMS-evozierte 
Oszillationen beobachtet. 
Zusammengenommen hat diese Arbeit unter Verwendung innovativer 
neurophysiologischer, Computer-gestützter und bildgebender Verfahren wichtige 
Aspekte in Bezug auf tDCS-induzierte neuroplastische Effekte untersucht, und 
liefert neue Erkenntnisse für zukünftige Anwendungen von tDCS in Grundlagen- 
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Neurological and neuropsychiatric disorders are leading the list of highly prevalent 
disorders, causing a major individual burden of disease (clinical symptoms, 
impairment of social functioning and quality of life, mortality) and high direct and 
indirect economic costs [1-4]. Despite major advances in treatments, including 
pharmaco-, physical or psychotherapy, these have significant limitations, such as 
nonspecific effects, insufficient tailoring to the individual, and moderate to severe 
adverse effects [5]. Stroke survivors are often left with significant and permanent 
residual motor impairments [6-8]. In Parkinsonian patients the clinical utility of 
medications tends to become limited over the years, often due to adverse effects such 
as dyskinesias [9].  Of all, 20 to 30% of patients with mood or anxiety disorders, and 
up to 50% of patients with schizophrenia do not sufficiently respond to standard 
therapeutic interventions, and 22–50% of major depressive disorder (MDD) patients 
suffer from recurrent episodes within 6 months after recovery [1-3, 10]. Thus, there 
is a need for novel effective treatment strategies in order to ameliorate the course of 
disease, to improve life quality and to elevate the level of individual functioning. 
Based on a large body of neurobiological evidence, neurological disorders are not 
simply the consequence of an initial insult, injury, inflammation or dysfunction of a 
specific compartment of the brain; they also reflect the attempt of the entire nervous 
system to adapt to the insult [5], and psychiatric disorders are conceptualized as 
system-level disorders of the brain. A number of lines of evidence point to a 
dysregulation or disruption of neuroplasticity, which refers to structural and 
functional alteration of the strength of synaptic connections in response to 
environmental or internal demands [11, 12], as a main contributor to the 
pathophysiology of neurological and neuropsychiatric disorders [5, 13, 14]. For 
example, stroke accompanied by motor deficits, in which the interhemispheric 
interaction between the primary motor cortices is impaired, is typically characterized 
by weakening of the excitability, and functionality of the motor cortex of the lesioned 
hemisphere and dysfunctional strengthening of the non-lesioned hemisphere [15]. 
For a second example, major depressive disorder has been shown to be accompanied 
by profound alterations of neural structure and function. An imbalance between the 
activity of the left and right dorsolateral prefrontal cortex (DLPFC), namely 
hypoactivity of the left, and hyperactivity of the right DLPFC, has been suggested 
as important factor in MDD [16]. The targeted modulation of plasticity might 




Considering these sources of evidence, research has focused on novel approaches 
that induce enduring changes of cortical excitability and neuroplasticity, using non-
invasive brain stimulation (NIBS) techniques [17, 18]. One of those tools, 
transcranial direct current stimulation (tDCS), has been shown to modulate cortical 
excitability in a polarity-dependent way, by delivering weak direct electrical currents 
through the scalp via two electrodes placed on the head. Anodal tDCS, which refers 
to surface inward current over the target area, enhances cortical excitability, while 
cathodal tDCS, which refers to outward current over the target area, results in 
excitability reduction with standard protocols at the circuit level [19, 20]. Respective 
after-effects can last for 1 h or longer.  
Promising research lines have provided sound preclinical and clinical data 
supporting the application of tDCS as treatment for neurological and psychiatric 
disorders in order to overrule treatment-resistance and chronicity [18, 21, 22].  For 
the improvement of motor functions, the mode of application of tDCS is based on 
diverse neuroimaging and electrophysiological data, indicating that a distributed 
neural network, including the primary motor, premotor and supplementary motor 
cortices, the cerebellum, thalamic nuclei and the striatum, are associated with motor 
skill learning, acquisition, early consolidation phases of motor learning, but also 
long-term skill consolidation [23-26]. Accordingly, anodal tDCS of the primary 
motor cortex improved motor learning as evaluated by the serial reaction time task, 
while cathodal stimulation decreased the rate of motor sequence learning [27, 28]. 
In addition, neuroimaging and electrophysiological data have further shown an 
involvement of the prefrontal cortex as neuronal basis for many high-level cognitive 
functions. Here, the DLPFC has been shown to be involved in positive mood, 
negative affect, and specific emotional processes [16, 29], as well as working 
memory, and other cognitive processes [30, 31]. In accordance, tDCS of the left 
DLPFC improved emotional face recognition, most markedly for emotionally 
positive faces [32], while tDCS over the right DLPFC enhanced fear memories, 
possibly by influencing the prefrontal cortex-amygdala circuit underlying fear 
memory [33], and anodal tDCS of the left DLPFC improved working memory [34], 
while no effects were observed for cathodal tDCS [35]. Improvement of the 
symptoms of neurological disorders by motor tDCS were reported in clinical studies 
for stroke [36, 37], and Parkinson’s disease [38], and improvement of symptoms of 
psychiatric disorders by prefrontal tDCS were reported in clinical studies for MDD 
[13, 39], schizophrenia [40], anxiety [41], and Alzheimer’s disease [42]. Despite 
these and other encouraging results of pilot studies, the overall efficacy of the 
technique is currently limited. 
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Multiple reasons might cause the limited efficacy of current tDCS protocols. First 
and probably most importantly, a relevant interindividual variability of tDCS 
outcomes has been reported [43, 44], which is one of the major challenges regarding 
its applicability for basic research, and clinical purposes. However, given the 
variation and complexity of the individual factors (including physical, physiological, 
and functional) proposed to affect outcomes, it is very difficult to simultaneously 
measure or examine the independent contribution of each factor to the response to 
interventions [45]. In addition, the direct measurement of electrical currents in the 
human brain is complex and not feasible as a routine procedure [46]. From the 
bioelectromagnetic point of view, tDCS alters brain functions by its effects on 
neurons, likely via shifting their operating point, which depends strongly on the 
induced electrical field (EF) strength and direction, but also stimulation duration [47, 
48]. At the microscopic level, computational, as well as in vivo and in vitro studies, 
have shown that the tDCS-induced EF alters neural membrane polarization, with a 
contribution of all neuronal compartments, i.e. dendrites, soma and axon, and that 
EF components oriented parallel to the axonal axes likely contribute to the 
directionality of stimulation effects [49-51]. These effects alter overall synaptic 
efficacy at the macroscopic level, if sufficient stimulation intensity/duration is 
applied [19, 20, 52, 53]. However, apart from this principle mechanism of action of 
tDCS, recent studies have shown a significant variability of effects between 
individuals, based on anatomical factors of the head, including head shape, tissues 
thickness, as well as cortical morphology [54, 55]. In addition, in vivo, as well as 
electrical impedance tomography studies have shown relevant differences of head 
tissue electrical conductivity between humans [56, 57]. With this in mind, recently 
developed computational simulation techniques, based on MR-derived detailed 
realistic head models, provide the opportunity to estimate the individual tDCS-
induced EF [47, 48, 58], and have highlighted a strong contribution of individual 
anatomical and/or electrical properties of the head for shaping the EF induced by 
tDCS. Accordingly, respective studies have shown a significant EF variability 
between humans, when one-size-fits-all tDCS protocols are used [59, 60]. Thus 
taken together, EF variability might be an important factor for heterogeneous 
outcomes of tDCS. Despite this, a few computational studies have so far investigated 
the association between individual physical factors, and neurophysiological effects 
of tDCS [59, 61-63]; it is however still unclear whether and to what extent individual 
physical factors explain the neurophysiological outcome of tDCS, at the level of the 
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individual. A systematic investigation of the impact of these parameters on the 
neuroplastic effects of tDCS is therefore required. 
Secondly, knowledge about protocols which induce optimal effects is scant; this 
might also partially explain limitations of clinical outcomes of tDCS, caused by 
application of suboptimal stimulation protocols, and also the large inhomogeneity 
between studies with respect to the used stimulation parameters. Indeed, earlier 
studies suggested a linear enhancement of tDCS efficacy by increasing the 
stimulation intensity and/or duration [19, 20]. Later works have however shown 
dosage-dependent non-linear effects of tDCS, both in human healthy [34, 64-70] and 
clinical populations [38, 40, 71], when stimulation duration and/or intensity exceed 
a certain limit, thus implying that enhancing stimulation dosage by simply increasing 
stimulation intensity, and duration, might have its limitations for efficacy 
improvement. This suggests the necessity of a systematic investigation of the 
neuroplastic effects induced by different tDCS dosages, aiming to decipher the 
neurophysiological effects of widely used tDCS protocols, but also to identify 
optimal tDCS parameter at the group level. 
Finally, neuromodulatory effects of tDCS over the primary motor cortex were 
largely taken as a template so far for the use of this intervention over non-motor 
regions, whereas a direct exploration of the physiological effects of tDCS of these 
brain areas is largely missing; this is of critical importance, as previous findings 
show only a gradual comparability of stimulation effects between the primary motor 
cortex and other cortical regions [72-74], due likely to anatomical, as well as 
receptor, and neurotransmitter differences between distinct cortical areas. A one-to-
one transferability of motor cortex tDCS effects to other cortical regions can 
therefore not be taken for granted, but direct physiological tests of tDCS effects over 
respective target areas are required.  
Collectively, these factors very likely explain the moderate and partially 
inhomogeneous effects of tDCS. To improve the efficacy of the technique, and 
understand its underlying mechanisms, these need to be addressed. 
As the ultimate goal, this dissertation is dedicated to:  
1. The improvement of the efficacy of cathodal tDCS to induce neuroplastic 
effects over the primary motor cortex by: 
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1.1. Titrating cathodal tDCS parameters for the human motor cortex model 
with different stimulation intensities, and durations, to explore the 
impact of these parameters on tDCS after-effects, and to identify a 
protocol that induces optimized effects. 
1.2. Exploring if repeated cathodal tDCS protocols with different intervals 
prolong the stimulation after-effects. 
1.3. Investigating if the dosage-dependent nonlinear effects of cathodal 
tDCS on cortical excitability, as potential sources of limited tDCS 
efficacy, can be explained by calcium channel dynamics as a main 
contributor. 
1.4. Testing another relevant aspect of limited efficacy of stimulation, i.e. 
interindividual variability. Here we aimed to explore whether and to 
which extent the neurophysiological outcome of tDCS, at the individual 
level can be explained by considering individual anatomical, and 
resulting electrical field factors. 
2. Explore if the cathodal tDCS results obtained over the primary motor cortex 
are transferable to non-motor areas.  
1.2. Structure and contribution of the Thesis 
The thesis is organized as follows:  Following this introductory chapter, Chapter 2 
addresses the first aim of the thesis. It consists of five parts including 1) an 
introduction part, in which the previous literature is reviewed, including knowledge 
gaps, and unsolved questions, and the aim of the study is developed , 2) the 
methodological part, in which we explain how we titrated cathodal tDCS parameters 
for the human motor cortex model with different stimulation intensities (1, 2 and 3 
mA), and durations (15, 20 and 30 min), 3) the results part, in which we show the 
detailed results of the experiment, 4) the discussion part, in which we explain the 
proposed mechanisms of the obtained results, limitations of this study and future 
directions, and 5) a concluding part.  
Chapter 3 also addresses the first aim of the thesis, by exploring the effects of 
repeated tDCS protocols with different intervals, aiming to extend the stimulation 
after-effects. It encompasses five sub-sections including 1) an introduction part, in 
which we review previous findings, address their limitations and respective unknown 
questions, and develop the aim of this study, 2) a methodological part, which 
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explains study procedures, in which we compared the impact of single interventions 
of conventional (1mA for 15min) and optimized (identified in the first study; 3mA 
for 20min) cathodal tDCS with the effects of repeated application of these 
interventions with intervals of 20 min and 24 h on motor cortex excitability, 3) a 
results part, in which we show the detailed results of the experiment, 4) a discussion 
part, in which we discuss the findings, explain the proposed mechanisms of the 
obtained results, and discuss limitations of this study and future directions, and 5) a 
concluding part. 
Chapter 4 addresses the underlying neurophysiological mechanisms of intensity-
dependent nonlinear effects of tDCS-altered corticospinal excitability, which can be 
considered as a source of tDCS limited efficacy. It consists of five sub-sections 
including 1) an introduction part, in which we review previous studies that highlight 
this nonlinearity, explain neurophysiological mechanisms with the main focus on the 
well-known contributor calcium channel dynamics, and develop the aim of this 
study, 2) a methodological part, in which we explain the experimental procedures, 
which include a pharmacological intervention with different dosages of calcium 
channel blocker flunarizine (low (2.5 mg), medium (5 mg) or high (10 mg)) before 
cathodal motor cortex tDCS with 3mA for 20min, 3) a results part, in which we 
present the detailed results of the experiment, 4) a discussion part, in which we 
discuss the findings in detail, including mechanistic explanations, and discuss 
limitations of this study and future directions, and 5) a concluding part. 
Chapter 5 also addresses the first aim of the study, by focussing on another source 
of limited efficacy of tDCS, i.e. interindividual variability, via considering the role 
of individual physical factors (anatomical, and resulting electrical field factors), 
which affect the tDCS-induced electrical field and therefore potentially its 
neuroplastic effects. It includes five sub-sections: 1) an introduction part, in which 
we review previous studies exploring different sources of tDCS interindividual 
variability, address their limitations and respective solved problems, and develop the 
aim of this study, 2) a methodological part, in which we explain, based on 
neurophysiological data obtained in former studies of our group, which explored 
tDCS-induced MEP (induced by TMS) and CBF (measured by ASL-fMRI) 
alterations[75], how we explored the association between individual anatomical 
factors and tDCS-induced EF, and the respective physiological outcomes at the level 
of the individual. In detail, for each individual, a structural MRI-based realistic head 
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model was developed, which was used to simulate, based on the finite element 
method (FEM), the tDCS- and TMS-induced EF. We then explored the contribution 
of individual anatomical factors to EF variabilities, and we investigated also whether 
and to which degree the individual anatomical factors and EFs predict the tDCS-
induced MEP and CBF changes, 3) a results section, in which we present the detailed 
results of the experiment, 4) a discussion part, in which we discuss the findings in 
detail, explain the proposed mechanisms of the obtained results, and discuss 
limitations of this study and future directions, and 5) a concluding part. 
Chapter 6 addresses the second aim of the study, by exploring the transferability of 
motor cathodal tDCS-induced neuroplasticity to the prefrontal cortex. In 
encompasses five sections including 1) an introduction, in which we review the 
previous work regarding the neurophysiological results obtained by tDCS on 
different brain regions, address their limitations and respective unsolved questions, 
and state the aim of this study, 2) a methodological part, in which we explain how 
we evaluated the transferability of the neuromodulatory effects of different dosages 
of motor cortex cathodal tDCS between the motor, and prefrontal cortex. In detail, 
in eight randomized sessions, four cathodal tDCS dosages, low, medium, and high, 
as well as sham stimulation, were applied over the primary motor and dorsolateral 
prefrontal cortex, and regional after-effects were evaluated via TMS-EEG, and 
TMS-MEP, for the outcome parameters TMS-evoked potentials (TEP), TMS-
evoked oscillations, and MEP amplitude alterations, 3) a results section, in which we 
present the detailed results of the experiment, 4) a discussion part, in which we 
discuss the findings, explain mechanistic aspects  of the outcome, and limitations of 
this study as well as future directions, and 5) a concluding part. 
Finally, in Chapter 7, we describe, and discuss the main outcomes of the conducted 











2 Study 1: Titrating the neuroplastic effects of cathodal tDCS 
over the primary motor cortex 
2.1. Introduction 
Alterations of the strength of neuronal connections caused by environmental 
demands, called neuroplasticity, are the foundation of various cognitive processes 
[11, 12]. In humans, non-invasive brain stimulation (NIBS) protocols provide an 
excellent avenue for modulating brain plasticity without disrupting the integrity of 
the skull [20, 76, 77]. These tools enable further investigation of brain functions, and 
have been probed to treat associated neurological and psychiatric disorders, in which 
aberrant cerebral excitability and plasticity play a role [26, 39, 78-81].  
One of those tools, tDCS, has been shown to modulate cortical excitability, in a 
polarity-dependent way, by delivering weak direct electrical currents through the 
scalp via two electrodes placed on the head. For the primary motor cortex, but also 
other areas, anodal tDCS, which refers to surface inward current over the target area, 
results in enhancement of cortical excitability, whereas cathodal tDCS, which refers 
to outward current over the target area, reduces it. Respective after effects can last 
for one hour or longer [19, 20].  Directionality of these effects however critically 
depend on stimulation intensity, duration, and also positioning of the return electrode 
[64, 82-84].  
Regional after-effects of tDCS can be explained by modification of synaptic strength 
by modulating the activity of N-methyl-D-aspartate (NMDA) receptors and calcium 
homeostasis [84, 85]. Downregulation of GABA activity might have a gating effect 
on respective plasticity of glutamatergic synapses [86]. tDCS has also been shown 
recently to alter cortico-cortical, as well as cortico-subcortical functional network 
connectivity, as explored by magnetic resonance imaging and 
electroencephalography  [87, 88].  
Studies in young healthy human populations show that increasing stimulation 
intensity and/or duration within certain limits enhances the efficacy of tDCS [19, 
20]. However, recent studies also showed non-linearities of tDCS-induced plasticity, 
when stimulation intensity or duration was increased beyond these limits [64, 66, 
82]. While 1mA-13 min anodal stimulation significantly increased cortical 
excitability, doubling stimulation duration led to excitability diminution [82]. 
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Another study showed a significant increase of MEP amplitudes by applying 
cathodal tDCS with 2mA for 20min, whereas cathodal tDCS with 1mA for 20min 
decreased cortico-spinal excitability [64]. These non-linearities of effects have been 
also shown by other studies [67, 89, 90]. A systematic investigation on the 
neuroplastic effects of different tDCS dosages is however so far missing. 
Because of its relatively low cost and simplicity, tDCS has been widely probed 
clinically to treat neurological and psychiatric disorders like stroke accompanied by 
motor deficits, in which the interhemispheric interaction between the primary motor 
cortices is impaired, typically by weakening of the excitability, and functionality of 
the motor cortex of the lesioned hemisphere and dysfunctional strengthening of the 
non-lesioned hemisphere [15]. tDCS (especially in combination with motor training) 
has shown its capability to improve clinical symptoms probably by rebalancing the 
activity of targeted areas [6, 91]. Despite these and other encouraging results 
reported in pilot studies, the overall efficacy of the technique is currently limited, 
probably caused by sub-optimal stimulation protocols   due to the fact that knowledge 
about protocols which induce optimal effects is limited [92]. 
In this study, we aimed to systematically explore the dose-dependent effect of 
cathodal tDCS over the primary motor cortex in healthy subjects, via titrating tDCS 
intensity from 1 to 3mA, and stimulation duration from 15 to 30 minutes. In 
accordance with previous studies, we hypothesized a nonlinear modulatory effect of 
tDCS on motor cortical plasticity, depending on stimulation intensity and duration. 
The results provide further insights on the dependency of tDCS-induced 
neuroplasticity from these stimulation parameters, and thereby deliver crucial 
information for future applications of cathodal tDCS. 
2.2. Materials and Methods 
2.2.1. Participants 
Sixteen healthy, non-smoking participants (7 males, mean age ± standard deviation 
(SD): 25.12 ± 4.61) were recruited. All participants were right-handed according to 
the Edinburgh handedness inventory [93] and had no history of neurological and 
psychiatric diseases, or fulfilled exclusion criteria for non-invasive electrical or 
magnetic brain stimulation [94, 95]. Central nervous system-acting medication or 
respective recreational substances served also as exclusion criteria. The study 
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conformed to the Declaration of Helsinki and was approved by the Ethics Committee 
of the Leibniz Research Centre for Working Environment and Human Factors. All 
participants gave informed written consent before starting the study, and were 
financially compensated for participating. 
2.2.2. Transcranial direct current stimulation of the motor cortex 
tDCS was applied with a constant-current battery powered stimulator (neuroConn, 
Ilmenau, Germany), through a pair of saline-soaked surface sponge electrodes (35 
cm2) placed on the scalp. One electrode was fixed over the motor cortex 
representational area of the right abductor digiti minimi muscle (ADM) as identified 
by TMS, and the other was placed contralaterally above supraorbital area [19, 96]. 
Prior to stimulation, a topical anesthetic cream (EMLA®, 2.5% lidocaine + 2.5% 
prilocaine) was applied to the stimulation site, in order to sufficiently blind the 
participants [97]. All participants received cathodal tDCS at an intensity of 1.0, 2.0 
or 3.0 mA for 15, 20 or 30 min with 10 sec ramp-up and down at the start and end 
of stimulation. For sham stimulation, 1.0 mA stimulation was delivered for 15 
seconds, with a 10 sec ramp up and down followed by 15min with 0.0 mA 
stimulation. Taking into account all intensity-duration combinations, including sham 
stimulation, this resulted in 10 sessions per participant. 
2.2.3. Motor cortical excitability assessment  
Single pulse TMS at 0.25 Hz ± 10% (random) delivered by a PowerMag magnetic 
stimulator (Mag&More, Munich, Germany) with a figure-of-eight magnetic coil 
(diameter of one winding, 70mm; peak magnetic field, 2T) which was held 
tangentially to the skull, with the handle pointing backwards and laterally at 45◦ from 
the midline was applied to the left primary motor cortex. Surface MEPs were 
recorded from the right ADM with gold cup electrodes in a belly-tendon montage. 
The signals were amplified, and filtered (1000; 3Hz- 3KHz) using D440-2 
(Digitimer, Welwyn Garden City, UK) and were digitized (sampling rate, 5kHz) 
with a micro 1401 AD converter (Cambridge Electronic Design, Cambridge, UK), 
controlled by Signal Software (Cambridge Electronic Design, v. 2.13). A waterproof 






Figure 2.1 Course of the study. Single-pulse TMS was conducted at a frequency of 0.25 Hz to 
the left motor cortex. The representational area of the right ADM, in which the largest MEPs were 
produced, was identified first. The intensity of the TMS pulses was adjusted to elicit MEPs with a 
peak-to-peak amplitude of on average 1 mV (SI1mV). Finally, baseline cortical excitability was 
determined by measuring 25 MEPs. Afterwards, cathodal real tDCS was applied in one of three 
different intensities (1, 2 and 3mA) and durations (15, 20 and 30mins), or sham tDCS was applied, 
in random order in 16 young healthy subjects. The after-effects were monitored with TMS-induced 
MEPs (each time point with 25 MEPs) every 5 min up to 30 min and the following time points of 
60 min, 90 min, 120 min, same evening (SE, ~ 7 hours after tDCS), next morning (NM, ~ 24 hours 
after tDCS), next noon (NN, ~ 4-5 hours after next morning time point) and next evening (NE, ~ 
4-5 hours after next noon).  
2.2.4.  Experimental procedures 
At the beginning of each session, participants were seated in a comfortable chair with 
head and arm rests. Then single-pulse TMS was conducted at a frequency of 0.25 Hz 
to the left motor cortex for identification of the representational area of the right 
ADM, in which the largest MEPs were produced. The intensity of the TMS pulses 
was adjusted to elicit MEPs with a peak-to-peak amplitude of on average 1 mV 
(SI1mV). Finally, baseline cortical excitability was determined by measuring 25 
MEPs. Afterwards, tDCS electrodes were mounted onto the head and cathodal tDCS 
was applied. tDCS with different intensities and durations (as outlined above), which 
resulted in 10 experimental sessions, was applied in randomized order with a 
minimum of seven days between each session to avoid carry-over effects [85]. After 
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finishing the intervention, tDCS electrodes were removed and corticospinal 
excitability was assessed by TMS measurements (with baseline TMS intensity, 25 
stimuli per time point) every 5 min for up to 30 min after tDCS, and 60 min, 90 min, 
120 min, same evening (~ 7 hours after tDCS), next morning (~ 24 hours after tDCS), 
next noon (~ 4-5 hours after the next morning measure) and next evening (~ 4-5 
hours after the next noon measure), Figure 2.1.  
For simplicity, in the following we indicate each condition, except for sham 
stimulation, according to the applied stimulation intensity and duration. For 
example, the condition in which tDCS was applied with 1mA for 15 minutes will be 
labelled as ‘1mA-15min’, and tDCS application with 2mA for 30-minutes duration 
is referred to as ‘2mA-30min’. 
2.2.5.  Discriminability and qualitative assessment of tDCS protocols 
In each session, subjects filled in a questionnaire which contained: 1. Guessed 
intensity of applied direct current (0, 1, 2 and 3mA), 2. Rating scales for the presence 
and severity of visual phenomena, itching, tingling and pain during stimulation, and 
3. Rating scales for the presence and severity of skin redness, headache, fatigue, 
concentration difficulties, nervousness and sleep problems within 24 hours after 
stimulation. The side-effects were rated on a numerical scale from zero to five, zero 
representing no and five extremely strong sensations.  
2.2.6. Calculations and statistics 
2.2.6.1. The effect of tDCS intensity and duration 
To disentangle the effects of tDCS intensity and duration, first, the individual means 
of each time point’s MEP amplitudes were calculated and then normalized to 
baseline MEPs (quotient of the averaged MEP amplitudes of each time point vs 
baseline, MEPs which were contaminated by muscle activity, tiredness, or arousal 
reactions were excluded from the analysis).  A repeated measures ANOVA was then 
calculated with normalized MEPs as dependent variable, and ‘intensity’ (3 levels), 
‘duration’ (3 levels), and ‘time point’ (15 levels) as within-subject factors.  
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2.2.6.2. Overall tDCS effect vs. sham 
To determine if the respective active stimulation conditions effects differ from those 
of sham stimulation, a repeated measures ANOVA was calculated with normalized 
MEPs as dependent variable, and ‘condition’ (10 levels) and ‘time point’ (15 levels) 
as within-subject factors.  
2.2.6.3. Early-, late-, and very-late- time point of tDCS effects 
To compensate for the variability between time-points and better define the time 
course of plasticity induction by tDCS, the normalized MEP amplitudes of all 
measured time points were pooled into three time points:  the MEPs grand average 
of first 30 min after stimulation (early-time point after-effects), 60 min-120 min 
(late-time point after-effects) and same-day evening to next-day evening (very-late-
time point after-effects). For these parameters, repeated measures ANOVAs were 
calculated with normalized MEPs as dependent variable, and 1) with ‘intensity’ (3 
levels), ‘duration’ (3 levels) and ‘time point’ (4 levels) as within-subject factors, and 
2) with ‘condition’ (10 levels) and ‘time point’ (4 levels) as within-subject factors.  
2.2.6.4. The effects of baseline measures ‘SI1mV’ and ‘baseline MEP’ on 
tDCS after-effects 
To test if baseline measures differed between sessions, two separated one-way 
repeated measures ANOVA were performed with ‘session’ as within-subject factor, 
and ‘SI1mV’ or ‘baseline MEP’ as dependent variables. 
2.2.6.5. Qualitative assessment of tDCS protocols 
To identify if participants correctly guessed the tDCS intensities, chi-square tests 
were conducted for each tDCS intensity. The presence of side-effects during and 
after tDCS were analyzed by a repeated measure ANOVA with ‘condition’ (10 
levels) as within-subject factor and rating scores (0-5) as dependent variable. In case 
of significant effects, follow-up exploratory post-hoc paired t-tests were conducted 
to examine if an active session resulted in a significant difference sensation relative 
to sham, and Pearson’s correlation coefficients were calculated to test a dependency 




Mauchly’s test of sphericity was conducted, and the Greenhouse-Geisser correction 
was applied when necessary, for all ANOVAs. The critical level of significance was 
set to p <= 0.05 for all statistics. Post hoc t-tests were exploratory, and conditional 
on significant results of the ANOVAs, and therefore were not corrected for multiple 
comparisons. Statistical analysis was performed with SPSS (IBM Corp. Version 
24.0). 
2.3. Results 
The MEP data for one of the subjects’ last session (1 mA – 30 min) was not available 
due to the subject’s refusal to attend. Also, data for the one time point of one another 
participant following right after tDCS (2 mA – 20 min) was not recorded due to a 
software technical issue. The following results are based on the analysis of all 
subject’s available data. The ratings of the qualitative assessment of tDCS protocols 
of one participant were also excluded because he stated that he rated completely at 
random, without reading the items. 
2.3.1. The effect of tDCS intensity and duration 
The 3-factorial ANOVA (‘intensity’ - 3 levels, ‘duration’ - 3 levels, and ‘time point’ 
- 15 levels) conducted to discern between intensity and duration effects of 
stimulation resulted in a significant main effect of intensity (df = 2, F = 8.953, p = 
0.001), but no main effects of duration, time point or the respective interactions, 
Figure 2.2; Table 2.1.A. Post hoc tests revealed a significant difference between 
1mA and 2 mA, 2 mA and 3 mA in which 1 mA and 3 mA resulted in LTD-like 
plasticity induction, while 2 mA intensity induced LTP-like plasticity. 
 
Table 2.1. Results of the ANOVAs conducted for tDCS-induced MEP alterations. A) The 3-
factorial repeated-measures ANOVA revealed a significant main effect of stimulation intensity, 
but no significant main effects of time, and duration, or respective interactions. B) The 2-factorial 
repeated-measures ANOVA conducted for all separately measured time points revealed a 
significant effect of stimulation condition, but no significant main effect of the factor time, or the 
respective interaction. C.1) The 3-factorial ANOVA for the grand averaged MEPs grouped into 
three time points of early, late and very late effects revealed a significant main effect of intensity 
and a significant interaction between intensity and time, but no significant main effect of time. C2) 
The 2-factorial repeated-measures ANOVA for the grand averaged MEPs grouped into three time 
point of early, late and very late effects revealed a significant effect of stimulation condition and 
its interaction with time, but no significant main effect of the factor time. Mauchly’s test of 
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sphericity was conducted, and the Greenhouse-Geisser correction was applied when necessary, for 
all ANOVAs. Asterisks indicate significant results. d.f. = degrees of freedom. 
 




Effects of intensity 
and duration of tDCS 
on MEP amplitudes 
Intensity 2 8.953 0.001* 
Duration 2 0.287 0.753 
Time 4.774 0.844 0.519 
Intensity × Duration 4 1.749 0.153 
Intensity × Time 7.623 1.865 0.077 
Duration × Time 8.122 0.919 0.505 
Intensity× Duration × Time 9.050 1.098 0.369 
B 
Effects of different 
tDCS conditions on 
MEP amplitudes 
Condition 4.554 3.714 0.007* 
Time 4.666 0.749 0.582 




Early, late and very 
late effects of different 
intensity and duration 
of tDCS 
on MEP amplitudes 
(Pooled MEPs) 
Intensity 2 8.617 0.001* 
Duration 2 0.328 0.723 
Time 2.219 1.768 0.185 
Intensity × Duration 4 1.839 0.134 
Intensity × Time 6 4.405 0.001* 
Duration × Time 6 0.728 0.628 
Intensity× Duration × Time 4.811 1.935 0.103 
 
C.2 
Early, late and very 
late effects of tDCS on 
MEP amplitudes 
(Pooled MEPs) 
Condition 4.605 3.561 0.008* 
Time 2.235 1.432 0.254 





Figure 2.2 Post-tDCS excitability alterations including 10 different levels of stimulation 
intensity/duration. (A) Based on stimulation intensities: sham, 1 mA, 2 mA and 3 mA with (A-
1) fixed tDCS duration of 15 min; 20 min (A-2) and   30 min (A-3). (B) Based on stimulation 
duration: 15 min, 20 min and 30 min with (B-1) fixed tDCS intensity of 1 mA; 2mA (B-2) and 3 
mA (B-3). 1 mA-15 min, 1 mA-30 min and 3 mA-20 min resulted in a significant excitability 
diminution, and 2 mA-20 min in a significant excitability enhancement. Sham stimulation did not 
induce any significant change of cortical excitability. Error bars represent standard error of mean. 
Filled symbols indicate a significant difference of cortical excitability against the respective 
baseline values. Floating symbols refer to each sub-figure, and indicate a significant difference 
between the respective active intensity/duration combination and sham stimulation condition. SE: 
same evening, NM: next morning, NN: next noon, NE: next evening. 
2.3.2. Overall tDCS effect vs. sham 
The 2-factorial ANOVA (‘condition’ - 10 levels, and ‘time point’ - 15 levels), which 
was conducted to compare if active stimulation condition effects differ from those 
of sham stimulation, revealed a significant main effect of tDCS condition (df = 
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4.554, F = 3.714, p = 0.007), but no main effect of time (df = 4.666, F = 0.749, p = 
0.582), or condition × time interaction (df = 10.509, F = 1.180, p = 0.245). Post hoc 
tests comparing sham tDCS with the respective real stimulation protocols revealed: 
The 1 mA-15 min (for about 30 min after stimulation) and 1 mA-30 min (for about 
one hour with a 20 min delay after stimulation) conditions induced a cortical 
excitability diminution, while 2 mA-20 min (for two hours after stimulation) resulted 
in a significant cortical excitability enhancement. Higher stimulation intensity (3 
mA-20 min) induced a significant excitability diminution lasting for about one and 
half hour after stimulation. The remaining protocols resulted in no significant effects 
on motor cortex excitability, Figure 2.2; Table 2.1.B, for results of individual 
participants, please refer to Figure 2.4. 
2.3.3. Early-, late-, and very-late-time points of tDCS effects 
The 3-factorial ANOVA (‘intensity’ - 3 levels, ‘duration’ -3 levels- and ‘time point’ 
- 4 levels) which was conducted to explore the time course of plasticity induction of 
each tDCS intensity and/or duration, showed a significant main effect of intensity 
(df = 2, F = 8.617, p = 0.001) and a significant interaction between intensity and time 
point (df = 6, F = 4.405, p = 0.001), but no significant main effect of duration, time 
point, or the remaining interactions, Table 2.1.C1). The respective post hoc tests 
revealed significant differences between 1mA and 2 mA, as well as 2 mA and 3 mA; 
whereas 1, and 3 mA stimulation intensities reduced MEP amplitudes, 2 mA 
stimulation had a MEP-enhancing effect, Figure 2.3. 
The 2-factorial ANOVA (‘condition’ - 10 levels, and ‘time point’ - 4 levels) which 
was conducted to better define the time course of plasticity induction of each tDCS 
condition showed a significant main effect of condition (df = 4.605, F = 3.561, p = 
0.008) and a significant interaction between condition and time point (df = 7.230, F 
= 2.469, p = 0.021), but no significant main effect of time point. Post-hoc 
comparisons between the active protocols and sham for the first 30 min after 
stimulation (early effects) showed a significant excitability diminution for 1 mA-15 
min, 1 mA-20 min, 1 mA-30 min, 3 mA-20 min and a significant excitability 
enhancement for 2 mA-20 min, while 60-120 min after stimulation (late effects) only 
1 mA-30 min, 3 mA-20 min and 2 mA-20 min resulted in a significant cortical 
excitability diminution or enhancement, respectively. No significant effects were 
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found for very late effects, including same day evening to next day evening 
measures, Figure 2.3; Table 2.1.C2. 
 
Figure 2.3 Pooled MEP Amplitudes early, late and very late tDCS post stimulation effects. 
grand-averaged MEPs were pooled into three time points of early (0-30 min), late (60-120 min) 
and very late (same day evening- next day evening) excitability changes. Error bars represent 
standard error of means. A) Results for the early time point, for intensities (A-1, 2 and 3) and 
duration (B-1, 2 and 3). Filled symbols indicate a significant difference of cortical excitability 
versus the respective baseline values. Floating symbols refer to each sub-figure, and indicate a 
significant difference between the respective active condition and the sham stimulation condition. 
SE: same evening, NE: next evening. 
 
2.3.4.  No difference of SI1mV and baseline MEPs between conditions  
Baseline MEP and SI1mV TMS intensity adjusted to elicit a ∼1 mV peak-to-peak 
amplitude of MEPs (SI1mV) are listed in Table 2.2. The ANOVAs showed no 
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significant differences of baseline MEP and SI1mV across sessions (Baseline MEP: 
df = 9, F = 0.767, p = 0.647; SI1mV: df = 4.095, F = 0.671, p = 0.618). 
Table 2.2 Baseline measurements and TMS stimulation intensities. Data are presented as mean 
± SD; SI1mV refers to the maximal stimulator output (%MSO) which was required for generating 




SI1mv (%) Baseline MEP (mV) 
Sham 57.15 ± 11.59 1.06 ± 0.16 
1mA-15min 56.43 ± 11.70 1.03 ± 0.13 
1mA-20min 58.18 ± 13.05 1.03 ± 0.11 
1mA-30min 55.93 ± 11.50 0.99 ± 0.09 
2mA-15min 55.93 ± 11.93 1.05 ± 0.11 
2mA-20min 56.00 ± 10.56 1.08 ± 0.13 
2mA-30min 57.53 ± 12.84 1.06 ± 0.14 
3mA-15min 57.21 ± 11.87 1.05 ± 0.09 
3mA-20min 55.76 ± 11.71 1.03 ± 0.09 
3mA-30min 56.25 ± 11.44 1.01 ± 0.10 
2.3.5.  Qualitative assessment of tDCS protocols 
Chi-square tests for each tDCS intensity including sham results indicated a 
significant effect for 3mA (χ2 = 10.200, p = 0.017) with no significant effects for 
sham (χ2= 1.600, P = 0.449), 1mA (χ2 = 5.578, P= 0.134) and 2mA (χ2 = 6.111, p 
= 0.106). Table 2.3 shows the results of guessed intensities vs. actual intensities.  
 
Table 2.3 Participants guess of the actual intensity. In each session, participants were asked to 
guess the intensity of the actually applied direct current (0, 1, 2 and 3mA). The table contrasts 
actually applied intensity (rows) with perceived intensity (columns). Differences in the sum of the 
ratings of each intensity are present, because only one sham stimulation condition was included in 
the experiments, but three sessions per intensity. The ratings of one participant were excluded 
because he stated that he rated completely at random, without reading the items. 
 
Intensity guessed by participants 




Sham 5 7 3 0 
1 mA 12 12 16 5 
2 mA 9 18 11 7 




Participant ratings for the presence and intensity of side-effects during and within 24 
hours after stimulation are listed in Table 2.4.  
Table 2.4 Presence and Intensity of Side Effects Participant ratings of the presence and 
intensity of side-effects. A) Visual phenomena, itching, tingling and pain during stimulation, and 
B) skin redness, headache, fatigue, concentration difficulties, nervousness and sleep problems 
within 24 hours after stimulation. The presence and intensity of the side-effects were rated in a 
numerical scale from zero to five, zero representing no and five extremely strong sensations. Data 
are presented as mean ± SD. The ratings of one participant were excluded because he stated that 








































































































































































































































The ANOVAs (‘condition’ - 10 levels) conducted for the side-effect questionnaires 
showed a significant effect for pain during stimulation, but no significant effects for 
visual phenomena, itching, tingling, redness, headache, fatigue, concentration, 
nervousness and sleep problems, Table 2.5. The numerical results indicate that the 
side-effects were all relatively minor over conditions.  
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Table 2.5 Statistical Results for Presence and Intensity of Side Effects. The presence and 
intensity of side-effects were analyzed by one-way repeated-measures ANOVAs. A significant 
effect of pain, but no significant effects of other side-effects was revealed. Asterisks indicate 
significant effects (where p<0.05). d.f.= degree of freedom. The ratings of one participant were 
excluded because he stated that he rated completely at random, without reading the items. 




Visual Phenomenon 3.337 1.465 0.234 
Itching 4.590 2.375 0.052 
Tingling 4.341 1.155 0.341 
Pain 2.988 2.919 0.045* 
 
24 hours after 
stimulation 
Redness 3.475 0.873 0.475 
Headache 2.820 1.287 0.292 
Fatigue 3.472 0.504 0.708 
Concentration 2.287 0.824 0.462 
Nervousness 1.993 1.915 0.166 
Sleep Problem 1.994 1.187 0.320 
 
Post hoc t-test comparisons between active stimulation sessions and sham for the 
pain ratings revealed significant differences between sham and 2mA-20min as well 
as 3mA-30min. However, the Pearson’s correlation coefficients, which were 
calculated to explore a possible dependency of MEP alterations from pain 
perception, revealed no significant association between tDCS early after-effects and 
pain sensations for the 2mA-20min (Pearson’s r = 0.268, p = 0.315), as well as 3mA-
30min (Pearson’s r = 0.150, p = 0.580).  
2.4. Discussion  
In this study, we systematically titrated the dose-dependent effect of cathodal tDCS 
for three different stimulation intensities (1, 2 and 3mA) and durations (15, 20 and 
30mins) on motor cortex excitability and observed non-linear after-effects. Both, 
LTD and LTP-like plasticity were induced by cathodal tDCS, while magnitude, 
duration, and direction of the effects were determined by specific stimulation 
intensities.  
The 1 mA low intensity protocols resulted in inhibitory effects. 1 mA cathodal tDCS 
with a duration of 15 min, 20 min and 30 min resulted in a significant reduction of 
motor cortical excitability for 30 min and about one hour after stimulation 
respectively. Different patterns of after-effects were observed by increasing tDCS 
intensity to 2 mA. For tDCS durations of 15 min and 30 min, the results indicate no 
significant effects on MEP amplitudes, while 20 min of 2mA cathodal tDCS shifted 
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cortical excitability from LTD- to LTP-like plasticity for about two hours after 
intervention. Interestingly, in contrast to the facilitatory effect of 2 mA – 20 min, we 
found again an excitability-diminishing effect of stronger stimulation. 3 mA – 20 
min cathodal tDCS again reduced MEP amplitudes for about one and half an hour 
after stimulation, whereas no significant excitability alterations were observed for 3 
mA – 15 min and 3 mA – 30 min. 
These results are in accordance with those described in previous studies, in which 
excitability-diminishing effects of cathodal tDCS were reported for low intensity 
stimulation (1 mA) with durations of 9 min [96], 15 min [98], 18 min [66] and 20 
min [64], and excitability-enhancing effects of 2 mA- 20 min cathodal tDCS [64] 
with no significant effects for 2 mA- 15 min [98].  No neurophysiological data were 
so far available for 3 mA stimulation. 
2.4.1. Proposed mechanism 
A linear neuroplasticity enhancement/reduction by anodal/cathodal stimulation has 
been reported when tDCS of low intensity/duration was applied over the left motor 
cortex with a return electrode over the contralateral supraorbital area [20, 96]. Recent 
studies however revealed nonlinearities of the physiological response for stimulation 
protocols with stronger intensity and longer duration [64, 82, 98]. Regarding 
mechanisms of these effects, it has been suggested that bi-directional excitability 
alterations induced by weak anodal/cathodal tDCS can be explained by 
glutamatergic plasticity involving NMDA receptors [99, 100]. Here, different levels 
of activation of NMDA receptors result in different levels of calcium influx, which 
might result in different effects on synaptic plasticity. It has been shown primarily 
in animal models so far that low postsynaptic calcium enhancement induces LTD, 
high calcium increases result in LTP, and calcium overflow again induces LTD/no 
plasticity; between these plasticity-inducing calcium concentrations  so –called no 
man’s lands do exist, which do not result in plasticity [101, 102]; thus one could 
speculate that 1 mA tDCS resulted in an LTD-inducing low calcium concentration, 
2 mA in a calcium concentration sufficient for the induction of LTP-like plasticity, 
and 3 mA in LTD-like plasticity due to calcium overflow. The discernable effects of 
stimulation duration within a specific current intensity condition might be due to 
respective intermediate calcium concentrations, which represent transition zones/no 
man´s lands. At present, these explanations are speculative, and should be explored 
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in future studies directly (e.g. by pharmacological interventions which alter calcium 
neuronal calcium influx). These are supported however by a couple of other tDCS 
studies, which showed that cathodal tDCS-induced LTD-like plasticity is NMDA 
receptor-dependent , that calcium dynamics play a role for tDCS-induced plasticity 
[103], and that non-linearities of tDCS effects can be antagonized by NMDA and 
calcium channel blockers [82, 104]. 
Alternative explanations cannot be ruled out at present. Increasing tDCS intensity 
should strengthen the electric field in deeper cortical layers, which are less affected 
under the weaker electric field with lower stimulation intensities. This enhanced field 
strength in deeper regions might then generate plasticity in neurons, which are not 
relevantly affected by weaker stimulation intensities. Indeed, animal studies using 
direct cortical stimulation revealed that anodal stimulation deactivated while 
cathodal stimulation activated neurons in deep cortical layers [105]. In addition, 
different thresholds for modulation have been reported for different neuronal 
subgroups, e.g. a physiological impact of DC stimulation on pyramidal neurons 
required higher total charges than that required for an effect on nonpyramidal 
neurons [105]. This stresses the important role of stimulation intensity and dosage 
on tDCS-induced neuromodulatory after-effects, and is a critical issue for future 
human studies. It might also be speculated that especially stronger protocols may 
affect not only the cortical regions of the target area, but enhance also recruitment of 
neighbored non-target brain regions to a larger extent, as suggested by modeling and 
fMRI studies, which might indirectly affect and strengthen, or change the direction 
of plasticity in the target regions. Thus, while low intensity (1 mA) cathodal tDCS 
results in a reduction of MEP amplitudes, doubling and/or tripling the intensity may 
shift resulting plasticity to an opposite direction by involving additional cortical 
regions and/ or layers. A slight drawback of this interpretation is the fact that for 
these stimulation intensities, no respective non-linearities of the respective plasticity 
direction were seen for anodal tDCS in previous studies [64, 82, 98]. This would 
however be expected if respective additional neuronal populations would be 
recruited by stronger stimulation, which because of the dependency of tDCS effects 
from induced electrical field to neuronal orientation should then result in antagonistic 
effects of anodal as compared to cathodal tDCS. 
The assessment of tolerability and side-effects during stimulation and 24 hours after 
stimulation indicates that participants tolerated all conditions well and side-effects 
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were minor. These were moreover largely equivalent between conditions, except for 
pain perception in higher intensities. In principle, this could have affected our 
experimental results. This seems however not have been the case, as shown by 
missing associations between pain ratings and MEP results, as explored by the 
respective correlations. These results are in accordance with previous studies that 
characterize tDCS as a well-tolerated technique [95, 106]. For blinding purposes, we 
used local anesthetics cream which relevantly reduces tDCS-induced sensory 
perceptions as shown in previous studies [98, 107]. Our results showed reasonable 
blinding quality, as participants could not correctly guess the intensities of the 
respective stimulation conditions for sham, 1 mA, and 2 mA stimulation. Only for 3 
mA stimulation intensity, “guessing” was not at chance level. This shows that the 
topical anesthetics cream we used works well with stimulation intensities between 1 
and 2 mA, but might have limited efficacy with stronger stimulation. However, the 
fact that the MEP results differed also within the 3mA condition between stimulation 
durations argues – together with the missing effects of pain ratings on MEP 
amplitudes - against a relevant impact of blinding quality under 3 mA tDCS intensity 
on the results of this study. 
2.4.2.  Limitations and future directions 
While our study mainly focuses on the neurophysiological effects of tDCS at the 
group level, inter-individual variability in healthy adults has also been reported for 
tDCS effects, similar to other neuromodulatory brain stimulation interventions [43, 
108], and can be seen also in our data (Figure 2.4). Potential contributing factors are 
anatomical and biophysical differences of the brain, genetics, sex, age, and brain 
state [109]. Our results did not show significant effects of age and gender on the 
neurophysiological outcome of tDCS. Anatomical and tissue differences, which 
affect tDCS outcome by their impact on current distribution, and could be explored 
by computational modelling, were not explored in this study [110-112]. For 
personalization of the intervention, with the aim to achieve optimal effects at the 
individual level, the next step would now be to use these models, and knowledge 
about other factors affecting the physiological impact of stimulation, and explore 





Figure 2.4. Intra-individual motor cortical excitability changes after cathodal transcranial 
direct current stimulation (tDCS) over the primary motor cortex. Individual excitability 
alterations after sham (A), 1mA-15min (B), 1mA-20min (C), 1mA-30min (D), 2mA-15min (E), 
2mA-20min (F), 2mA-30min (G), 3mA-15min (H), 3mA-20min (I) and 3mA-30min (J) of tDCS 
are depicted. Each color line of each graph represents MEP values of one participant. MEP 
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amplitudes are normalized to baseline values individually. Each colored line in each graph 
represents MEP values of one participant (S1–S16). 
The targeted population in this study were healthy young humans. It should not be 
taken for granted that the results obtained from these participants are one-to-one 
transferable to different age populations, as well as patient groups. Indeed, it was 
shown that identical tDCS protocols can have different effects in healthy young 
adults, children/adolescents, and aged subjects [113-115]. Similarly, differences 
between healthy participants and neuropsychiatric patients should also be considered 
with regard to the extension of current results to clinical settings. 
Although investigating inter-individual variability was not the main scope of this 
study, it is possible that the covariates analysed may have been masked due to a 
relatively low sample size. For future studies which aim to investigate inter-
individual variability, larger sample sizes would be beneficial for being able to detect 
subtle differences. 
2.5. Conclusion 
This study shows a nonlinear modulatory effect of cathodal tDCS on motor cortical 
plasticity, depending on stimulation parameters. We titrated cathodal tDCS intensity 
from 1 to 3mA, and stimulation duration from 15 to 30 minutes.  As 1 mA and 3 mA 
stimulation induced a reduction of MEP amplitudes, but 2 mA resulted in excitability 
enhancement at the group level, this nonlinearity should be taken into account 
particularly when an inhibitory effect is aimed for by cathodal tDCS. These nonlinear 
effects might be due to NMDA receptor-dependent calcium dynamics and/or 
stimulation intensity-dependent effects of tDCS on cortical layers. The results of the 
present study give hints for optimally suited tDCS protocols to reduce excitability of 
the primary motor cortex. They might also help to improve the efficacy of tDCS as 
therapeutic tool for the treatment of neurological and psychiatric disorders. It should 
however be noted that a one-to-one transferability of these effects to other cortical 
areas, and patient populations should not be taken for granted due to state-
dependency of tES effects, anatomical differences, and differences of 











3 Study 2: Probing the relevance of repeated cathodal tDCS over 
the primary motor cortex for prolongation of after-effects 
 
3.1. Introduction 
Application of a weak direct current via electrodes placed over the scalp (transcranial 
direct current stimulation, tDCS) can bidirectionally induce neuroplasticity in the 
targeted area. The direction, magnitude and duration of respective effects depend on 
stimulation parameters, such as polarity and intensity/duration. Anodal tDCS, which 
refers to surface inward current over the target area, enhances cortical excitability, 
while cathodal tDCS, which refers to outward current over the target area, results in 
excitability reduction with standard protocols at the macroscopic level [20, 96, 116]. 
These effects alter symptoms of neurological and psychiatric disorders accompanied 
by pathological alterations of cortical excitability, such as in stroke [117], 
Parkinson´s disease [118], depression [119], and schizophrenia [40].  
However, the overall efficacy of the technique is currently limited, most probably 
caused by sub-optimal stimulation protocols [120]. Earlier studies indicated that 1 
mA tDCS for 4 seconds over the primary motor cortex alters cortical excitability 
during stimulation [116]. Increasing the duration of stimulation to some minutes 
induces long term potentiation (LTP)- and long term depression (LTD)-like 
neuroplastic after-effects, respectively [20, 96]. These results show that stronger 
and/or longer stimulation extends the neuromodulatory after-effects of tDCS within 
specific windows of stimulation intensity and duration. However, recent studies 
revealed a non-linear dosage dependency of tDCS-induced neuroplasticity, when 
stimulation duration and intensity exceed the limits of these “classic” protocols. 
While 1mA  cathodal tDCS for 15min significantly reduced cortical excitability, no 
significant effects were observed with 2mA for the same duration [98], and 
prolongation of 2 mA cathodal tDCS to 20 min resulted in an excitability 
enhancement [64, 65]. A respective dosage-dependent non-linearity of tDCS after-
effects has also been revealed by other studies [67, 89, 90], which can partially be 
explained by the dependency of the direction of plasticity on the amount of neuronal 
calcium influx [101, 121]. Thus, for enhancing the efficacy of tDCS, increasing 
stimulation intensity, and duration, might have its limitations. 
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Animal studies revealed the possibility of extending neurophysiological after-effects 
of plasticity-inducing stimulation from early- to late-phase plasticity by means of 
repeated stimulation protocols with short time intervals [122-124]  In accordance, 
studies in humans have also shown that single intervention cathodal tDCS-induced 
excitability-reducing after-effects can be extended by repeated tDCS protocols with 
certain inter-stimulation intervals. In a former study, the excitability-diminishing 
after-effects of single intervention of cathodal tDCS with 1mA for 9min over the 
primary motor cortex, which induces after-effects of about 1 h duration, were 
enhanced by repeating the same protocol with short intervals (3, or 20 min), but 
abolished when the interval was extended to 3, or 24 hours [66]. In another study 
however, the excitability-diminishing after-effects of a single intervention of 1mA 
cathodal tDCS for 5min, which induces short-term depression-like effects, were 
reversed or unchanged by repeated tDCS protocols with 3 min and 30 min intervals, 
respectively [125]. These results suggest that an enhanced efficacy of cathodal tDCS 
to reduce cortical excitability can be induced by repeated stimulation within specific 
intervals, but that beyond the interval between interventions, also the respective 
stimulation protocol itself is of critical relevance. It is however also important to 
mention that in difference to respective results in animal models, so far repeated 
stimulation in humans has gradually enhanced the efficacy of respective cathodal 
stimulation protocols, but not resulted in late phase effects, which should last for 
more than 3h. 
In the first study, we systematically titrated cathodal tDCS parameters for the human 
motor cortex model with different intensities (1, 2, and 3mA) and durations (15, 20 
and 30 min), to explore systematically the impact of these parameters on after-
effects, and identify most efficient protocols. The results revealed that stimulation 
with 1 mA for 15 min, and 1 mA for 30 min induced a significant MEP amplitude 
diminution, while stimulation with 2 mA for 20 min resulted in a significant 
corticospinal excitability enhancement. Protocols with higher stimulation intensity 
(specifically stimulation with 3 mA for 20 min) induced again a significant 
excitability diminution lasting for about one and half hour after stimulation, and thus 
were more efficient than the other protocols [65].  Since a former cathodal tDCS 
repetition study with a standard stimulation protocol with 1 mA did not lead to after-
effects lasting for more than a few hours, we were interested to explore if repetition 
of a protocol, whose single application had shown superior effects, would also 
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induce improved effects with a repeated protocol. Accordingly, in the present study, 
tDCS with the cathode positioned over M1 was applied with 1mA for 15 min 
(conventional protocol), and 3 mA for 20 min (optimized protocol). To explore if 
repeated tDCS protocols with different intervals prolong the after-effects, we 
compared the impact of single interventions of conventional and optimized cathodal 
tDCS with the effects of repeated application with intervals of 20 min and 24 hours 
on motor cortex excitability. These intervals were selected since in a previous study 
the 20-minute interval prolonged the neuroplastic after-effects as compared to a 
single intervention protocol, and an interval of 24 h is often used for repeated tDCS, 
but did reduce the neurophysiological effects of tDCS in that study [126]. In 
accordance with previous studies, we hypothesized an enhancement of the cathodal 
tDCS-induced excitability diminution by repeated application of conventional and 
optimized protocols with the short interval, and a reduction of the efficacy of the 
respective intervention with the long interval. Furthermore, we hypothesized that the 
high intensity protocol should improve tDCS-induced neuroplastic after-effects 
more than the low intensity (1 mA) condition for repeated stimulation. This study 
aimed to provide further information about the dependency of tDCS-induced 
neuroplasticity from the respective stimulation parameters, and thereby to deliver 
crucial information for future applications of cathodal tDCS. 
3.2. Materials and Methods 
3.2.1. Participants 
Sixteen healthy, non-smoking participants (7 males, mean age 25.56 ± 4.96 standard 
deviation (sd)) were recruited. All participants were right-handed according to the 
Edinburgh handedness inventory [93]. None of the participants had a history of 
neurological or psychiatric disease, current or previous drug abuse, alcohol abuse, 
present pregnancy or metallic head implants, and all fulfilled the exclusion criteria 
for non-invasive electrical or magnetic brain stimulation [94, 95]. The study 
conformed to the Declaration of Helsinki and was approved by the local ethics 
committee. All participants gave written informed consent before starting the study, 
and were financially compensated for participation. 
3.2.2. Transcranial direct current stimulation over the motor cortex 
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tDCS was applied with a battery-powered constant current stimulator (neuroCare, 
Ilmenau, Germany), through a pair of saline-soaked surface sponge electrodes (7x5 
cm, 35 cm2) placed on the scalp. The target electrode was fixed over the motor cortex 
representational area of the right abductor digiti minimi muscle (ADM) as identified 
by TMS, and the return electrode was placed contralaterally over the right orbit [19, 
96]. The participants received two single interventions of cathodal tDCS of 
conventional (1mA for 15min), and optimized (3mA for 20min) protocols and two 
additional repeated cathodal tDCS protocols with 20min and 24 h intervals, for each 
single protocol. Taking into account all single and repeated protocols, including 
sham stimulation, this resulted in 7 sessions per participant, Figure 3.1. For sham 
stimulation, 1.0mA stimulation was delivered for 15 seconds followed by 15min 
with 0.0mA stimulation. All protocols were conducted with 10 seconds ramp-up and 
down at the start, and end of stimulation.  
3.2.3. Motor cortical excitability assessment  
Single pulse TMS was delivered by a PowerMAG stimulator (Mag&More, Munich, 
Germany) to measure excitability changes of the representational motor cortical area 
of the right ADM, indexed as the amplitude of motor evoked potentials (MEP). The 
TMS pulses were delivered via a figure-of-eight-shaped coil (diameter of one 
winding 70 mm; peak magnetic field 2 T) at a frequency of 0.25 Hz with 10% jitter. 
The coil was held tangentially to the scalp at an angle of 45° to the sagittal plane 
with the coil handle pointing laterally and posterior. Surface EMG was recorded 
from the right ADM in a belly-tendon montage. The signals were amplified, and 
filtered (1000; 3Hz- 3KHz) using D440-2 (Digitimer, Welwyn Garden City, UK), 
and were digitized (sampling rate, 5kHz) with a micro 1401 AD converter 
(Cambridge Electronic Design, Cambridge, UK), controlled by Signal Software 




Figure 3.1 Course of Study. To obtain baseline motor cortex excitability, twenty-five single-pulse 
TMS-generated MEP were recorded from the right ADM. Afterwards, cathodal tDCS was applied 
as (A) single intervention with the conventional, optimized, or sham protocol (no repetition), or 
the same stimulation protocols were applied repeated with (B) 20min (short) or (c) 24 hours (long) 
intervals. The after-effects were monitored with TMS-induced MEPs of baseline intensity every 5 
min for up to 30 min and the following time points of 60 min, 90 min, 120 min, same evening (SE, 
~ 7 hours after tDCS), next morning (NM, ~ 24 hours after tDCS), next noon (NN, ~ 4-5 hours 
after next morning time point) and next evening (NE, ~ 4-5 hours after next noon). 
3.2.4. Experimental procedures 
The study was performed in a cross-over, single-blinded, randomized design. At the 
beginning of each session, participants were seated in a comfortable chair with head- 
and arm-rests. Then single-pulse TMS was conducted at a frequency of 0.25 Hz over 
the left motor cortex for identification of the representational area of the right ADM, 
in which the largest MEPs were produced by a given TMS intensity (hot spot 
determination). The TMS intensity (SI1mV) was then adjusted to elicit MEPs with 
on average 1 mV peak-to-peak amplitudes. Finally, baseline cortical excitability was 
determined by recording 25 MEPs with that TMS intensity from the right ADM. 
Prior to intervention, a topical anesthetic cream (EMLA®, 2.5% lidocaine + 2.5% 
prilocaine) was applied to the stimulation site, in order to decrease somatosensory 
sensations and sufficiently blind the participants [97, 107]. Afterwards, tDCS 
electrodes were mounted onto the head, and tDCS was applied. After finishing the 
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intervention, tDCS electrodes were removed and corticospinal excitability was 
monitored by 25 MEP obtained by TMS with baseline intensity every 5 min for up 
to 30 min, and 60 min, 90 min, 120 min, and then same evening, next morning, next 
noon, and next evening after tDCS (Figure 3.1). A waterproof pen was used to mark 
the position of the TMS coil on the scalp, as well as EMG electrodes on the hand. 
Different tDCS protocols were applied in separate sessions and in randomized order 
with a minimum one-week interval between each session to avoid carry-over effects 
[85]. 
3.2.5. Calculations and Statistics  
MEP amplitudes were first visually inspected to exclude trials in which background 
electromyographic activity was present. Then, the individual means of MEP-
amplitudes recorded at each time point were calculated for all subjects and all 
conditions separately. The post-intervention mean MEP amplitudes were then 
normalized to the respective individual mean baseline MEP-amplitude (quotient of 
post intervention versus pre-intervention MEP amplitudes). 
3.2.5.1. The effects of baseline measures ‘SI1mV’ and ‘baseline MEP’ on 
tDCS after-effects  
To investigate if baseline measures differed between sessions, two separate one-way 
repeated measures ANOVA were performed with ‘condition’ (7 levels) as within-
subject factor and ‘SI1mV’ or ‘baseline MEP’ as dependent variables. 
3.2.5.2. Overall effects of active tDCS protocols vs sham 
To determine if the respective active stimulation conditions altered cortical 
excitability relative to sham, and if the effects of the real stimulation protocols 
differed from each other, a repeated measures ANOVA was calculated with 
normalized MEPs as dependent variable, and ‘condition’ (7 levels) and ‘time point’ 
(15 levels) as within-subject factors.  
3.2.5.3. Early-, late-, and very-late-epochs of tDCS effects 
To compensate for variability between single time bins, the normalized MEP 
amplitudes of all time points were grand-averaged and pooled into three epochs:  0-
30 min after stimulation (early after-effects), 60-120min (late after-effects) and 
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same-day evening to next-day evening (very late after-effects). For these parameters, 
a repeated measures ANOVA was separately calculated with normalized MEPs as 
dependent variable and ‘condition’ (7 levels) and ‘epoch’ (4 levels) as within-subject 
factors. 
3.2.5.4. Qualitative assessment of tDCS protocols 
After finishing each session, participants were asked to fill in a questionnaire which 
contained: 1. Guessed intensity of applied direct current (0, 1 and 3mA), 2. Rating 
scales for the presence and amount of visual phenomena, itching, tingling and pain 
during stimulation, and 3. Rating scales for the presence and amount of skin redness, 
headache, fatigue, concentration difficulties, nervousness and sleep problems within 
24 hours after stimulation. The side-effects were rated on a numerical scale from 
zero to five, zero representing no and five extremely strong sensations.  
Mauchly’s test of sphericity was conducted, and the Greenhouse-Geisser correction 
was applied when necessary, for all ANOVAs. Exploratory post hoc t-tests were 
conducted in case of significant results of the ANOVAs, without correction for 
multiple comparisons [127]. The critical level of significance was set to p ≤ 0.05 for 
all statistics. Statistical analysis was performed with SPSS (IBM Corp. Version 
25.0). 
3.3. Results 
All participants completed the entire study.  
3.3.1. No difference of SI1mV and baseline MEPs between conditions 
Baseline MEP and SI1mV are listed in Table 3.1. The respective one-way ANOVAs 
showed no significant differences of baseline MEP and SI1mV across conditions 
(Baseline MEP: df = 6, F = 0.592, P = 0.736; SI1mV: df = 3.112, F=0.989, p=0.404). 
 
Table 3.1 MEP baseline measurements and TMS stimulation intensities. Data are presented as 
mean ± SD; SI1mV refers to the maximal stimulator output (%MSO) which was required for 
generating ~1mV MEP. The ANOVAs showed no significant differences of baseline MEP and 
SI1mV across sessions. 
Experimental Session SI1mv (%) 
Baseline MEP 
(mV) 
Sham 57.18 ± 15.11 1.01 ± 0.08 
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Conventional protocol 57.40 ± 16.00 0.98 ± 0.15 
Conventional protocol with 20min 
interval 
57.68 ± 16.50 
1.01 ± 0.09 
Conventional with 24 h interval 58.68 ± 16.82 1.04 ± 0.14 
Optimized protocol 57.28 ± 15.30 1.01 ± 0.08 
Optimized protocol with 20min 
interval 
58.71 ± 16.62 
1.04 ± 0.10 
Optimized protocol with 24h 
interval 




3.3.2. Overall effects of active vs sham tDCS protocols  
The overall ANOVA conducted to test if active tDCS sessions differ from sham 
stimulation resulted in significant main effects of tDCS condition (df = 6, F = 5.031, 
p < 0.001) and time (df = 3.473, F = 17.989, p < 0.001), but a non-significant 
condition × time interaction, Figure 3.2; Table 3.2.A. Post hoc tests comparing the 
active tDCS protocols with the respective baseline measures revealed a significant 
reduction of MEP amplitudes after conventional single intervention tDCS, 
conventional tDCS with a 20min, and 24 hour interval (all protocols induced after-
effects for about 1 hour after stimulation), as well as the optimized single 
intervention protocol (after-effects for about 2 hours after stimulation), optimized 
tDCS with a 20min interval (after-effects for about 60min after stimulation) and 
optimized tDCS with a 24 hours interval (after-effects for about 25min after 
stimulation). Post hoc comparisons of the respective active tDCS protocols with 
sham stimulation indicated a significant reduction of MEP amplitudes after 
conventional single intervention tDCS (for about 60min after stimulation), 
conventional tDCS with a 20min interval (for about 30 min after stimulation), 
conventional tDCS with a 24 hour interval (for about 30 min after stimulation), 
optimized single intervention tDCS (for about 2 hours after stimulation), optimized 
tDCS with a 20min interval (for about 2 hours after stimulation, but not for all 
respective time points) and optimized tDCS with a 24 h interval (for the time-points 
of immediately and 20min after  stimulation).  Furthermore, post hoc tests comparing 
MEPs between active protocols indicated that neuroplastic after-effects of the 
optimized single intervention protocol lasted significantly longer than those 
following the repeated optimized protocol with a 24 hours interval, Figure 3.2.  
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Table 3.2 Results of the ANOVAs conducted for tDCS-induced MEP alterations. A) The 2- 
factorial repeated-measures ANOVA conducted to discern active vs sham protocols revealed a 
significant effect of stimulation condition and time point, but no significant interaction. B) The 2-
factorial repeated-measures ANOVA conducted for grand-averaged pooled MEPs to discern active 
vs sham protocols revealed significant main effects of stimulation condition, and epoch, and a 
respective significant interaction. Asterisks indicate significant results. d.f, degrees of freedom. 
  Factor d.f. F value p value 
A 
Overall effects of 
tDCS on MEP 
amplitudes 
Condition 6 5.031 <0.001* 
Time point 3.473 17.989 <0.001* 
Condition × Time point 10.189 1.265 0.256 
B 
 
Early, late and very 
late effects of tDCS 
on MEP amplitudes 
(Pooled MEPs) 
Condition 6 4.953 <0.001* 
Epoch 3 28.532 <0.001* 






Figure 3.2 Post-tDCS motor cortical excitability alterations. Single intervention protocols with 
no repetition, repeated tDCS with the short (20 min), and the long interval (24h) are shown for the 
conventional, and the optimized tDCS protocol. Statistical data indicate a significant difference of 
all active protocols in comparison with sham tDCS. Error bars represent standard error of mean. 
Filled symbols indicate a significant difference of cortical excitability after tDCS, as compared to 
the respective baseline values. Floating symbols indicate a significant difference between the 
respective active and sham stimulation conditions. SE: same evening, NM: next morning, NN: next 
noon, NE: next evening. 
3.3.3. Early-, late-, and very-late- epochs of tDCS effects 
The 2-factorial ANOVA (‘condition’ - 7 levels, and ‘epoch’ - 4 levels) revealed 
significant main effects of condition (df = 6, F = 4.953, p < 0.001), epoch (df = 3, F 
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= 28.532, p < 0.001) and the respective interaction (df = 7.495, F = 2.548, p = 0.016), 
Figure 3.3; Table 3.2.B. Exploratory post hoc tests comparing the respective active 
tDCS protocols with baseline cortical excitability measures for the first 30 min after 
stimulation (early epoch) revealed a significant reduction of MEP amplitudes after 
all active protocols. For the late epoch (60-120 min after stimulation), conventional 
single intervention tDCS, conventional tDCS with a 20min interval, optimized single 
intervention tDCS and optimized tDCS with a 20min interval results differed 
significantly from respective baseline values. For the very late epoch, no significant 
differences versus baseline were revealed. In addition, post-hoc comparisons 
between the active protocols and sham showed a significant excitability diminution 
of all active protocols for the early epoch. For the late epoch, the conventional single 
intervention, the optimized single intervention and the optimized tDCS protocol with 
a 20min interval induced significant motor cortical excitability diminution. No 
significant effects were found for the very late epoch (same evening to next day 
evening). Furthermore, post hoc tests comparing MEPs between active protocols 
indicated that neuroplastic after-effects of the single intervention conventional (for 
the early epoch), and optimized protocols (for early and late epochs) were 
significantly larger than those obtained by the repeated optimized protocol with a 24 





Figure 3.3 MEP amplitudes grand-averaged for early, late, and very late tDCS post 
stimulation effects. MEP were grand-averaged and pooled into three epochs of early (0-30 min), 
late (60-120 min) and very late (same day evening- next day evening) excitability changes. Single 
intervention includes conventional, and optimized tDCS protocols. The short interval includes 
repeated conventional and optimized tDCS with a 20 min interval. The long interval includes 
repeated conventional and optimized tDCS with a 24 h interval. Statistical data indicate that in 
comparison with sham, all protocols significantly reduced MEP amplitudes in the early epoch (0-
30min after stimulation). For the late epoch (60-120min after stimulation), only conventional 
single intervention, optimized single intervention and optimized intervention with a 20min interval 
induced significant motor cortical excitability diminution. No significant effects were found for 
the very late epoch. Error bars represent standard error of means. Filled symbols indicate a 
significant difference of cortical excitability versus the respective baseline values. Floating 
symbols refer to each sub-figure, and indicate a significant difference between the respective active 







3.3.4. Qualitative assessment of tDCS protocols 
Chi-square tests for each actual tDCS intensity including sham results indicated a 
significant effect for 3 mA (χ2 = 27.167, p < 0.001) with no significant effects for 
sham (χ2 = 0.250, p = 0.617) and 1 mA (χ2 = 4.875, p = 0.087).  Table 3.3 shows 
the results of guessed intensities vs. actual intensities. Participant ratings for the 
presence and intensity of side-effects during and within 24 h after stimulation are 
listed in Table 3.4. The ANOVAs (‘condition’ - 7 levels) conducted for the side-
effect questionnaires showed no significant differences between stimulation 
protocols for visual phenomena, itching, tingling, redness of the skin under the 
electrodes, pain, headache, fatigue, concentration, nervousness and sleep problems 
Table 3.5. 
Table 3.3 Participants guess of the actual intensity.  In each session, participants were asked to 
guess the intensity of the actually applied direct current (0, 1 and 3mA), merged over all intervals 
(single intervention, 20 min, and 24h intervals). The table contrasts actually applied intensity 
(rows) with perceived intensity (columns). Differences in the sum of the ratings of each intensity 
are present, because only one sham stimulation condition was included in the experiments, but 
three sessions per intensity for the real tDCS applications. 
 
Intensity guessed by participants 




Sham 7 9 0 
1 mA 17 21 10 
3 mA 4 24 20 
 
Table 3.4 Participant ratings of the presence and intensity of side-effects.  Visual phenomena, 
itching, tingling and pain during stimulation and skin redness, headache, fatigue, concentration 
difficulties, nervousness and sleep problems within 24 h after stimulation. The presence and 
intensity of the side-effects were rated in a numerical scale from zero to five, zero representing no 



















































































































































































Table 3.5 The presence and intensity of side-effects were analyzed by one-way repeated-
measures ANOVAs. no significant effects were found for side-effects neither during nor 24 hours 
after tDCS.  




Visual Phenomenon 2.837 2.281 0.096 
Itching 3.574 1.935 0.125 
Tingling 3.541 1.915 0.129 
Pain 3.317 2.066 0.111 
 
24 hours after 
stimulation 
Redness 3.031 0.887 0.456 
Headache 2.748 1.304 0.286 
Fatigue 3.623 0.893 0.466 
Concentration difficulties 2.425 0.681 0.540 
Nervousness 2.095 2.199 0.126 
Sleep Problem 2.063 2.143 0.133 
 
3.4. Discussion  
In this study, we explored if repetitive stimulation with short or long intervals 
extends the neuroplastic after-effects of low and high dosages of single interventions 
of cathodal tDCS. In a sham-controlled repeated measures design, single 
intervention cathodal tDCS protocols with 1mA for 15min and 3mA for 20min, and 
two repeated cathodal tDCS protocols with short (20min) and long (24 hours) 
intervals, for both single intervention protocol parameter combinations, were tested.  
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In general, the results of the study show that all cathodal tDCS protocols significantly 
reduced cortical excitability. The respective excitability alterations reflect however 
early-phase LTD-like neuroplasticity, since the duration of the after-effects was 
shorter than 3 hours [122, 128]. For repeated stimulation with short intervals, the 
after-effects of stimulation with conventional and optimized protocols remained 
nearly unchanged, as compared to the respective single intervention protocols. For 
the long interval (24 h) protocols, stimulation with the conventional protocol did not 
significantly alter respective after-effects, while stimulation with the optimized 
protocol reduced after-effects, as compared with the respective single interventions.  
These results are in general accordance with previous findings from other studies 
conducted in healthy humans, in which late-phase LTD-like plasticity could not be 
induced by repeated cathodal stimulation with short intervals, and after-effects were 
reduced with an intervention interval of 24 h [66]. Similarly, repeated continuous 
theta burst stimulation (cTBS), another non-invasive brain stimulation tool suited to 
induce LTD-like plasticity, did not induce late phase LTD, when repeated with short 
intervals, in one study [129]. Other studies using comparable cTBS protocols showed 
however gradual enhancements of LTD-like plasticity with spaced protocols, which 
were nevertheless still in the range of early phase plasticity [130, 131]. Interestingly, 
in the latter study, intensified stimulation- similar to the results of the present study- 
reduced the excitability reduction in case of repeated stimulation. In contrast, 
prolonged effects in the range of late phase plasticity were elicited at the behavioral 
level via spaced theta burst stimulation over the frontal eye field in healthy humans, 
and the parietal cortex in patients affected by visual neglect, especially when more 
than 2 interventions were combined [132-134]. Studies in animal models to induce 
late phase LTD are comparatively rare, but showed a respective potential of slice 
preparations with repeated pharmacological [135], and also electrical stimulation 
interventions [124]. Interestingly in these studies, spacing between interventions 
differed between minutes, and 24h, and the repetition rate was usually larger than 
one.  
3.4.1. Proposed mechanism 
The question emerges why repeated plasticity-inducing cathodal tDCS did not 
generate late-phase LTD-like plasticity in healthy humans in the present, and some 
previous studies, along with studies in humans, in which related non-invasive brain 
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stimulation protocols were applied. One explanation might be challenges regarding 
to the translation of results from animal in vitro and/or in vivo studies to humans due 
to differences in stimulation parameters, such as intensity, duration and inter-
stimulation intervals as well as differences in spontaneous activity, neuro-transmitter 
and neuromodulator concentration, among others [136, 137]. Standard animal in-
vivo stimulation protocols affect relatively small populations of neurons in the target 
area, while tDCS protocols, in humans, stimulate hundreds of thousands of neurons 
of diverse origin, including excitatory as well as inhibitory neurons, concurrently. In 
addition, magnitude and direction of plasticity have been shown to be critically 
affected by the number of repetition blocks and the inter-stimulation interval. Three 
stimulation blocks with 10min interval were applied to induce late-phase LTD in the 
respective animal slice model [124], while in most studies in humans, including the 
present one, only one repetition was applied. Interestingly, however, larger repetition 
frequencies might be also more efficient in humans, and should therefore be targeted 
in future studies [132-134].  
With respect to the mechanistic foundation of these effects, it has been shown in 
animal models, that NMDA receptors, trafficking of AMPA receptors and calcium 
channel activities are involved in the early and late phase of long term plasticity [12], 
and modification of gene expression and protein synthesis are required for the 
maintenance of LTD [138-140]. Similar mechanisms have been described for tDCS-
induced cortical excitability alterations in humans [86, 103, 136]. Basic mechanisms 
of action of tDCS in humans are thus similar to respective mechanisms revealed in 
animal models. Animal studies have however also described forms of LTD triggered 
by metabotropic glutamate receptors (mGluRs) [141, 142], including late phase LTD  
[135]. While these different forms of LTD share similarities, they might have a 
discernable impact on the direction and rate of LTD plasticity induction. Whereas 
the contribution of NMDA receptors to tDCS-induced cortical excitability 
alterations is well-studied [86, 103, 143], a potential impact of metabotropic 
glutamate receptors, which might be relevant for late phase LTD induction, has not 
been revealed so far for cathodal tDCS in humans. A potential missing effect of tDCS 
on these receptors might contribute to the limited efficacy of tDCS to induce late 
phase LTD. At present, these explanations are however speculative, and should be 
explored in future studies directly. 
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Another important feature of the results is that the 24h interval of interventions 
resulted in diminished LTD-like effects of tDCS. Importantly, this diminution was 
present only for the intensified stimulation protocol, and observed with the second 
tDCS intervention applied at a time far beyond the time point when the single 
intervention resulted in MEP alterations. Homeostatic regulatory mechanisms, 
which control for the amount of neuroplastic alterations to avoid neuronal network 
destabilization, might help to explain these results. Here, prior synaptic activity 
influences the magnitude and direction of subsequently induced plasticity [144]. 
According to the Bienenstock-Cooper-Munro rule, a prolonged decrease of 
postsynaptic activity will shift the synaptic modification threshold, reducing the 
amount of LTD induced by a respective intervention [145]. NIBS studies in humans 
have shown similar mechanisms [66, 125, 146], and also showed that synergistic or 
homeostatic effects of repeated stimulation critically depend on the respective 
intervals. With respect to the latter, the pattern of results obtained in the present study 
fits nicely to those of a previous one, suggesting that intervals longer than a few 
minutes are required for the induction of homeostatic effects in case of LTD-
inducing protocols [66]. They furthermore suggest that homeostatic counter-
regulation is more easily induced by intensified stimulation protocols, which might 
lead to stronger saturation of the system, and that the mechanism driving these 
effects is beyond overt excitability alterations observable by MEP alterations. 
The failure to induce late phase LTD in the present study does however not imply 
that it is principally not possible to induce such kind of plasticity in the human brain 
by tDCS. On the one hand, as outlined above, increasing the number of repetitions 
could make the intervention more efficient, similar as for other NIBS protocols, such 
as TBS. On the other hand, it was shown that enhancement of global dopaminergic 
activity in combination with cathodal tDCS induces late phase LTD-like plasticity 
[147], and that this effect is at least partially driven by D2 receptors [148]. Respective 
mechanisms of this synergistic effect are not explored in detail so far, but one 
possibility might be that NMDA receptor activity diminutions induced by D2 
receptor activation reduce spontaneous activity of the stimulated neuronal networks, 
which might disturb or counteract the effects of cathodal tDCS. 
For blinding purposes, we used local anaesthetic cream to decrease tDCS-induced 
somatosensory sensations, as reported in previous studies for 2 mA tDCS [97]. 
However, the participants’ slightly higher rating of the presence and intensity of side-
65 
 
effects during stimulation under the high stimulation intensity implies that the topical 
anaesthetic cream might have limited efficacy at this intensity (here, 3 mA), which 
might potentially reduce the quality of blinding. 
3.4.2.  Limitations and future directions 
In the present study, we probed the neurophysiological effects of tDCS at the group 
level, but individual characteristics relevantly affect the outcomes of tDCS and other 
NIBS protocols [43, 108]. In accordance, the data obtained in the present experiment 
show some variability, Figure 3.4. Potential contributing factors are anatomical and 
biophysical differences of individual brains, including genetics, time of day, and 
brain state [109, 114, 149]. Thus, to improve stimulation efficacy at the level of the 
individual, an important next step would now be to understand/control for individual 
factors affecting the physiological and behavioral outcome of tDCS [45].  Moreover, 
the targeted population in this study was composed of healthy young humans. One-
to-one transferability of our results from motor to other cortical areas as well as 
transferability to different age populations and patient groups should not be taken for 
granted due to state-dependency of tDCS effects, anatomical differences, and 
differences of neuromodulator activities and cortical excitability between healthy 




Figure 3.4  Intra-individual motor cortical excitability changes after single and repeated 
sessions of cathodal transcranial direct current stimulation (tDCS) over the primary motor 
cortex. The panels show individual excitability alterations after single intervention with the 
conventional protocol (1 mA for 15 min) (A), repeated intervention with the conventional protocol 
with a 20 min interval (B), repeated intervention with the conventional protocol with a 24 h interval 
(C), single intervention with the optimized protocol (3 mA for 20 min) (D), repeated stimulation 
with the optimized protocol with a 20 min interval (E), repeated intervention with the optimized 
protocol with a 24 h interval (F). Each colored line in each graph represents MEP values of one 
participant (S1–S16). MEP amplitudes are normalized to baseline values individually. SE, same 
evening; NM, next morning; NN, next noon; NE, next evening. 
In general, and in difference to the inducibility of late phase LTP-like effects, it 
seems to be more difficult to induce late phase LTD-like effects in humans, 
independent from the specific plasticity induction tool. In this line, non-linearities of 
the effects of cathodal tDCS, dependent largely on stimulation intensity, but possibly 
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also on other parameters, play a prominent role [65, 98]. Respective mechanisms are 
largely unexplored, but might be important for the informed development of more 
efficient stimulation protocols. Based on results of animal, and some human studies, 
furthermore a promising way might be spaced stimulation with a frequency larger 
than one, which should be explored systematically in future studies, or combination 
of stimulation with pharmacological interventions. In this connection, it needs also 
to be stressed that the results of the present study do not allow to derive assumptions 
about the physiological effects of multi-session once daily stimulation protocols, 
which are often used in clinical trials. Finally, a further limitation of this study is that 
we included only one sham condition, because inclusion of a higher number of sham 
conditions would have reduced the feasibility of this already relatively laborious 
study. 
3.5. Conclusion 
The main results of this study show that late-phase plasticity was not induced by a 
single repetition of cathodal tDCS with short and/or long intervals by standard, and 
intensified stimulation protocols. We investigated the effects of repeated stimulation 
protocols with short (20min), and long intervals (24 hours) for a conventional (1mA 
for 15min) and a newly developed optimized tDCS protocol (3mA for 20min). Our 
results revealed that, compared to the single intervention protocols, the duration of 
after-effects of repeated conventional and optimized protocols remained largely 
unchanged, or was reduced. The results of the present study are thus not in 
accordance with the induction of late-phase LTD by a single repetition of cathodal 
tDCS, but hint for partially non-linear, probably homeostatic counter-regulation. 
Since more frequent repetition of intervention induced cumulative effects in other 
studies, and combination of cathodal tDCS with pharmacological interventions 








4 Study 3: Ca2+ channel dynamics explain the nonlinear 
neuroplasticity induction by cathodal tDCS over the primary 
motor cortex 
4.1. Introduction 
Neuroplasticity is suggested to be a fundamental basis for many cognitive functions 
such as learning and memory formation [11]. At the cellular level, long-term 
potentiation (LTP) and long-term depression (LTD) have been the major target of 
plasticity research, which refer to alterations of the strength and/or efficacy of 
synaptic connections as reaction to internal and environmental demands, involving 
cascades of molecular reaction in synapses [11, 150, 151]. The induction and 
direction of long-term plasticity rely on the pre-post synaptic activity, as well as the 
activation of N-methyl-D-aspartate (NMDA) receptors, which results in calcium 
influx and thereby triggers biochemical changes that modify the strength of synapses 
[12].  
Stimulation with weak direct currents (transcranial direct current stimulation, tDCS) 
induces neuroplasticity of the human brain  non-invasively [85, 152]. The 
directionality of tDCS-induced plasticity depends on stimulation parameters: anodal 
tDCS enhances cortical excitability, while cathodal tDCS has inhibitory effects with 
conventional protocols of motor cortex stimulation [19, 20]. Similar to the induction 
of LTP and LTD in animal models, cortical plasticity induced by tDCS has been 
shown to be NMDA receptor-dependent, and the duration of after-effects can last for 
more than an hour [20, 96, 143]. Earlier studies revealed a positive association of the 
magnitude and duration of tDCS effects with stimulation duration/intensity below 
20min and 1.5mA [19, 98]. However, non-linear after-effects of tDCS have been 
reported recently when duration and/or intensity were further increased. The 
inhibitory effect of 1 mA cathodal tDCS for 20 min was reversed to excitation when 
the intensity increased to 2 mA [64]. It has also been shown that excitatory effects 
of 1mA anodal tDCS for 13 min resulted in reduced motor cortical excitability by 
doubling the duration of the intervention [82]. 
One likely explanation for these non-linear after-effects might be the calcium-
dependency of plasticity. Results of animal studies show that intracellular Ca2+ 
concentration determines the increase or decrease of the synaptic weight, i.e. LTP or 
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LTD [101, 121].  Hereby the strength of a plasticity induction protocol results in a 
specific level of NMDA receptor, and calcium channel activation, leading to 
corresponding amounts of Ca2+ influx. Low and prolonged Ca2+ influx causes LTD, 
a moderate increase of calcium influx induces no synaptic modulation, and larger 
calcium increases result in LTP [101, 121, 153]. Calcium influx beyond the LTP-
inducing level might again result in no or excitability-diminishing plasticity due to 
potassium channel-controlled counter-regulatory mechanisms [102]. With this in 
mind, earlier tDCS studies in human participants showed that NMDA receptor block, 
which reduces calcium influx, prevents increased excitability after anodal and 
decreased excitability after cathodal tDCS [143]. Thus, the non-linear effects of 
tDCS induced by higher dosages might be caused by respective calcium dynamics. 
In principal accordance, it was shown that blockage of NMDA receptors abolished 
the inhibitory after-effects of 1 mA  anodal tDCS applied for 26 minutes [82]. 
Therefore, Ca2+ channel dynamics are a candidate mechanism to explain non-linear 
after-effects of tDCS. 
In the first study conducted for motor cortex tDCS, we systematically titrated 
cathodal tDCS parameters including different intensities (1, 2 and 3mA) and 
durations (15, 20 and 30mins) [154]. We observed non-linear after-effects, including 
induction of LTD- and LTP-like plasticity. While 1 mA cathodal tDCS induced a 
reduction of MEP amplitudes, 2 mA resulted in excitability enhancement and 3mA 
induced a secondary motor cortical excitability diminution. We hypothesize that the 
switch from LTD- to LTP-like plasticity by 20 min cathodal tDCS with 2mA was 
due to an enhancement of Ca2+ influx to a level sufficient for induction of LTP-like 
plasticity, and that the further intensified 20 min 3mA protocol resulted in counter-
regulatory mechanisms due to calcium overflow, which would cause LTD-like 
plasticity due to activation of hyperpolarizing potassium channels, which will again 
reduce calcium influx [102]. To test this hypothesis, in the present study we applied 
the calcium channel blocker flunarizine in low, medium, and high dosages before 
cathodal tDCS (3mA, 20min) to induce different levels of intraneuronal Ca2+ 
concentrations. We expected that depending on the amount of intracellular calcium 
alteration induced by this substance, LTP- or LTD-like plasticity is induced in a 




4.2. Materials and Methods 
4.2.1. Participants 
Twelve healthy, non-smoking participants (6 males, mean age ± standard deviation 
(SD): 25.16 ± 4.98) who participated in our previous study investigating neuroplastic 
after-effects of different cathodal tDCS dosages [154] were recruited. All 
participants were right-handed according to the Edinburgh handedness inventory 
[93]. History of neurological or psychiatric disease, current or previous drug abuse, 
alcohol abuse, bronchial asthma or allergies to components of the flunarizine (FLU) 
tablets, present pregnancy or metallic head implants, and fulfilled exclusion criteria 
for non-invasive electrical or magnetic brain stimulation [94, 95], served as 
exclusion criteria. The study conformed to the Declaration of Helsinki and was 
approved by the local ethics committee of the Leibniz Research Center for Working 
Environment and Human Factors (IfADo). All participants gave written informed 
consent before starting the study and were financially compensated for participating. 
4.2.2. Transcranial direct current stimulation of the motor cortex 
tDCS was administered by a battery-driven constant current stimulator (neuroConn 
GmbH, Ilmenau, Germany), through a pair of rubber electrodes covered by saline-
soaked sponges (35 cm2). The target electrode was placed over the primary motor 
cortex area representing the right abductor digiti minimi muscle (ADM), with the 
return electrode over the contralateral supraorbital region. Participants received 
cathodal motor cortex tDCS of 3mA for 20min, and sham tDCS. Prior to stimulation, 
topical dermal anesthetic cream (Emla® Creme – Lidocaine 2.5% and Prilocaine 
2.5%) was applied on the skin directly under the electrodes, in order to decrease 
somatosensory sensations caused by tDCS [107]. Sham stimulation was delivered 
for 15 seconds followed by 20min with 0.0mA stimulation. All protocols were 
conducted with a 10seconds ramp-up and down at the start, and end of stimulation, 
Figure 4.1. 
4.2.3. Assessing motor cortex excitability 
Single pulse TMS was delivered by a PowerMAG stimulator (Mag&More, Munich, 
Germany) to measure excitability changes of the representational motor cortical area 
of the right ADM indexed as the amplitude of motor evoked potentials (MEP). The 
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TMS pulses were conducted via a figure-of-eight-shaped coil (diameter of one 
winding 70 mm; peak magnetic field 2 T) at a frequency of 0.25 Hz with 10% jitter. 
The coil was held tangentially to the scalp at an angle of 45° to the sagittal plane 
with the coil handle pointing laterally and posterior. The optimal coil position on the 
head was defined as the site where the stimulation results consistently in the largest 
MEPs with a given TMS intensity. A waterproof pen was used to mark the position 
of TMS coil on the scalp. The intensity of the TMS pulses was adjusted to elicit 
MEPs with a peak-to-peak amplitude of 1 mV (SI1mV) on average for baseline 
recordings. Finally, baseline cortical excitability was determined by measuring 25 
MEPs. Surface EMG was recorded from the right ADM in a belly-tendon montage. 
The signals were amplified, and filtered (1000; 3Hz- 3KHz) using D440-2 
(Digitimer, Welwyn Garden City, UK) and were digitized (sampling rate, 5kHz) 
with a micro 1401 AD converter (Cambridge Electronic Design, Cambridge, UK), 
controlled by Signal Software (Cambridge Electronic Design, v. 2.13). 
 
Figure 4.1  Course of the study. Experiment 1: to investigate the calcium channel dynamics 
involvement on tDCS-induced nonlinear neuroplasticity induction, 12 volunteers participated in 
this experiment. In each session, twenty-five single-pulse TMS stimuli were applied over the motor 
cortex representation area of the right ADM to measure baseline cortical excitability. Afterwards, 
placebo or FLU was administered in dosages of 2.5, 5 or 10 mg, and two hours later a second 
baseline was recorded to explore the effect of medication on corticospinal excitability, and TMS 
intensity was adjusted, if necessary. Then cathodal tDCS was administered with 3mA for 20 min. 
Immediately after finishing tDCS, after-effects were monitored by TMS-induced MEPs every 5 
min for up to 30 min and the following time points of 60 min, 90 min, 120 min. Experiment 2: to 
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explore an impact of flunarizine alone on corticospinal excitability monitored by MEP, 8 (out of 
12) participants participated in an additional session, in which 10 mg FLU was administered 2 
hours before sham tDCS. Cortical excitability alterations were evaluated as in the sessions with 
active tDCS.    
4.2.4. Pharmacological intervention 
In each session, FLU in dosages of 2.5, 5, and 10 mg, or a respective placebo 
medication was administered 2h before tDCS. The substance is a L-type calcium 
channel antagonist that diminishes intracellular calcium levels. FLU at a dosage of 
10 mg has been previously shown to diminish and/or abolish tDCS‐induced 
neuroplastic after‐effects; thus, it has relevant effects on neuroplasticity [82, 143]. 
Maximum plasma levels are reached approximately two hours after oral intake [155].  
4.2.5. Experimental Course 
Experiment1: The study was performed in a cross-over, double blind and 
randomized design. At the beginning of each session, subjects were seated in a 
comfortable chair in a reclined position with head- and arm-rests and were required 
to relax completely. EMG electrodes were placed over the right ADM as described 
above. Then TMS was applied over the left motor representation area of the right 
ADM to measure baseline cortical excitability (baseline 1, bl1), as explained above. 
After the baseline measurement (bl1), placebo or FLU was administered in dosages 
of 2.5, 5 or 10 mg in each session. Two hours later, the baseline MEP-amplitude was 
controlled (baseline 2, bl2), and if needed, TMS-intensity was adjusted to acquire 
MEP amplitudes of 1 mV on average (baseline 3, bl3). After that, 3mA cathodal 
tDCS was applied for 20 min, followed by recordings of 25 MEPs at the time-points 
of 1, 5, 10, 15, 20, 25, 30, 60, 90, and 120 minutes, Figure 1.  
Experiment 2: to explore an impact of flunarizine alone on corticospinal excitability 
monitored by MEP, 8 (out of 12) participants were included in an additional session, 
in which 10 mg FLU was administered 2 hours before sham tDCS. Cortical 
excitability alterations were evaluated as in the sessions with active tDCS, Figure 1.  
A minimum one-week interval between sessions was obligatory to avoid carry-over 
effects [85].  
4.2.6. Calculations and statistics  
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MEP amplitudes were first visually inspected to exclude trials in which background 
electromyographic activity was increased. Then, the individual mean of MEP-
amplitudes recorded at each time point were calculated for all subjects and all 
conditions separately. The post-intervention mean MEP amplitudes were then 
normalized to the respective individual mean baseline MEP-amplitude (quotient of 
post intervention versus pre-intervention MEP amplitudes). 
4.2.6.1. Impact of ‘SI1mV’ and ‘baseline MEP’ 
Differences between baseline measures can impact the outcome results. To exclude 
this, first three repeated measures ANOVAs were performed for values obtained 
before medication with ‘session’ (4 levels) as within-subject factor and ‘SI1mV’ )for 
bl1) , ‘baseline MEPs’ (bl1) and ‘MEP used for normalization’ (bl2/3) as dependent 
variables, respectively. Then, to test if medication affected baseline cortical 
excitability, two additional ANOVAs were calculated with ‘condition’ (3 levels) and 
‘time-point’ (2 levels) as within-subject factors, and ‘baseline MEP’ (bl1 and bl2) or 
TMS intensities (measured for bl1 and bl3) as dependent variables.  
4.2.6.2. Dose-dependent effect of FLU on tDCS-induced neuroplasticity: 
overall time course  
To determine if the respective stimulation conditions with pharmacological 
intervention (FLU dosages: 2.5, 5 or 10 mg) effects differ from stimulation with 
placebo medication, a repeated measures ANOVA was calculated with normalized 
MEPs as dependent variable, and ‘condition’ (4 levels) and ‘time point’ (11 levels) 
as within-subject factors. In addition, to rule out possible effects of flunarizine itself 
on MEP amplitudes over the time course of the experiment, another repeated 
measures one-way ANOVA was calculated for experiment 2 with normalized MEPs 
as dependent variable, and ‘time point’ (11 levels) as within-subject factor. 
4.2.6.3. Dose-dependent effect of FLU on tDCS-induced neuroplasticity: 
early and late after-effects 
To better define the time course of plasticity induction by tDCS and compensate for 
variability between time points, the normalized MEP amplitudes of all-time points 
were pooled into two epochs:  the average of MEP measures from the first 30 min 
after stimulation (early-phase after-effects) and from 60-120 min measurement after 
tDCS (late-phase after-effects). A repeated measures ANOVA was calculated with 
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‘condition’ (4 levels) and ‘epoch’ (3 levels) as within-subject factors and pooled 
MEPs as dependent variable. We conducted another repeated measures one-way 
ANOVA for experiment 2, with normalized MEPs as dependent variable, and ‘time 
point’ (3 levels) as within-subject factors, to exclude a possible effect of FLU alone 
on MEP amplitudes over the time course of the experiment. 
We also performed an analysis of covariance (ANCOVA) with order of stimulation 
sessions (for the two-way ANOVAs in 4.2.6.2 and 4.2.6.3) as covariate to exclude a 
confounding effect of order on the results. 
Mauchly’s test of sphericity was conducted, and when necessary, the Greenhouse-
Geisser correction was applied, for all ANOVAs. Exploratory post hoc Student´s t-
tests (paired samples, two-tailed, p ≤ 0.05) were conducted to determine significant 
differences between baseline and post-tDCS MEPs within each medication 
condition, and between FLU conditions for each time point. Exploratory post-hoc 
tests were not corrected for multiple comparisons according to Perneger [156]. 
Statistical analyses were performed with SPSS (IBM Corp. Version 26.0).  
4.3. Results 
All participants completed the entire study. Two subjects reported slight itching at 
the beginning and a slight redness of the skin site underneath the return electrode 
that did not interfere with the experiments. All other subjects tolerated the 
interventions well and no other adverse effects were reported. 
4.3.1. Comparison of ‘SI1mV’ and ‘baseline MEP’ between sessions 
Baseline MEP and SI1mV are listed in Table 4.1. The one-way repeated measure 
ANOVA showed no significant differences of baseline MEPs and SI1mV, obtained 
for bl1 (Baseline MEPs: df = 3, F = 0.907, p = 0.448; SI1mV: df = 3, F = 1.827, p = 
0.161) and MEP used for normalization (df = 3, F = 0.186, p = 0.905), across all 
sessions. The 2-factorial ANOVAs revealed no significant difference between bl1 
and bl2 (Condition: df = 3, F = 0.810, p = 0.497, Time point: df = 1, F = 0.144, p = 
0.711, Condition × Time point: df = 3, F = 0.564, p = 0.643) and TMS intensities 
before (for bl1) and after medication (for bl3) (Condition: df = 3, F =1.761, p = 0.173, 
Time point: df = 1, F = 0.849, p = 0.377, Condition × Time point: df = 3, F = 0.371, 
p = 0.774).  
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Table 4.1 TMS stimulation intensities and baseline measurements. SI1mV refers to the 
maximal stimulator output (%MSO) which was required for generating ~1mV MEP.  bl1 refers to 
the baseline MEPs measured at the beginning of each session, bl2 refers to the baseline MEPs 
measurement two hours after medication and bl3 refers to the last baseline measurement if TMS 
adjustment was needed. The results of the ANOVAs indicate no significant differences of baseline 
MEP and SI1mV before and after medication between sessions. Data are presented as mean ± SD. 
Experimental 
Session 
SI1mv (%MSO) Baseline MEP (mV) 
 For bl1 For bl3 bl1 bl2 bl3 
Placebo 59.37 ± 14.26 59.37 ± 14.06 1.00 ± 0.07 1.03 ± 0.11 1.06 ± 0.09 
2.5 mg FLU 58.87 ± 11.81 58.46 ± 11.30 1.08 ± 0.20 1.07 ± 0.19 1.04 ± 0.11 
5 mg FLU 59.20 ± 12.24 59.21 ±12.80 1.09 ± 0.28 1.02 ± 0.13 1.02 ± 0.08 
10 mg FLU 61.75 ± 13.14 61.60 ± 13.43 1.04 ± 0.11 1.02 ± 0.14 1.03 ± 0.11 
 
4.3.2. Dose-dependent effect of FLU on tDCS-induced neuroplasticity: overall 
time course 
The 2-factorial ANOVA revealed significant main effects of condition (df = 3, F= 
3.907, p = 0.017) and time-point (df = 10, F = 2.003, p = 0.040), but no significant 
effect of the condition × time-point interaction (df = 5.763, F = 1.345, p = 0.225), 
Figure 4.2; Table 4.2.A. The exploratory post-hoc t-test, comparing the tDCS after-
effects with the respective baseline values showed significant alterations of MEP 
amplitudes with respect to the factor time. MEP amplitudes were significantly 
reduced in the placebo session for about one hour after stimulation. Administration 
of low dosage FLU resulted in a significant reduction of MEP amplitudes for about 
30min after stimulation, while no significant MEP alteration were observed in the 
medium dosage FLU session. The results of the post-hoc tests indicate furthermore 
that the expected cathodal tDCS-induced LTD-like plasticity was initially abolished 
and later converted into facilitation in the high dosage FLU condition (for 90 min 
and 120 min time-points after stimulation). With respect to the factor condition, the 
exploratory post hoc t-tests reveal a significantly higher excitability under high 
dosage FLU as compared to placebo, and low dosage FLU sessions.  In addition, the 
one-way repeated measures ANOVA calculated to exclude a contribution of FLU 
itself on cortical excitability (experiment 2) revealed no effect of FLU on cortical 
excitability over the time course of the experiment (time point: df = 10, F= 0.283, p 
= 0.983), Figure 4.3.A.  
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Table 4.2 Results of the ANOVAs conducted for the effect of FLU on tDCS-induced MEP 
alterations. A) The 2-factorial ANOVA calculated to investigate the overall effects of FLU on 
tDCS-induced corticospinal excitability alterations reveals significant main effects of condition, 
and time-point, but no interaction between condition and time-point. B) The 2-factorial ANOVA 
with pooled MEP values reveals a significant main effect of condition, and interaction between 
condition and epoch, but no significant main effect of epoch. Asterisks indicate significant results. 
d.f. = degrees of freedom. 
  Factors df F value p value 
A Overall effects of FLU on 
tDCS-induced MEP 
alterations 
Condition 3 3.907 0.017* 
Time-point 10 2.003 0.040* 
Condition × Time-point 5.736 1.345 0.225 
B Early and Late effects of 
FLU on tDCS neuroplastic 
after-effects 
Condition 3, 33 4.287 0.012* 
Epochs 2, 22 2.053 0.152 




Figure 4.2 Dose-dependent effect of FLU on tDCS-induced neuroplasticity (overall time 
course). The results of the ANOVA reveal significant main effects of condition and time-point, 
but no significant effect of condition × time interaction. A dosage-dependency of medication on 
the tDCS-generated excitability-diminishing after-effects was identified. Medium and high dosage 
FLU reduced, abolished or converted tDCS-induced excitability diminution to an excitability 
enhancement. Error bars represent standard error of means. Filled symbols indicate a significant 
difference of cortical excitability against the respective baseline values. Floating symbols indicate 
a significant difference between the session with high dosage FLU, and placebo (◆) or low dosage 




Figure 4.3 No effects of FLU on cortical excitability for prolonged time course measures. To 
exclude a possible effect of FLU alone on cortical excitability, eight participants (out of 12 from 
the primary study), participated in a control experiment in which 10 mg FLU was administrated 2 
hours before sham tDCS. The results indicate no significant effects of medication on MEP 
amplitudes, for the overall (A) and pooled MEPs (B: Grand-averaged MEPs were pooled into two 
epochs of early (0-30 min) and late (60-120 min) excitability changes. Error bars represent standard 
error of means. 
4.3.3. Dose-dependent effect of FLU on tDCS-induced neuroplasticity: early and 
late after-effects 
The 2-factorial ANOVA with pooled MEP values reveals a significant main effect 
of condition (df = 3, F = 4.287, p = 0.012), and  a significant interaction between 
condition and epoch (df = 6, F = 2.774, p = 0.018), but no significant effect of epoch  
(df = 2, F = 2.053, , p = 0.152), Figure 4.4; Table 4.2.B. The exploratory post-hoc t-
tests, comparing the tDCS after-effects with the respective baseline values showed 
that MEP amplitudes were significantly reduced in the placebo and low dosage FLU 
session for the early epoch (first 30 minutes after stimulation), while an excitability 
enhancement was observed following the session with high dosage of FLU for the 
late epoch (60-120min after stimulation). Post-hoc tests comparing MEP sizes 
between conditions for a given time point showed significantly enhanced excitability 
for the early and late-epoch for the high dosage of FLU, as compared with the 
placebo session (for early and late epochs), and the session with low dosage of FLU 
(for early and late epochs). Moreover, the repeated measures ANOVA calculated to 
investigate effects of medication itself on the plasticity alteration revealed no 
significant results over the time course of the experiment (df = 2, F = 0.067, p = 
0.936), Figure 4.3.B. 
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The ANCOVA results show no significant effect of session order on tDCS after-
effects for both, pooled and non-pooled measures (Pooled MEPs: df = 2, F = 0.198, 
p = 0.824; non-pooled MEPs: df = 2, F = 0.332, p = 0.762). 
 
Figure 4.4 Dose-dependent effect of FLU on tDCS-induced neuroplasticity: early and late 
after-effects. Grand-averaged MEPs were pooled into two epochs of early (0-30 min) and late (60-
120 min) excitability changes. Error bars represent standard error of means. Filled symbols indicate 
a significant difference of cortical excitability versus the respective baseline values. Floating 
symbols indicate a significant difference between the session with high dosage FLU, and placebo 
(◆) or low dosage FLU condition (●) in the respective epochs. 
4.4. Discussion  
In the present study, we explored the effects of calcium influx on tDCS-induced 
cortical excitability changes in healthy subjects via application of different dosages 
of a calcium channel blocker. In general, the results of the study show that tDCS-
generated neuroplastic alterations are calcium-dependent, and that calcium-
dependency can explain the nonlinear dosage-dependency of cathodal tDCS-induced 
neuroplastic after-effects, which were recently demonstrated.  
We administrated low (2.5 mg), medium (5 mg) and high dosages (10 mg) of FLU, 
and showed that the inhibitory after-effects of 3 mA cathodal tDCS applied for 20 
min were dosage-dependently diminished, abolished, or converted into a delayed 
excitability enhancement. FLU itself did not alter MEP amplitudes, as shown by the 
additional session with 10mg FLU administrated 2 hours before sham tDCS. 
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Animal in-vivo experiments revealed that direct current stimulation (DCS) impacts 
neuronal firing rate by a facilitatory effect under the anode and an inhibitory effect 
under the cathode, which can modify synaptic efficacy at both, the single cell and 
network level and thus induce long term effects, dependent on the intensity/duration 
of stimulation [157-162]. It has been, primarily in animal in-vivo studies and more 
recently by neuroimaging techniques, revealed that calcium dynamics, which 
involve NMDA receptors, are relevant for DCS-induced short- and long-term 
synaptic modifications [12, 103, 163-166].  
In accordance, also for tDCS in humans, a glutamatergic process involving NMDA 
receptors, which have calcium channel properties, has been proposed by a series of 
studies as a possible mechanism of action of tDCS-induced plasticity. 
Pharmacological studies show that  NMDA receptor block prevents tDCS-induced 
excitability alterations, both for anodal and cathodal tDCS, whereas NMDA receptor 
agonists enhance anodal tDCS-induced excitability increases [143, 167]. In line with 
these pharmacological studies, magnetic resonance spectroscopy (MRS) studies 
showed reduced glutamate after cathodal and at least trend-wise enhanced glutamate 
after anodal tDCS [168-170], and anodal tDCS enhances, while cathodal tDCS 
reduces intracortical facilitation, which depend on glutamatergic mechanisms [171, 
172]. It can therefore be assumed that bidirectional plasticity induction via tDCS 
requires the contribution of NMDA receptors, and is therefore calcium-dependent. 
Important for the results of the present study, animal models moreover demonstrated 
a dependency of the direction of plasticity from the amount of neuronal calcium 
influx [173]. Low-level Ca2+ influx has been shown to induce LTD, whereas a 
moderate calcium enhancement results in no synaptic modulation, a larger increase 
induces LTP, and maximum calcium influx might again abolish or convert plasticity 
due to counter-regulatory mechanisms [101, 102]. Similarly, neuromodulatory after-
effects of tDCS in humans are suggested to be Ca2+-dependent, since blocking 
calcium channels prevents respective plasticity induction. Calcium dynamics are 
therefore a candidate mechanism to explain the nonlinearities of tDCS effects, which 
were recently revealed by enhanced tDCS intensity and duration. For cathodal tDCS, 
2 mA stimulation for 20 minutes shifted motor cortex excitability from LTD- to LTP-
like plasticity, while 1mA with 20 minutes significantly diminished it [64, 154]. In 
a recently conducted study we have shown that further enhancement of cathodal 
tDCS intensity again induces an excitability diminution, which provides further 
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evidence for a complex non-linear dose-dependency of cathodal tDCS-induced 
neuroplastic after-effects. We hypothesized that this double conversion of cathodal 
tDCS-induced after-effects depend on calcium dynamics. Based on the model 
described above, we would expect that stimulation with 1 mA induces LTD-like 
plasticity due to low calcium influx, 2 mA stimulation enhances calcium level to the 
LTP-induction range, and 3 mA stimulation results in LTD-like plasticity again due 
to counter-regulatory mechanisms, which help to avoid calcium overflow. For the 
3mA stimulation scenario, which was explored in the present study, this would mean 
that dependent on the amount of calcium concentration reduction accomplished by 
calcium channel block, we expect a dosage-dependent reduction, abolishment, or 
conversion of LTD-like after-effects to LTP-like plasticity. The results of the present 
experiment fully confirm this hypothesis.  
Non-linear cortical plasticity induction is not limited to tDCS effects, but has also 
been reported for other forms of non-invasive brain stimulation (NIBS). While low-
intensity continuous theta burst stimulation (cTBS) at an intensity of 65% resting 
motor threshold (RMT) induced cortical excitability reduction, an excitability-
enhancement was obtained by an otherwise identical protocol at an intensity of 70% 
RMT [174]. Similarly, for cTBS, which induces LTD-like plasticity at the group 
level with conventional protocols, enhancement of stimulation intensity beyond the 
intensity which induced LTD-like plasticity at the level of the individual resulted in 
LTP-like plasticity [175]. Similar effects have been shown for full spectrum tRNS, 
and 140 Hz tACS, where 0.4 mA stimulation intensity induced cortical excitability 
diminution, while stimulation with 1mA resulted in an enhancement of MEP 
amplitudes [176]. Since plasticity induced by these stimulation techniques is also 
NMDA receptor-dependent, a calcium-dependency of these effects is also probable 
[177, 178], and should be explored in future studies. 
4.4.1. Limitations and Future Directions 
The results of the present study imply that calcium channel dynamics are involved 
in the non-linear after-effects of high intensity cathodal tDCS. For a full overview 
about respective dynamics, systematic studies including application of medium 
(2mA) and lower intensity (1mA) tDCS combined with different flunarizine dosages 
would be desirable. In addition, increasing tDCS intensity might relevantly affect 
deeper cortical layers, and also generate plasticity in other types of neurons, which 
82 
 
have a different sensitivity to electrical fields, as indicated in animal models [105]. 
These mechanisms should be investigated in future research in larger detail. 
Furthermore, pharmacological interventions only deliver indirect information on the 
contribution of calcium dynamics to the effects of tDCS. Studies in which calcium 
dynamics are directly explored are suggested to confirm these results. Moreover, 
identical dosages of FLU were administered to all participants; substance dosage was 
not adjusted to body weight, or body mass index. A respective individualization of 
medication to reduce variability of efficacy of the intervention should be considered 
in future studies. Finally, we did not monitor drug concentration levels in individuals. 
Thus, our experimental results allow to make qualitative statements about dosage-
level substance-dependent effects, but deliver no quantitative information. 
The results of the present study are relevant for the field, because they offer an 
explanation why cathodal tDCS results are relatively variable between studies. 
Furthermore, they might be important for clinical application settings with respect 
to several aspects. First, they hint to the fact that pharmacological therapy of patients 
might relevantly alter physiological stimulation effects. Second, they rise the 
question if a stimulation protocol which might result in secondary, counter-
regulatory LTD-like effects, is well suited if primary weakening of synaptic 
connections is aimed for. The latter question is not easy to answer, and should be 
explored in larger details in future studies. 
Recent advances in computational modeling of neurophysiological phenomena 
provide an important avenue to investigate tDCS effects ranging from single cell to 
network and whole brain levels [52, 160, 179, 180]. Computational modeling has 
also been utilized to link neurophysiological and brain structural properties to further 
explain tDCS responses at the individual level [62, 170]. However, to the best of our 
knowledge, current modeling approaches cannot well explain tDCS dosage-
dependent nonlinear responses. It thus might be of interest for future modeling 
approaches to integrate conceptual mechanistic data, such as the proposed calcium-
dependency of tDCS effects, for simulating the effects of tDCS on behavioral, 




The results of this study suggest a calcium-dependency of non-linear motor cortical 
plasticity effects of cathodal tDCS in human subjects. Inhibitory after-effects of 
high-intensity cathodal tDCS were dosage-dependently diminished, decreased, or 
converted into facilitation by calcium channel block via flunarizine. This improves 
our understanding of neurophysiological mechanisms underlying tDCS effects, 
especially with respect to the involvement of calcium dynamics in non-linearities, 








5 Study 4: A Comprehensive Study of the Association Between 
Individual Electrical Field and Anatomical Factors on the 




In humans, non-invasive brain stimulation (NIBS) provides an excellent avenue for 
modulating brain plasticity without disrupting the integrity of the skull, and is thus 
used to shed light on human brain physiology, brain functions underlying cognition 
and behaviour [76, 181], and probed to alter symptoms of neurological and 
psychiatric disorders [17, 18]. One of those, transcranial direct current stimulation 
(tDCS), changes regional cortical excitability in a polarity-dependent way, via 
delivering weak direct electrical currents, by electrodes placed on the head [22]. 
Despite promising results reported in pilot studies, effects are however largely 
moderate, show interindividual variability, and more sustained, and homogeneous 
effects are required, especially for clinical applications [18, 45]. 
Recent studies indicate an improvement of tDCS efficacy by manipulating the 
stimulation parameters at the group level [38, 65, 82, 182-184]. Despite dosage-
dependent non-linearities in healthy humans [34, 64-68], and clinical populations 
[38, 40, 71], these however take not into account another relevant aspect of 
stimulation effects, which might limit efficacy, i.e. interindividual variability [45]. 
Indeed, relevant inter-individual variability of outcomes is reported in tDCS studies 
[43, 44], similar to other NIBS techniques [108, 185], which is one of the major 
challenges regarding its applicability for basic research, and clinical purposes. 
Various sources of variability have been identified, including physical (brain 
anatomy, tissue properties and neural orientation), physiological (genetics, sex- and 
age-dependency, pharmacology), and functional factors (psychological and 
behavioral processes) [109]. 
While causes of variability have yet to be explored in detail [45], recent human in-
vivo experiments [186, 187], and current-flow simulations [60, 62, 188] indicate that 
both, spatial distribution and intensity of the tDCS-induced electrical field (EF) 
depend strongly on individual brain anatomy and tissue conductivity properties; 
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biophysical factors that can potentially impact the outcome of tDCS [58]. This 
highlights the importance of understanding and controlling the impact of these 
biophysical factors on neurophysiological and/or behavioral effects of tDCS at the 
level of the individual.  
To address this, lately analytical, and more recently numerical simulation methods 
have been developed to estimate the electrical current throughout the head induced 
by transcranial electrical stimulation. However, analytical methods cannot fully 
account for the complex brain geometry, which can results erroneous EF analysis 
[189, 190]. To compensate for this shortcoming, numerical simulation methods, 
based on MR-derived detailed realistic head models, have been developed to predict 
the tDCS-induced EF distribution in the individual human brain [48, 58, 187, 191]. 
Numerical equations are typical solved by finite element (FEM) [192, 193], 
boundary element [57, 194, 195], or finite difference methods [196]. Despite open 
questions regarding to the validation [46, 187, 192] , and cost and complexity [48, 
197] of these simulation methods, MR-derived realistic FEM simulation is widely 
used to predict the EF induced by transcranial electrical and/or magnetic stimulation, 
due to its capability of probing complex brain tissue characteristics such as 
anisotropy, and considering head models with morphologically realistic cortical 
neurons, as well as modeling tissues with continuously varying tissue conductivities 
[112, 198-203]. The results of computational studies have so far highlighted a strong 
contribution of individual head anatomical and/or electrical properties for the shape 
of the EF induced by tDCS, and shown further significant EF variability between 
humans, when one-size-fits-all tDCS protocols are used [59, 60]. Thus taken 
together, EF variability might be an important factor for heterogeneous outcomes of 
tDCS. However, despite increasing sophistication of these computational models, 
much less is known about the association of the individual tDCS-induced EF, and 
neurophysiological or behavioral effects of tDCS.  
Up to now, a few pilot studies have shown an association of neurophysiological or 
behavioral effects of tDCS and EF differences at the group level. A negative 
correlation has been shown between the tDCS-induced EF strength under the target 
electrode and resting motor threshold (RMT) [61]. Furthermore, opposite changes of 
motor cortical excitability caused by 1mA anodal tDCS for 20min were reported, 
where individuals with large EFs showed decreased motor evoked potentials 
(MEPs), whereas volunteers with low EFs showed either no effect or increased MEP, 
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as compared to sham stimulation [62]. In another study, anodal tDCS (1 mA for 15 
min) applied over the sensorimotor cortex altered GABA, and increased functional 
connectivity to a larger amount in participants with stronger EFs, whereas a negative 
relationship between EF strength and functional connectivity was observed when the 
same dosage of cathodal tDCS was applied [63]. Beyond these associations between 
simulated EF, and physiological parameters, another study suggested also the 
relevance of individual EF for cognitive effects of tDCS. Here, the magnitude of 
simulated current density values and improvements in verbal working memory 
performance were positively correlated for anodal tDCS with 1mA for 20min over 
the left dorsolateral prefrontal cortex [204]. With respect to the anatomical 
determinants of respective EF strengths resulting from tDCS, in a small sample size 
study (n=2), thickness of skull and cerebrospinal fluid (CSF), gyral depth and 
interelectrode distance accounted for up to 50% of the spatial variation of EF strength 
[60]. In another study with a larger sample size (n=24), which took the contribution 
of 11 anatomical factors into consideration, regional CSF thickness was the only 
single factor influencing EF strength, and explained about one-half of the variation 
of EFs between subjects [59]. However, it is still unclear whether and to what degree 
these individual physical factors (including tDCS-induced EF and/or anatomical 
factors) affect and/or explain the individual neurophysiological outcome of tDCS. A 
systematic investigation of the impact of these factors on the neuroplastic effects of 
different tDCS dosages is therefore required. 
In addition, the regional neuroplastic after-effects of tDCD have largely been 
investigated for the motor cortex with TMS. Neuroanatomical studies however 
indicate that multiple circuits contribute to MEP generation, including afferent 
pathways from the somatosensory cortex and the dense inhibitory and facilitatory 
connections between the premotor cortex and M1, resulting in a compound signal 
with different generators [205, 206]. In principle accordance, computational 
modeling studies have also highlighted the contribution of the sensorimotor network 
into TMS-elicited MEP [198, 207-210]. This suggests that a computational model 
designed to investigate tDCS effects, based on motor cortex excitability measures, 
should also account for TMS EF distribution.  
In two consecutive studies, we systematically titrated the effects of 15min of anodal 
and cathodal tDCS over the motor cortex at five intensities (sham, 0.5, 1.0, 1.5 and 
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2.0 mA), evaluated via (1) changes in TMS-induced MEP (Experiment 1: tDCS-
TMS-MEP) [98], and (2) changes in cerebral blood flow (CBF) measured by fMRI 
(Experiment 2: tDCS-fMRI) [75], for up to 2h after intervention. The results of the 
tDCS-TMS-MEP experiment, at the group level, showed equivalent facilitatory 
effects at all tested anodal tDCS intensities relative to sham, while for cathodal tDCS, 
only 1.0mA resulted in a sustained excitability diminution. The outcome of the 
tDCS-fMRI experiment, in which the same participants were involved, revealed an 
increased CBF under the M1 electrode for all anodal intensities, while all active 
cathodal conditions, with exception of 0.5mA intensity, showed decreased CBF; 
tDCS with 2.0mA resulted in the greatest change of CBF in both polarities.  
In the present study, we asked based on these data whether and to which extent the 
neurophysiological outcome of tDCS, at the individual level, can be explained by 
considering individual anatomical, and resulting EF factors. To this end, for each 
individual, we designed a structural MRI-based realistic head model, which was then 
used to simulate, based on the FEM, the tDCS- and TMS-induced EF, for two 
regions: 1) hand motor knob under the targeted electrode, and 2) TMS-induced 
effective EF. Based on these individual models, we obtained anatomical factors with 
potential relevance for the resulting EFs. We then investigated if any of these 
individual anatomical factors could explain the simulated EF variabilities. We finally 
explored whether specific anatomical and/or EF factors explained the 
neurophysiological outcomes of tDCS (including MEP and CBF). Based on previous 
findings, we anticipated a positive association between the individual EF and tDCS-
induced sustained MEP and/or CBF alterations, with larger MEP and/or CBF 
changes linked with higher EF induction. Accordingly, we expected that anatomical 
factors resulting in lower EF strengths would also impact negatively on tDCS-
induced neurophysiological alterations. The results of the present study would thus 
enhance comprehension of the dependency of tDCS effects from individual physical 
factors. 
5.2. Materials and Methods 
5.2.1. Participants 
The neurophysiological, and anatomical data were obtained from Twenty-nine 
participants (16 males, mean age 25.0 ± 4.44 years) who were involved in our former 
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experiments (‘tDCS-TMS-MEP [98] and ‘tDCS-fMRI’ [75]). In these experiments, 
participants were randomly allotted to two groups of anodal (fifteen participants), or 
cathodal tDCS (fourteen participants) over the course of five pseudo-randomized 
experimental sessions of different tDCS intensities (sham, 0.5, 1.0, 1.5, and 2.0mA). 
All participants were right-handed according to the Edinburgh handedness inventory  
[93]. None of the participants had a history of neurological or psychiatric disease, 
and none fulfilled exclusion criteria for non-invasive electrical or magnetic brain 
stimulation [94, 95]. The study conformed to the Declaration of Helsinki and was 
approved by the Medical Ethics Committee of the University of Göttingen.  
5.2.2. tDCS over the primary motor cortex 
For both experiments, tDCS was applied with a MR-compatible battery-powered 
constant current stimulator (neuroCare, Ilmenau, Germany), through a pair of 
surface rubber electrodes placed on the scalp. For the ‘tDCS-TMS-MEP’ experiment, 
electrodes were covered with a saline soaked sponge, and for the ‘tDCS-fMRI’ 
experiment, a layer of conductive paste (Ten20®,Weaver) was used to make 
contact between electrodes and scalp. The target electrode (35cm2) was fixed over 
the motor cortex representational area of the right abductor digiti minimi muscle 
(ADM) as identified by TMS (‘ADM hotspot’), and the return electrode (100 cm2) 
was placed contralaterally over the right orbit. To further reduce any discomfort of 
the stimulation and to ensure adequate blinding, a topical anesthetic 
cream (EMLA®, AstraZeneca, UK) was pre-applied to the electrode areas on the 
scalp and was also layered on the bottom surface of the electrodes [97]. Based on the 
experimental group and session conditions, anodal or cathodal tDCS at an intensity 
of 0.5, 1.0, 1.5, 2.0mA, or sham was delivered for 15 min, with a 10 sec ramp at the 
beginning and end of stimulation. For the sham condition, 1.0mA was delivered for 
30sec, with a 20sec ramp, which has been shown to achieve effective stimulation 
blinding [211, 212]. 
5.2.3. Motor cortical excitability assessment by TMS-induced MEPs 
Monophasic TMS pulses were delivered via a figure-of-eight-shaped coil (diameter 
of one winding 70 mm; peak magnetic field 2T) at a frequency of 0.25Hz with 10% 
jitter. The coil was held tangentially to the scalp at an angle of 45° to the sagittal 
plane with the handle pointing laterally and posterior. MEP signals were sampled 
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(5kHz), amplified and bandpass filtered at 2Hz–2kHz 
(Digitimer,Welwyn Garden City, UK), and recorded/controlled with Signal 
software v.2.13 (CambridgeElectronicDesign, Cambridge, UK). 
5.2.4. Structural and Functional MRI acquisition 
For the ‘tDCS-fMRI’ experiment, anatomical and functional MR images were 
conducted in a 3 Tesla Magnetom TrioTim (Siemens Healthcare, Erlangen, 
Germany) using a 32-channel head coil. Before subjects were placed inside the 
magnet bore, stimulation electrodes were fitted over the targeted area (as explained 
in section 5.2.2). Initially, anatomical images based on a T1-weighted 3D turbo fast 
low angle shot (FLASH) MRI sequence at 1 mm3 isotropic resolution were recorded 
(repetition time (TR) 2250 ms echo time (TE) 3.32 ms, inversion time 900 ms, flip 
angle 9 degrees). Subsequent scans were divided in ten blocks: pre-stimulation 
(baseline measurement), and then after-effects measurements immediately as well as 
15, 30, 45, 60, 75, 90, 105, and 120 minutes after stimulation. For each of the ten 
blocks, three measurements were obtained: a resting-state blood-oxygen-level-
dependent (BOLD) measurement (5 min 51 s), a resting-state arterial spin labeling 
(ASL) measurement (5 min 8 s), and a gradient echo field mapping scan (1 min). 
The ordering of the ASL and BOLD scans was counter-balanced evenly between 
subjects to mitigate any ordering effects. The analysis of the BOLD dataset was not 
considered within the scope of the current study. ASL images were acquired using a 
pseudo-continuous ASL (pcASL) sequence with the following parameters: TE 12 
ms, TR 3750 ms, 24 slices, in-plane resolution 3x3 mm, slice thickness 4 mm, 20% 
gap, flip angle 90, FOV 192 mm, labelling time 1484 ms, post-label delay 1 s, RF 
gap 360 us, RF blocks 80. Each ASL sequence was accompanied by a background-
suppressed proton density (PD) reference image using the same parameters, but 
without ASL labeling, which was used for functional registration and CBF 
calibration. 
5.2.5. tDCS-induced Electrical Field Simulation 
Each participant’s T1 image was first automatically segmented into seven head tissue 
compartments, including white matter (WM), gray matter (GM), CSF, skull, scalp, 
eyeballs and air cavities, using the SPM12 software package [213] including an 
improved tissue probability map [214]. A custom 
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MATLAB (R2019a,MathWorks,MA) script was then used to correct for  automatic 
segmentation errors [214]. Afterwards, a 3D head model, based on the segmented 
images, was developed using Simpleware ® 
software (Synopsys, Inc. , Mountain View, USA) [215], with electrodes (2mm 
thickness) and Ten20 paste (3mm thickness) precisely located on the head, over the 
targeted areas, by visual inspection of the structural T1 images, using the render view 
of MRIcron [216], and a custom Matlab script for electrode placement [214]. The 
3D head model was then meshed with tetrahedral elements using adaptive meshing 
(+ScanFE, Simpleware software). The volume-meshed model was imported to 
COMSOL Multiphysics software package v.5.5 (COMSOL Inc. , MA, USA),  and 
tissue electrical conductivity values were assigned (in S/m ): GM:0.276; WM:0.126; 
CSF:1.65; skull:0.01; scalp:0.465; air:2.5×10-14; Ten20 paste:1.5; electrode rubber: 
29 [112, 217]. The EF was then calculated under the quasi-static approximation for 
1mA tDCS [191]. Finally, the EF strength,  |𝐸| = √𝐸𝑥
2 + 𝐸𝑦
2 + 𝐸𝑧
2, and the 
component of the EF perpendicular to the interface, 𝑛.̂ ?⃗? =  ?⃗? 𝑥 . ?⃗? 𝑥 + ?⃗? 𝑦 . ?⃗? 𝑦 +
?⃗? 𝑧. ?⃗? 𝑧 (where ?⃗?  is the inner normal vector), on the mesh grids were imported to 
MATLAB, and interpolated then onto a regular grid similar to the original MR 
images (1mm3) [191, 214]. All processes were performed on a workstation, with 
128GB of RAM and 16 physical AMD-Ryzen-Threadripper 1950X 3.40GHz 
processors, Figure 5.1C. 
5.2.6. TMS-induced Electrical Field Simulation 
First, a realistic model of the coil (Magstim 70mm figure-8) was designed using 
AutoCAD (Autodesk Inc. , CA, USA), with  two circular wings with nine turns each 
and a wire cross section of 1.75mm×6mm [218-220], and imported to the 
Simpleware® software (+ScanCAD). The coil was then precisely placed over the 
individual head model, with the center placed at the midpoint of the tDCS target 
electrode and 3mm distance to the scalp, and the handle held 45° to the midline [209, 
221]. The head and coil models were then placed inside a spherical surrounding 
composed of air (r = 0.5m), and the full model was meshed with tetrahedral elements 
using an adaptive meshing algorithm (+ScanFE, Simpleware®). The volume-
meshed model was finally imported to COMSOL Multiphysics software package to 
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calculate the total EF (?⃗? = −
𝑑𝐴 
𝑑𝑡
− ∇⃗ 𝜑, where 𝐴  and 𝜑 represent the magnetic vector 




)=67A/μs) delivered by the coil connected with the Magstim 200 
stimulator to induce a posterior–anterior current flow in the brain [223, 224], Figure 
5.1C. Electrical conductivity of the respective head tissue compartments was 
assigned as in the tDCS simulation, in addition with an electrical permittivity of 104 
for all head tissues [220], coil (5.8×107S/m) [225],  and surrounding air (permittivity 
of free space, and a conductivity of 2.5×10−14S/m). The EF results were finally 
imported to MATLAB and interpolated onto a similar regular grid of the MR images 
(1mm3) [191, 214].  
 
Figure 5.1 Study design. Twenty-nine participants, who took part in two consecutive experiments, 
(‘tDCS-TMS-MEP’ and ‘tDCS-fMRI’), randomly divided into two groups (Anodal: n=15; 
Cathodal: n=14). In each group, participants were involved in five randomized sessions, to receive 
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15min of sham, 0.5, 1.0, 1.5 or 2.0 mA tDCS, with the target electrode(35cm2) placed over M1 
and the reference electrode (100cm2) positioned contralaterally above the right supraorbital region. 
A) Experiment 1- ‘tDCS-TMS-MEP’: The neuroplastic effects of tDCS were obtained by single-
pulse TMS-MEP, by comparing the baseline (obtained prior to tDCS) motor cortical excitability 
of the right ADM, and MEPs obtained every 5 min up to 30min, and 60, 90 and 120min, after 
tDCS. B) Experiment 2- ‘tDCS-fMRI’: Scanning acquisition: a high resolution anatomical T1 
image (only before tDCS), and resting state ASL-fMRI, as a measure of CBF, were recorded prior 
to, during, and every 15min up to 120min after motor cortical tDCS, to investigate the tDCS effects 
on cortical neurovascular activity. C) 3D MR-derived FEM simulation: the anatomical image was 
first automatically segmented into scalp, skull, eyeballs, air cavities, CSF, GM and WM, using the 
SPM12 toolbox, and then corrected for the inherent segmentation errors, using a custom MATLAB 
script. Segmented-corrected images were then imported to Simpleware software package to: 1) 
design a 3D model of the head (+ScanIP), 2) locating the tDCS electrode or TMS coil over the 
targeted area (+ScanCAD), and 3) mesh the model via a tetrahedral adaptive meshing algorithm 
(+ScanFE). The meshed models were then imported to the COMSOL software package to simulate 
the EF distribution (tDCS: including the EF strength (|𝐸|) and normal component (𝒏.̂ ?⃗⃗? ); TMS:|𝐸|) 
for 1mA anodal (group 1), cathodal tDCS (group 2), and TMS (for both groups). D) Regions of 
Interest (ROI): two ROIs including 1) 𝑅𝑂𝐼𝐻𝐾: motor hand knob and 2) 𝑅𝑂𝐼𝑇𝑀𝑆: where the total 
TMS-induced EF meet the predefined condition: 𝐸 > 
√2
2
 𝐸𝑚𝑎𝑥, which refers to the half power 
region, the region in which the EF is at least 50% of the maximum power for a specific depth. E) 
Anatomical Factors: for each individual, the anatomical measures including thickness of scalp, 
skull and CSF, and CSF volume (without ventricles), were performed by Simpleware measurement 
tools, in addition to measures of the Euclidian distance from the center of the target electrode to 
the individual coordinate of the hand motor area. F) Statistics: the objective was to first testify if 
any of the measured anatomical factors explain individual EF variability. Secondly, we 
investigated whether and to what extent the individual anatomical factors and/or EFs explain the 
variability of the neurophysiological outcomes of tDCS (MEP and CBF measures).  
5.2.7. Experimental procedure: ‘tDCS-TMS-MEP’ and ‘tDCS- fMRI’ 
The details of the experimental procedures can be found in our former studies [75, 
98]. Briefly, for the ‘tDCS-TMS-MEP’ experiment, subjects were seated in a 
comfortable chair with head and arm rests. First the ADM hotspot was identified, 
and TMS intensity adjusted to elicit MEPs with a peak-to-peak amplitude of on 
average 1mV (SI1mV). Afterwards, baseline cortical excitability was determined by 
measuring 25 MEPs, following 15min of anodal or cathodal stimulation (in five 
sessions: sham, 0.5, 1.0, 1.5, and 2.0mA). After finishing the stimulation, cortico-
spinal excitability was assessed by TMS measurements, every 5 min for up to 30min, 
and then 60min, 90min, 120min after tDCS, Figure 5.1.A. Experiment 1. For the 
‘tDCS-fMRI’ sessions, stimulation electrodes were first placed over the head with 
the target electrode positioned over the ‘ADM hotspot’, as identified by TMS 
measures, and the return electrode on the right supraorbital region. Subjects were 
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then situated comfortably inside the scanner, to obtain an initial T1 anatomical scan, 
followed by baseline measures: resting-state BOLD, ASL sequences, and a Field 
Mapping sequence in counterbalanced order. Then, anodal or cathodal tDCS was 
delivered for 15 min in five sessions in randomized order (as explained above); a 
resting-state block was also recorded during stimulation. After finishing stimulation, 
the tDCS device was turned off, and the after measures resting-state blocks were 
acquired in intervals of 15 min until 120 min after the end of stimulation, Figure 
5.1.B. Experiment 2. 
For both experiments, there was at least 1 week interval between each session to 
avoid carry-over effects [85]. 
5.2.8. Calculations  
5.2.8.1. Neurophysiological effects of tDCS (TMS-MEP and ASL-fMRI) 
Details of the calculations and statistical analyses of the MEP and CBF data are 
available in our former studies [75, 98]. Briefly, for the first experiment ‘tDCS-TMS-
MEP’, individual means of each time point's MEP amplitudes (𝑀𝐸𝑃𝑡), were 
calculated and then normalized (∆) to baseline MEPs (𝑀𝐸𝑃𝑏𝑙): ∆MEP = (𝑀𝐸𝑃𝑡 −
𝑀𝐸𝑃𝑏𝑙)/𝑀𝐸𝑃𝑏𝑙. For the second experiment ‘tDCS-ASL-fMRI’, the grand-average 
mean perfusion time course of the voxels was averaged over the time-series (𝐶𝐵𝐹𝑡) 
and then normalized to the pre-stimulation baseline (𝐶𝐵𝐹𝑏𝑙): ∆𝐶𝐵𝐹 = (𝐶𝐵𝐹𝑡 −
𝐶𝐵𝐹𝑏𝑙)/𝐶𝐵𝐹𝑏𝑙. In the present study, to compensate for variability between time-
points, and reduce also the number of required time-points for the analysis, the 
neurophysiological after-stimulation measures including ∆MEP amplitudes (ten 
time-points) or ∆CBF values (eight time-points; excluding the scanning block during 
stimulation) were separately grand-averaged and pooled into two epochs of early (0-
60min after stimulation) and late (75-120min after stimulation) effect.  
5.2.8.2. Regions of Interest  
To investigate the association between neurophysiological responses to tDCS, and 
the individual EF and/or anatomical factors (please see below), we defined two 
ROIs: 1) 𝑅𝑂𝐼𝐻𝐾, and 2) 𝑅𝑂𝐼𝑇𝑀𝑆. The 𝑅𝑂𝐼𝐻𝐾was selected to explore the direct tDCS 
effects over the hand knob motor representation area, which was defined in the 
cortex using a 2.5cm radius sphere centered at MNI coordinates (x=−37.4, y=−19.1, 
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z=52.4 mm [226]). The 𝑅𝑂𝐼𝑇𝑀𝑆 was selected based on neuroanatomical and 
computational studies, suggesting the contribution of different neural generators of 
the sensorimotor network for the TMS-evoked MEP. We first extracted the 
respective regions (Brodmann areas corresponding to the left sensorimotor network, 
including the somatosensory cortex (BA1, BA3), M1 (BA4), and the premotor cortex 
(BA6)) from the parcellated Brodmann atlas generated by Freesurfer reconstruction 
of each individual T1 image. We then defined an area over this region, where the 
TMS-induced EF met the predefined condition 𝐸 > 
√2
2
𝐸𝑚𝑎𝑥;  the half power region 
[227-229]), Figure 5.1.D. Remote brain areas and/or regions underneath the 
reference electrode, were not within the scope of the current study. 
 
5.2.8.3. Anatomical measures 
The aim here was to investigate the influence of individual anatomical factors, which 
might affect neurophysiological responses to tDCS, by shaping the tDCS-induced 
EF [59, 60, 230]. To this end, we measured 1) scalp thickness, 2) skull thickness, 3) 
CSF thickness, 4) CSF volume (without ventricles), and 5) distance from the center 
of the tDCS target electrode to the individual hand motor area (ECD). The individual 
tissue thickness and CSF volume were obtained by respective measurement tools in 
Simpleware. We first selected the compartment corresponding to the target electrode 
(plus additional 2cm at each side; to include the area in which the target electrode 
exerted strong effects [60]), and extruded the layer of the thickness dimension to 
include the tissue regions underneath. From these individual models, we then 
quantified the thickness of the tissues of interest. For determination of ECD, first the 
center of each electrode was identified using a render view of MRIcron [216], the 
Euclidian distance was then calculated from this location to the individual hand 
motor area coordinate (MNI coordinates: x=−37.4, y=−19.1, z=52.4 mm [226]), 
Figure 5.1.E.   
5.2.9.  Statistics 
Multiple linear regressions were first applied to investigate if the individual averaged 
EF (|E| and 𝑛.̂ ?⃗? ) for the 𝑅𝑂𝐼𝐻𝐾 or 𝑅𝑂𝐼𝑇𝑀𝑆 (as dependent variable) can be explained 
by respective individual anatomical factors (as explanatory variables). The same 
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statistical analysis was then used to test whether and to which extent the individual 
variability of the neurophysiological effects of tDCS (including ∆MEP and ∆CBF as 
dependent variables) can be explained by the respective individual EF ((|E| and 𝑛.̂ ?⃗? ; 
for the 𝑅𝑂𝐼𝐻𝐾 and 𝑅𝑂𝐼𝑇𝑀𝑆), or anatomical factors. Note that, for ∆CBF, we only 
used EF for the 𝑅𝑂𝐼𝐻𝐾 because of the missing TMS condition in the MRI 
experiment. In addition, for each regression analysis, we further calculated Pearson’s 
correlation coefficient to identify the directionality of the predictors. The respective 
p-values were adjusted for multiple comparisons via the False Discovery Rate (FDR)  
[231, 232].  
5.3. RESULTS  
5.3.1. tDCS-induced MEP and CBF alterations 
The detailed results of the neurophysiological effects of tDCS are available in our 
former studies [75, 98]. Briefly, for the ‘tDCS-TMS-MEP’ experiment, a dosage-
dependent effect on cortico-spinal excitability was observed, with significant 
facilitatory effects for all anodal active tDCS protocols relative to sham, while for 
cathodal tDCS, only 1.0mA resulted in a sustained excitability diminution, Figure 
5.2.A (for the individual results see Figure 5.3). For the ‘tDCS-fMRI’ experiment, 
CBF increased under M1, for all active anodal tDCS conditions, while all active 
cathodal conditions, with the exception of 0.5mA intensity, decreased CBF (most 
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clearly in late epochs), with 2.0mA showing the largest change for both polarities, 
Figure 5.2.B (for individual results see Figure 5.4 ) 
 
 
Figure 5.2 Summary of the neurophysiological effects of tDCS on cortico-spinal excitability 
and cerebral blood flow.  Anodal or cathodal tDCS (in five sessions: sham, 0.5, 1.0, 1.5, and 
2.0mA) were applied for 15min, and the effects of the interventions were obtained over the 2-h 
after-stimulation period. To compensate for variability between single time-points, MEP 
amplitudes (ten time-points) or CBF values (eight time-points) were separately grand-averaged 
and pooled into two epochs of early (0-60min after stimulation) and late (75-120min after 
stimulation) effects. A1,2) dosage-dependent effects of tDCS on cortico-spinal excitability were 
observed, with significant facilitatory effects for all anodal active tDCS protocols, relative to sham, 
while for cathodal tDCS, only 1.0 mA resulted in a significant excitability diminution. B) CBF 
increased under M1 for all active anodal tDCS conditions, while all active cathodal conditions, 
with the exception of 0.5mA intensity, showed decreased ∆CBF; with 2.0mA resulting in the 
largest change of CBF for both polarities. Error bars represent standard error of means. Floating 
symbols indicate a significant difference between stimulation after-effects and sham (*), or 
baseline (●) in the respective epochs. Asterisks indicate significant results. Figures adapted from 






Figure 5.3. Intra-individual motor cortical excitability changes after tDCS over the primary 
motor cortex. The panels show individual excitability alterations after anodal tDCS (A1-4), and 
cathodal tDCS (B1-4), with 0.5, 1.0, 1.5, and 2mA, each intensity applied for 15min. Each colored 
line in each graph represents MEP values of one participant (A1–A16: anodal group; C1-C14: 





Figure 5.4. Intra-individual CBF changes after tDCS over the primary motor cortex. The 
panels show individual CBF alterations after anodal tDCS (A1-4), and cathodal tDCS (B1-4), with 
0.5, 1.0, 1.5, and 2mA, each intensity for 15min. Each colored line in each graph represents CBF 
values of one participant (A1–A16: anodal group; C1-C14: cathodal group). AVG: averaged across 





5.3.2. tDCS- and TMS-induced Electrical Field Simulation 
Figures 5.5 and 5.6 show the EF distribution (|𝐸| and 𝑛.̂ ?⃗?  for tDCS and |𝐸| for 
TMS) on grey matter surface, for the anodal (15 participants), and cathodal groups 
(14 participants), respectively.  
 
Figure 5.5 Anodal Group EF distribution.  For each individual, the tDCS and TMS- induced EF 
were calculated. For 1mA anodal tDCS (which refers to surface inward current over the target 
area), the target electrode (35cm2) was positioned over the scalp targeting the ADM muscle 
representation, and the reference electrode (100cm2) placed contralaterally above the supraorbital 
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area. The resulting electrical fields over the gray matter surface are presented for tDCS-induced 
EF strength (|𝐸|), -EF normal component (𝑛.̂ ?⃗? ), and EF strength of the TMS-induced EF (|𝐸|).  
 
Figure 5.6 Cathodal Group EF distribution. For each individual, the tDCS- and TMS-induced 
EF were calculated. For 1mA cathodal tDCS (which refers to outward current over the target area), 
the target electrode (35cm2) was placed over the scalp, targeting the ADM muscle representation, 
and the reference electrode (100cm2) placed contralaterally above the supraorbital area. The results 
over the gray matter surface present the tDCS-induced EF strength (|𝐸|), -EF normal component 
(𝑛.̂ ?⃗? ), and EF strength of TMS-induced EF (|𝐸|).  
5.3.3. Association between Anatomical Factors and Electrical Field 
The average, standard deviation and median values of the anatomical factors, and 
calculated EF are listed in Table5.1. The results of the linear regression analyses, 
along with Pearson’s correlation coefficients, which were used to test if any of the 
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anatomical factors explained the individual EF (strength |E|, and normal components 
n.̂ E⃗  ) at the two ROIs (𝑅𝑂𝐼𝐻𝐾 and 𝑅𝑂𝐼𝑇𝑀𝑆), indicated that, for the anodal group, 
CSF thickness significantly predicted the |E| (R2=0.476, p=0.008; r =-0.690, and 
𝑅𝑂𝐼𝑇𝑀𝑆: R
2=0.620, p<0.001; r =-0.788), and n.̂ E⃗  at 𝑅𝑂𝐼𝑇𝑀𝑆 (R
2=0.308, 𝑝FDR=0.032, 
r=-0.555). Also ECD had significant predictive value for the |E| (𝑅𝑂𝐼𝐻𝐾:R
2=0.482, 
p=0.004, r=-0.695, 𝑅𝑂𝐼𝑇𝑀𝑆: R
2= 0.681, 𝑝FDR<0.001, r=-0.825), and n.̂ E⃗  (𝑅𝑂𝐼𝐻𝐾: 
R2=0.337, 𝑝FDR=0.023, r=-0.581, and 𝑅𝑂𝐼𝑇𝑀𝑆: R
2= 0.339, 𝑝FDR=0.012, r=-0.632). 
There were no significant predictive effects of the remaining anatomical factors, 
Figure 5.7.A, Figure 5.8.A, Table 5.2. For the cathodal group, CSF volume explained 
significantly the |E| at 𝑅𝑂𝐼𝑇𝑀𝑆 (R
2=0.342, 𝑝FDR=0.028, r=-0.585), and ECD 
significantly predicted the |E| (𝑅𝑂𝐼𝐻𝐾 : R
2= 0.436, 𝑝FDR=0.010, r=-0.660 , and 
𝑅𝑂𝐼𝑇𝑀𝑆: R
2= 0.329, 𝑝FDR=0.032, r=-0.574), and n.̂ E⃗  (𝑅𝑂𝐼𝑡𝑎𝑟𝑔𝑒𝑡𝐸𝑙𝑒𝑐 : R
2= 0.379, 
𝑝FDR=0.020, r=-0.616, and 𝑅𝑂𝐼𝑇𝑀𝑆: R
2= 0.522, 𝑝FDR=0.004, r=-0.723). The 
remaining anatomical factors had no significant predictive value for the EFs of the 
cathodal group Figure 5.7.B, Figure 5.8.B, Table 5.2. 
 
Table 5.1. Measured anatomical and EF values. Average, standard deviation and median of 
the measured anatomical factors and calculated EF for the anodal, and cathodal group. 
  Thickness   Electrical Field 




































































Median 0.826 0.579 0.221 0.274 3.167 0.077 0.046 0.182 0.045 
 
Table 5.2 Association between Anatomical Factors and Electrical Field. Multiple linear 
regressions (Reg) were first applied to investigate if the individual averaged EF for the 𝑅𝑂𝐼𝐻𝐾 or 
𝑅𝑂𝐼𝑇𝑀𝑆 (as dependent variable) can be explained by respective individual anatomical factors (as 
explanatory variables). In addition, Pearson’s correlation coefficient (Corr) was calculated to 
further identify the directionality of each regression result. The p-values were adjusted for multiple 
comparisons using the False Discovery Rate (FDR). Asterisks indicate significant results. 























Reg R2 0.016 0.001 0.476* 0.172 0.482* 
p 0.654 0.906 0.008* 0.124 0.004* 
Corr  r -0.126 0.033 -0.690* -0.415 -0.695* 
𝐧.̂ ?⃗?  
𝐑𝐎𝐈𝐇𝐊 
Reg R2 0.002 0.008 0.244 0.019 0.337* 
p 0.932 0.750 0.085 0.624 0.023* 
Corr  r -0.013 -0.090 -0.495 0.138 -0.581* 
|E| 
𝐑𝐎𝐈𝐓𝐌𝐒 
Reg R2 0.007 0.070 0.620* 0.221 0.681* 
p 0.928 0.337 <0.001* 0.077 <0.001* 
Corr  r -0.126 -0.266 -0.788* -0.470 -0.825* 
𝐧.̂ ?⃗?  
𝐑𝐎𝐈𝐓𝐌𝐒 
Reg R2 0.037 0.224 0.308* 0.002 0.399* 
p 0.495 0.075 0.032* 0.871 0.012* 














Reg R2 0.003 0.052 0.161 0.125 0.436* 
p 0.854 0.432 0.155 0.215 0.010* 
Corr  r 0.054 0.229 -0.401 -0.353 -0.660* 
𝐧.̂ ?⃗?  
𝐑𝐎𝐈𝐇𝐊 
Reg R2 0.002 0.006 0.111 0.259 0.379* 
p 0.961 0.802 0.245 0.063 0.020* 
Corr  r 0.014 0.074 -0.333 -0.510 -0.616* 
|E| 
𝐑𝐎𝐈𝐓𝐌𝐒 
Reg R2 0.003 0.013 0.028 0.342* 0.329* 
p 0.845 0.703 0.565 0.028* 0.032* 
Corr  r 0.057 0.057 -0.169 -0.585* -0.574* 
𝐧.̂ ?⃗?  
𝐑𝐎𝐈𝐓𝐌𝐒 
Reg R2 0.125 0.001 0.104 0.274 0.522* 
p 0.215 0.963 0.261 0.054 0.004* 





Figure 5.7 Association between Anatomical Factors and Electrical Field. Multiple linear 
regressions were used to test which of the obtained anatomical factors explained the individual EF 
(strength |𝐸|, and normal components 𝑛.̂ ?⃗?  ) at the two ROIs (𝑅𝑂𝐼𝐻𝐾 and 𝑅𝑂𝐼𝑇𝑀𝑆). The results 
indicate that electrode to cortex distance (ECD), explains the EFs for both ROIs, and that also CSF 
volume, and thickness partially explains the variability of EFs. No correlation was found however 
for the remaining anatomical factors. Values at the top of each bar-graph represent the percentage 




Figure 5.8. Scatterplots for the association between individual Anatomical Factors and 
Electrical Fields. The associations between anatomical factors including scalp, skull and CSF 
thickness, CSF volume and electrode to cortex distance (ECD), and averaged EFs (strength (|E|) 
and normal component (𝑛.̂ ?⃗? )) extracted from two ROIs (𝑅𝑂𝐼𝐻𝐾 and 𝑅𝑂𝐼𝑇𝑀𝑆), are shown for 




5.3.4. Association between Anatomical Factors, Electrical Fields and tDCS-
induced MEP Alterations 
The results of linear regressions and Pearson correlation coefficients indicated that, 
for the anodal group, skull thickness significantly predicted the ∆MEP variance of 
2.0mA-tDCS (early epoch: R2=0.427, 𝑝FDR=0.014, r=0.653). CSF thickness 
significantly predicted  the ∆MEP variabilities of stimulation intensities at the early 
epoch (0.5mA-tDCS: R2=0.409, 𝑝FDR=0.042, r=-0.640, 1.0mA-tDCS: R
2= 0.364, 
𝑝FDR=0.041, r=-0.604, r=-0.530, and 2.0mA-tDCS: R
2=0.379, 𝑝FDR=0.021, r=-
0.616), and ECD had a similar predictive power (early epoch: 0.5mA-tDCS: 
R2=0.302, 𝑝FDR=0.045, r=-0.550, 1.0mA-tDCS: R
2=0.300, 𝑝FDR=0.045, r=-0.546, 
1.5mA-tDCS: R2=0.370, 𝑝FDR=0.032, r=-0.609, and 2.0mA-tDCS: R
2=0.500, 
𝑝FDR=0.012, r=-0.707). In addition, |E| predicted ∆MEP variance significantly at  
𝑅𝑂𝐼𝐻𝐾 (early epoch: 0.5mA-tDCS: R
2=0.385, 𝑝FDR=0.042, r=0.621, 1.0mA-tDCS: 
R2=0.480, 𝑝FDR=0.036, r=0.693, 1.5mA-tDCS: R
2=0.454, 𝑝FDR=0.044, r=0.674), 
and at 𝑅𝑂𝐼𝑇𝑀𝑆 (early epoch: 0.5mA-tDCS: R
2= 0.416, 𝑝FDR=0.012, r=0.645, 1.0mA-
tDCS: R2= 0.361, 𝑝FDR=0.040, r=0.601, and 2.0mA-tDCS: R
2= 0.421, 𝑝FDR=0.014, 
r=0.650). Furthermore, n.̂ E⃗  predicted ∆MEP variance significantly at  𝑅𝑂𝐼𝐻𝐾 (early 
epoch: 0.5mA-tDCS: R2= 0.300, p=0.048, r=0.546, 1.0mA-tDCS: R2=0.405, 
𝑝FDR=0.041, r=0.636, and 2mA-tDCS: R
2=0.480, 𝑝FDR=0.012, r=0.693), and at 
𝑅𝑂𝐼𝑇𝑀𝑆 (early epoch: 1.0mA-tDCS: R
2= 0.339, 𝑝FDR=0.041, r=0.582, and 2.0mA-
tDCS: R2= 0.494, 𝑝FDR=0.012, r=0.703), Figure 5.9.A.1, Figure 5.10, Table 5.3. 
However, none of the predictors did explain the MEP variabilities of anodal tDCS 
intensities at the late epoch, Figure 5.9.A.2, Figure 5.11, Table 5.3. For the cathodal 
group, CSF thickness only explained the ∆MEP variance of 1.0mA-tDCS (early 
epoch: R2=0.553, 𝑝FDR=0.009, r=-0.774; late epoch: R
2= 0.372, 𝑝FDR=0.025, r=-
0.609) respectively. In addition, ECD significantly explained the ∆MEP variability 
of only 1mA tDCS (early epoch: R2=0.497, 𝑝FDR=0.011, r=-0.705; late epoch: 
R2=0.444, 𝑝FDR=0.020, r=-0.666). Furthermore, the |E| and n.̂ E⃗ , both at 𝑅𝑂𝐼𝐻𝐾, 
predicted MEP variabilities induced by tDCS intensities of 1.0mA at the early epoch 
(R2=0.444, 𝑝FDR=0.015, r=0.666, R
2=0.508, 𝑝FDR=0.011, r=0.712), and n.̂ E⃗  at 
𝑅𝑂𝐼𝐻𝐾 predicted MEP variability for 1mA also at the late epoch (R
2=0.534, 
𝑝FDR=0.014, r=0.734). Moreover, at 𝑅𝑂𝐼𝑇𝑀𝑆, |E| and n.̂ E⃗   significantly predicted the 
∆MEP variabilities of 1mA-tDCS intensity (early epoch: R2= 0.445, 𝑝FDR=0.015, 
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r=0.667, R2= 0.332, 𝑝FDR=0.034, r=0.568; late epoch (only |E|): R
2= 0.539, 
𝑝FDR=0.014, r=0.734), Figure 5.9.B.1,2, Figure 5.12,  Figure 5.13, Table 5.4.  
Table 5.3 Association between Anatomical Factors, Electrical Fields and anodal tDCS-
induced MEP Alterations. Multiple linear regressions (Reg) were used to test whether and to 
which extent the individual variability of the neurophysiological effects of anodal tDCS (evaluated 
by MEP amplitude alterations) can be explained by the respective individual EF (for the (ROIHK 
and ROITMS), or anatomical factors. In addition, Pearson’s correlation coefficient (Corr) was 
calculated to further identify the directionality of each regression result. The p-values were 
adjusted for multiple comparisons using the False Discovery Rate (FDR). Asterisks indicate 
significant results.     
     Thickness   Electrical Field 
































Reg R2 0.035 0.041 0.409* 0.294 0.302* 0.385* 0.300 0.416* 0.269 
p 0.502 0.502 0.042* 0.055 0.045* 0.042* 0.048* 0.012* 0.061 
Corr r -0.188 0.202 -0.640* 0.542 -0.550* 0.621* 0.546* 0.645* 0.518 
1.0 
mA 
Reg R2 0.007 0.001 0.364* 0.022 0.300* 0.480* 0.405* 0.361* 0.339* 
p 0.850 0.900 0.041* 0.757 0.045* 0.036* 0.041* 0.040* 0.041* 
Corr r -0.087 0.035 -0.604* 0.148 -0.547* 0.693* 0.636* 0.601* 0.582* 
1.5 
mA 
Reg R2 0.079 0.027 0.281 0.006 0.370* 0.454* 0.195 0.310 0.261 
p 0.395 0.631 0.094 0.791 0.032* 0.044* 0.148 0.093 0.094 
Corr r -0.282 0.163 -0.530 0.075 -0.609* 0.674* 0.442 0.557 0.510 
2.0 
mA 
Reg R2 0.012 0.427* 0.379* 0.149 0.500* 0.256 0.480* 0.421* 0.494* 
p 0.700 0.014* 0.021* 0.174 0.012* 0.064 0.012* 0.014* 0.012* 
























Reg R2 0.002 0.211 0.055 0.244 0.099 0.035 0.062 0.033 0.061 
p 0.886 0.378 0.579 0.378 0.579 0.579 0.579 0.579 0.579 
Corr r 0.041 0.456 -0.236 -0.495 -0.315 0.186 0.248 0.182 0.275 
1.0 
mA 
Reg R2 0.041 0.041 0.011 0.012 0.031 0.004 0.006 0.001 0.010 
p 0.873 0.897 0. 897 0. 886 0. 847 0.827 0.782 0.897 0.830 
Corr r -0.444 0.203 -0.106 0.109 -0.178 0.062 0.078 0.037 0.097 
1.5 
mA 
Reg R2 0.006 0.006 0.087 0.002 0.148 0.008 0.045 0.022 0.061 
p 0.865 0.775 0.745 0.865 0.721 0.754 0.746 0.798 0.773 
Corr r 0.139 0.081 -0.296 -0.048 -0.385 0.089 0.213 0.148 0.249 
2.0 
mA 
Reg R2 0.093 0.092 0.052 0.021 0.121 0.201 0.063 0.128 0.084 
p 0.729 0.532 0.532 0.678 0.532 0.532 0.632 0.521 0.601 










Figure 5.9 Explanatory power of anatomical factors and electrical fields for tDCS-induced 
MEP alterations. Anatomical factors, and individual EF (magnitude |𝐸|, and normal 
component 𝑛.̂ ?⃗? s ) at two ROIs (𝑅𝑂𝐼𝐻𝐾 and 𝑅𝑂𝐼𝑇𝑀𝑆) were used to explore if these can explain 
MEP variabilities of four active tDCS conditions (0.5mA, 1.0mA, 1.5mA and 2.0mA) at early (0-
60min) and late (75-120min) epochs after stimulation. A) Anodal group: the results indicate that 
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CSF thickness and electrode to cortex distance (ECD), and |𝐸| and 𝑛.̂ ?⃗?  for 𝑅𝑂𝐼𝐻𝐾 and 𝑅𝑂𝐼𝑇𝑀𝑆 
significantly predicted the ∆MEP variance of almost all tDCS dosages for the early, but not late 
epoch. B) Cathodal group: CSF thickness, ECD, |𝐸| and 𝑛.̂ ?⃗?  for 𝑅𝑂𝐼𝐻𝐾 and 𝑅𝑂𝐼𝑇𝑀𝑆 significantly 
predicted the ∆MEP variance of only 1mA-tDCS at early and late epochs (with the exception of 
|𝐸| for 𝑅𝑂𝐼𝐻𝐾, and 𝑛.̂ ?⃗?  for 𝑅𝑂𝐼𝑇𝑀𝑆, both at late epoch). Values at the top of each bar-graph 
represent the percentage of explained variability (R2), for p<0.05. The p-values were adjusted for 
multiple comparisons using the False Discovery Rate (FDR). Asterisks indicate significant results. 
 
Figure 5.10. Scatterplots for the association between Anatomical Factors, Electrical Fields 
and anodal tDCS-induced MEP Alterations (early epoch). The associations between 
anatomical factors including scalp, skull and CSF thickness, CSF volume and electrode to cortex 
distance (ECD), averaged EFs (strength (|E|) and normal component (𝑛.̂ ?⃗? )) extracted from two 
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ROIs (𝑅𝑂𝐼𝐻𝐾 and 𝑅𝑂𝐼𝑇𝑀𝑆), and tDCS-induced MEP alterations are shown for anodal tDCS (early 
epoch). The best fitting regression lines are superimposed. 
 
Figure 5.11. Scatterplots for the association between Anatomical Factors, Electrical Fields 
and anodal tDCS-induced MEP Alterations (late epoch). The associations between anatomical 
factors including scalp, skull and CSF thickness, CSF volume and electrode to cortex distance 
(ECD), averaged EFs (strength (|E|) and normal component (𝑛.̂ ?⃗? )) extracted from two ROIs 
(𝑅𝑂𝐼𝐻𝐾 and 𝑅𝑂𝐼𝑇𝑀𝑆), and tDCS-induced MEP alterations are shown for anodal tDCS (late epoch). 







Figure 5.12. Scatterplots for the association between Anatomical Factors, Electrical Fields 
and cathodal tDCS-induced MEP Alterations (early epoch). The associations between 
anatomical factors including scalp, skull and CSF thickness, CSF volume and electrode to cortex 
distance (ECD), averaged EFs (strength (|E|) and normal component (𝑛.̂ ?⃗? )) extracted from two 
ROIs (𝑅𝑂𝐼𝐻𝐾 and 𝑅𝑂𝐼𝑇𝑀𝑆), and tDCS-induced MEP alterations are shown for cathodal tDCS 






Figure 5.13. Scatterplots for the association between Anatomical Factors, Electrical Fields 
and cathodal tDCS-induced MEP Alterations (late epoch). The associations between 
anatomical factors including scalp, skull and CSF thickness, CSF volume and electrode to cortex 
distance (ECD), averaged EFs (strength (|E|) and normal component (𝑛.̂ ?⃗? )) extracted from two 
ROIs (𝑅𝑂𝐼𝐻𝐾 and 𝑅𝑂𝐼𝑇𝑀𝑆), and tDCS-induced MEP alterations are shown for cathodal tDCS (late 






Table 5.4 Association between Anatomical Factors, Electrical Fields and cathodal tDCS-
induced MEP Alterations. Multiple linear regressions (Reg) were used to test whether and to 
which extent the individual variability of the neurophysiological effects of cathodal tDCS 
(evaluated by MEP amplitude alterations)  can be explained by the respective individual EF (for 
the (ROIHK and ROITMS), or anatomical factors. In addition, Pearson’s correlation coefficient 
(Corr) was calculated to further identify the directionality of each regression result. The p-values 
were adjusted for multiple comparisons using the False Discovery Rate (FDR). Asterisks indicate 
significant results.    
     Thickness    Electrical Field 



































R2 0.057 0.049 0.139 0.113 0.065 0.136 0.036 0.046 0.003 
p 0.517 0.485 0.473 0.541 0.579 0.594 0.517 0.560 0.840 




R2 0.054 0.080 0.553* 0.003 0.497* 0.444* 0.508* 0.445* 0.322* 
p 0.478 0.420 0.009* 0.851 0.011* 0.015* 0.011* 0.015* 0.034* 




R2 0.087 0.178 0.001 0.006 0.013 0.008 0.017 0.004 0.174 
p 0.891 0.833 0.972 0.798 0.731 0.754 0.760 0.834 0.137 




R2 0.108 0.076 0.008 0.419 0.020 0.005 0.001 0.001 0.018 
p 0.252 0.339 0.818 0.108 0.626 0.809 0.950 0.851 0.646 

























R2 0.002 0.007 0.079 0.276 0.028 0.099 0.009 0.011 0.036 
p 0.878 0.867 0.867 0.486 0.842 0.873 0.744 0.828 0.517 




R2 0.009 0.031 0.372* 0.115 0.444* 0.250 0.534* 0.539* 0.243 
p 0.748 0.617 0.025* 0.305 0.020* 0.102 0.014* 0.014* 0.074 




R2 0.035 0.049 0.001 0.002 0.006 0.014 0.001 0.006 0.042 
p 0.724 0.747 0.923 0.872 0.933 0.686 0.880 0.791 0.480 




R2 0.019 0.075 0.103 0.193 0.044 0.103 0.057 0.024 0.001 
p 0.635 0.630 0.630 0.516 0.670 0.662 0.611 0.699 0.913 







5.3.5. Association between Anatomical Factors or Electrical Fields and tDCS-
induced CBF alterations 
The results of the linear regressions and Pearson correlation coefficients indicate that 
for the anodal group, CSF thickness significantly predicted the ∆CBF variabilities 
(early epoch: 1.0mA-tDCS: R2=0.403, 𝑝FDR=0.047, r=-0.635). CSF volume had also 
significant predictive power for the early epoch (1.0mA-tDCS: R2=0.470, 
𝑝FDR=0.040, r=-0.685). Furthermore, ECD significantly explained the ∆CBF 
variabilities for the late epoch in the 1.0mA-tDCS condition (R2=0.448, 𝑝FDR=0.040, 
r=-0.670). In addition, the |E| at 𝑅𝑂𝐼𝐻𝐾 explained the ∆CBF variance with 
significant predictive power (early epoch: 2.0mA-tDCS: R2=0.770, 𝑝FDR=0.007, 
r=0.878), and n.̂ E⃗  at 𝑅𝑂𝐼𝐻𝐾 had predictive power for the early epoch (1.0mA-tDCS: 
R2=0.504, 𝑝FDR=0.040, r=0.710) Figure 5.14.A.1, Figure 5.15, Table 5.5. However, 
none of the predictors could explain the ∆CBF variabilities at the late epoch, Figure 
5.14.A.2, Figure 5.16, Table 5.5. For the cathodal group, none of the predictors could 
explain the ∆CBF variabilities at the early epoch, Figure 5.14.B.1, Figure 5.17, Table 
5.6. However, for the late epoch, CSF thickness significantly predicted ∆CBF 
variabilities (1.5mA-tDCS: R2=0.559, 𝑝FDR=0.007, r=-0.774). Furthermore, ECD 
significantly explained the ∆CBF variabilities for the late epoch (1.5mA-tDCS: 
R2=0.485, 𝑝FDR=0.014, r=-0.696). In addition, the |E| at 𝑅𝑂𝐼𝐻𝐾 explained the ∆CBF 
variance with significant predictive power for the late epoch (1.5mA-tDCS: 
R2=0.558, 𝑝FDR=0.007, r=0.747, 2.0mA-tDCS R
2=0.504, 𝑝FDR=0.014, r=0.710), and 
n.̂ E⃗  at 𝑅𝑂𝐼𝐻𝐾 predicted ∆CBF also for the late epoch (1.5mA-tDCS: R
2=0.608, 




Figure 5.14 Anatomical factors and electrical field values to explain tDCS-induced CBF 
alterations. The impact of anatomical factors and/or individual EF (magnitude |𝐸|, and normal 
components 𝑛.̂ ?⃗?  ) at 𝑅𝑂𝐼𝐻𝐾, were explored with respect to their predictive power for ∆CBF 
variabilities, of four active tDCS conditions (0.5mA, 1.0mA, 1.5mA and 2.0mA) for early (0-
60min) and late (75-120min) epochs after stimulation.. A) Anodal group: CSF thickness and 
volume, and ECD predicted ∆CBF variabilities for 1mA-tDCS at the early epoch. Moreover, the 
|𝐸| at 𝑅𝑂𝐼𝐻𝐾 significantly explained ∆CBF variability of the 2.0mA-tDCS condition at the early 
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epoch, and 𝑛𝐸 had significant predictive power for 1mA-tDCS at early the epoch. B) Cathodal 
group: CSF thickness, ECD, |𝐸| and 𝑛𝐸 at 𝑅𝑂𝐼𝐻𝐾, predicted ∆CBF variability of 1.5mA-tDCS, 
with also significant predictive power of |𝐸| for 2mA-tDCS, all only at the late epoch. Values at 
the top of each bar-graph represent the percentage of explained variability (R2), for p<0.05. The p-
values were adjusted for multiple comparisons using the False Discovery Rate (FDR). Asterisks 
indicate significant results. 
 
Figure 5.15. Scatterplots for the association between Anatomical Factors, Electrical Fields 
and anodal tDCS-induced CBF alterations (early epoch). Anatomical factors including scalp, 
skull and CSF thickness, CSF volume and electrode to cortex distance (ECD), and averaged EFs 
(strength (|E|) and normal component (n.̂ E⃗ )) extracted from two ROIs (ROIHK and ROITMS), are 
shown for the tDCS anodal group in relation to the tDCS effects on CBF (early epoch). The best 







Figure 5.16. Scatterplots for the association between Anatomical Factors, Electrical Fields 
and anodal tDCS-induced CBF alterations (late epoch). Anatomical factors including scalp, 
skull and CSF thickness, CSF volume and electrode to cortex distance (ECD), and averaged EFs 
(strength (|E|) and normal component (n.̂ E⃗ )) extracted from two ROIs (ROIHK and ROITMS), are 
shown for the tDCS anodal group in relation to the tDCS effects on CBF (late epoch). The best 





Figure 5.17. Scatterplots for the association between Anatomical Factors, Electrical Fields 
and cathodal tDCS-induced CBF alterations (early epoch). Anatomical factors including scalp, 
skull and CSF thickness, CSF volume and electrode to cortex distance (ECD), and averaged EFs 
(strength (|E|) and normal component (𝑛.̂ ?⃗? )) extracted from two ROIs (𝑅𝑂𝐼𝐻𝐾 and 𝑅𝑂𝐼𝑇𝑀𝑆), are 
shown for the tDCS cathodal group in relation to the tDCS effects on CBF (early epoch). The best 












Figure 5.18. Scatterplots for the association between Anatomical Factors, Electrical Fields 
and cathodal tDCS-induced CBF alterations (late epoch). Anatomical factors including scalp, 
skull and CSF thickness, CSF volume and electrode to cortex distance (ECD), and averaged EFs 
(strength (|E|) and normal component (𝑛.̂ ?⃗? )) extracted from two ROIs (𝑅𝑂𝐼𝐻𝐾 and 𝑅𝑂𝐼𝑇𝑀𝑆), are 
shown for the tDCS cathodal group in relation to the tDCS effects on CBF (early epoch). The best 
fitting regression lines are superimposed. 
 
 
Table 5.5 Association between Anatomical Factors, Electrical Fields and anodal tDCS-
induced CBF Alterations. Multiple linear regressions (Reg) were used to test whether and to 
which extent the individual variability of the neurophysiological effects of anodal tDCS (evaluated 
by CBF amplitude alterations) can be explained by the respective individual EF (for the 𝑅𝑂𝐼𝐻𝐾), 
or anatomical factors. In addition, Pearson’s correlation coefficient (Corr) was calculated to further 
identify the directionality of each regression result. The p-values were adjusted for multiple 
comparisons using the False Discovery Rate (FDR). Asterisks indicate significant results.    
     Thickness   Electrical Field 
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R2 0.078 0.023 0.221 0.005 0.256 0.204 0.171 
p 0.497 0.709 0.242 0.805 0.242 0.245 0.248 




R2 0.026 0.015 0.403* 0.470* 0.448* 0.310 0.504* 
p 0.701 0.701 0.047* 0.040* 0.040* 0.065 0.040* 




R2 0.022 0.094 0.001 0.067 0.002 0.090 0.060 
p 0.908 0.778 0.922 0.778 0.922 0.770 0.740 




R2 0.043 0.113 0.277 0.108 0.342 0.770* 0.309 
p 0.518 0.347 0.138 0.346 0.138 0.007* 0.138 

























R2 0.298 0.018 0.221 0.185 0.212 0.146 0.152 
p 0.206 0.647 0.207 0.208 0.198 0.289 0.209 




R2 0.032 0.152 0.100 0.001 0.135 0.132 0.068 
p 0.677 0.551 0.551 0.982 0.520 0.501 0.580 




R2 0.054 0.060 0.315 0.072 0.384 0.127 0.232 
p 0.464 0.443 0.151 0.168 0.154 0.357 0.198 




R2 0.118 0.143 0.002 0.034 0.001 0.007 0.001 
p 0.955 0.950 0.960 0.900 0.960 0.950 0.940 
Corr r -0.344 0.378 -0.045 -0.186 -0.032 0.082 0.006 
 
 
Table 5.6 Association between Anatomical Factors, Electrical Fields and cathodal tDCS-
induced CBF Alterations. Multiple linear regressions (Reg) were used to test whether and to 
which extent the individual variability of the neurophysiological effects of cathodal tDCS 
(evaluated by CBF amplitude alterations) can be explained by the respective individual EF (for the 
𝑅𝑂𝐼𝐻𝐾), or anatomical factors. In addition, Pearson’s correlation coefficient (Corr) was calculated 
to further identify the directionality of each regression result. The p-values were adjusted for 
multiple comparisons using the False Discovery Rate (FDR). Asterisks indicate significant results.    
     Thickness   Electrical Field 






























R2 0.001 0.002 0.169 0.069 0.092 0.042 0.084 
p 0.876 0.876 0.538 0.639 0.638 0.674 0.639 




R2 0.250 0.073 0.005 0.120 0.011 0.004 0.009 
p 0.546 0.868 0.817 0.865 0.883 0.883 0.851 
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R2 0.003 0.130 0.009 0.016 0.001 0.002 0.023 
p 0.891 0.826 0.758 0.880 0.835 0.891 0.822 




R2 0.052 0.027 0.004 0.015 0.006 0.010 0.002 
p 0.876 0.812 0.838 0.807 0.807 0.854 0.887 

























R2 0.001 0.008 0.066 0.207 0.036 0.001 0.056 
p 0.941 0.941 0.386 0.721 0.941 0.946 0.714 




R2 0.063 0.278 0.034 0.011 0.005 0.002 0.008 
p 0.870 0.448 0.553 0.739 0.845 0.870 0.773 




R2 0.166 0.095 0.559* 0.036 0.485* 0.558* 0.608* 
p 0.246 0.355 0.007* 0.536 0.014* 0.007* 0.007* 




R2 0.318 0.241 0.240 0.323 0.327 0.504* 0.192 
p 0.082 0.125 0.225 0.082 0.066 0.014* 0.176 
Corr r -0.563 0.491 -0.490 0.568 -0.572 0.710* 0.439 
 
5.4. Discussion  
In the present study, based on neurophysiological data obtained in former studies of 
our group, which explored tDCS-induced MEP (induced by TMS) and CBF 
(measured by ASL-fMRI) alterations, we investigated the association between 
individual anatomical factors and tDCS-induced EF, and the respective 
physiological outcomes at the level of the individual. To this end, we first explored 
the contribution of individual anatomical factors to EF variabilities (strength: |E|, 
and normal components: n.̂ E⃗  ) at two ROIs (𝑅𝑂𝐼𝐻𝐾 and 𝑅𝑂𝐼𝑇𝑀𝑆). At the second 
level, we investigated whether and to which degree the individual anatomical factors 
and EFs predict the tDCS-induced MEP and CBF changes. In general, of the 
included anatomical factors, ECD, and partially CSF parameters, significantly 
explained interindividual EF variabilities. Higher EF values were associated with 
lower ECD, and CSF thickness. In addition, apart from the observed tDCS dosage-
dependent physiological effects, the results of the present study revealed that CSF 
thickness and ECD, as well as EFs, reliably predicted physiological effects of 
stimulation. These associations were however restricted to stimulation conditions 
which altered respective physiological measures in comparison with respective 
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baseline and/or sham values. In what follows, we discuss these findings in more 
detail, and add mechanistic explanations. 
The results are in accordance with previous findings, in which CSF thickness and 
also ECD were suggested as key factors of EF simulations, and negatively correlated 
with individual EFs [59, 60]. Furthermore, with respect to the association between 
EFs and neurophysiological outcomes of tDCS, the results of our study are in 
accordance with those of another study showing a positive correlation between EF 
strength and physiological outcomes of the intervention [63]. An opposing finding 
was however reported for 1mA anodal tDCS-induced EFs and individual MEP 
amplitude alterations in another study, where no significant MEP modulations were 
observed for the active condition vs. sham [62]. The missing overall effect of tDCS 
in that study is however in line with our findings in which the significant association 
between the predictors and the neurophysiological effects were obtained only for 
epochs with observed physiological responses.  
5.4.1. Proposed mechanism 
From the amount of electrical current that is applied between two electrodes 
positioned on the head, a portion is shunted across the scalp [233]. The remaining 
current is then passed via the different tissue components of the skull, the CSF, and 
then reaches the brain, resulting in EF at the level of the gray matter and underlying 
tissues. The high inter-individual anatomical variability of respective tissues [234, 
235] has been shown to strongly contribute to tDCS-induced EF variability across 
subjects [109].  
Despite the complex interplay between tissue compartments, we found that a major 
part of  the variance of the regional EFs can be explained by individual ECD and 
CSF-related parameters. With respect to the relevance of ECD, this finding is 
supported by reports showing that RMT, which is positively correlated with scalp-
to-cortex distance [236], correlates negatively with tDCS-induced EF strength [61]. 
It can be thus assumed that a larger electrode-to-cortex distance results in lower 
current densities, and EF induced by tDCS over the targeted area. In the same vein, 
a thicker layer of CSF results in weaker EF at the level of the cortical target areas 
[59, 60]. Indeed, the significant role of CSF thickness might be due to the 
considerably larger electrical conductivity of CSF compared to other brain tissues, 
123 
 
resulting in a preferential pathway for the injected currents. The lack of predictive 
power of the other anatomical factors might be related to their limited volumes, and 
heterogeneous electrical conductivities. In principle accordance, individual CSF 
thickness and coil/scalp-to-cortex distance have shown to correlate strongly not only 
with tDCS-, but also with TMS-induced EFs [237], and TMS-evoked motor 
thresholds [236, 238, 239], respectively.  
The principle mechanism responsible for the physiological effects of tDCS at the 
neuronal level is assumed to be a subthreshold alteration of neuronal membranes, 
whose directionality depends on the relation of EF to neuronal orientation, and 
subsequently alter firing rates. Prolonged stimulation modulates synaptic efficacy, 
which is controlled by NMDA receptors, calcium-dependent mechanisms, and 
downregulation of the GABAergic system [85, 169, 240]. In this line, a positive 
association between increased stimulation dosage, within certain limits, and tDCS 
efficacy enhancement has been reported [20, 96]. It has however also been shown 
that exceeding stimulation dosage beyond respective limits with respect to 
stimulation intensity, and duration results in non-linear effects, which depend on 
calcium concentration [65, 67, 68, 82, 89]. The observed positive correlation 
between the individual EFs, and anodal tDCS after-effects in the present study fits 
nicely with these prior findings, indicating  stimulation intensity-dependent 
increased efficacy of anodal tDCS to enhance MEP amplitudes [19], and CBF 
changes, as far as these can be dedicated to neuronal effects. The relatively lower 
predictive power of EF values for anodal tDCS effects on CBF, as compared to MEP, 
might be due to the mixed effects of tDCS on vessels, and neural excitability [241, 
242].  
In contrast, our results showed a more limited predictive power of CSF thickness, 
ECD, and EF for explaining intensity-dependent cathodal tDCS-induced MEP 
alterations. This might be caused to some degree by the non-linear physiological 
effects of motor cortex cathodal tDCS within the tested dosage range. While anodal 
tDCS shows a linear dosage-effect relationship for a relatively broad range of 
stimulation intensities, non-linear effects were observed for cathodal tDCS, with 
higher intensities converting the effects of cathodal tDCS into an excitability 
enhancement, or no effects [64, 65, 98, 183]. This was also observed in the present 
study, where only 1 mA stimulation resulted in a clear excitability diminution. In 
accordance, the clearest effects with respect to the association of EF, and MEP size 
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were seen for a stimulation intensity of 1.0 mA. For CSF, furthermore for 1.5 mA 
stimulation intensity such an association was revealed. These results further support 
previous findings that an association between EF, and physiological effects of tDCS 
can only be identified if the latter do emerge, which is the case for 1.0 mA stimulation 
intensity for MEP, and additionally 1.5 mA stimulation intensity for CSF measures. 
Furthermore, in difference to associations between EF and MEP, which did already 
emerge in the early epoch, respective EF associations with CSF were visible only in 
the later epoch. On the one hand, this fits to the assumption that clear physiological 
effects should be present to identify such an association, because CSF effects of 
cathodal tDCS were larger in the late epoch. On the other hand, the missing 
predictive power of explanatory variables for the early epoch of cathodal tDCS-
altered CBF amplitudes could be explained by non-homogeneous effects of cathodal 
tDCS on neural excitability, and vessels, as well as different temporal dynamics of 
the respective contributions [88, 241, 242]. At present, these explanations are 
speculative, and should be explored in future studies directly. 
In general, the model developed in this study showed relatively good predictions of 
tDCS-induced physiological effects, it explained about 50% of the observed 
variability. Beyond the physical factors, which were explored in the present study, 
however other confounding factors might also contribute to inter-individual 
variability of tDCS effects, including brain state, neurotransmitter and modulator 
availability [45, 109, 243], as well as network effects of locally induced plasticity 
[87, 244-247], which have already been shown to affect tDCS outcome. Moreover,  
for predicting the neuromodulatory effects of NIBS, nonlinearities of neuroplastic 
responses have to be taken into account, which also differ inter-individually, as 
shown in a recent study for theta burst stimulation [175]. Therefore, advanced 
computational approaches, which incorporate realistic neuronal models, are required 
to approximate the effects of the intervention on different neural circuits, in addition 
to respective EF simulations [197, 198]. Finally, the models developed in this study 
might be relevant for other NIBS modes beyond tDCS, such as TMS, where 
stimulation intensity with respect to various cortical targets is individualized based 
on motor cortex reactivity, which however might has limited value for stimulation 
of other brain areas, such as the dorsolateral prefrontal cortex, a hub for cognitive 




5.4.2. Limitation and future directions 
In the present study, we used a well-stablished computational modeling pipeline to 
simulate tDCS-induced EF, which has been shown to predict in-vivo intra-cranial EF 
recordings well [187].  However, this modeling approach might be improved by 
considering several issues in future studies. The first issue is related to the validity 
of the estimated EF. Efforts have been made to validate and/or evaluate the accuracy 
of ´ modelling results by comparing measurements from electroencephalography 
(EEG) surface recordings [192], physiological effects in vivo in simians [248], and 
humans [249, 250], in vivo intracranial recordings from humans [251], and magnetic 
resonance current density imaging (MRCDI) [252, 253]. Model predictions from 
scalp surface voltages face however limitations, as the induced scalp voltages can 
prove the accuracy of the high-resolution individualized model at the level of the 
scalp, but not directly validate the model prediction of current flow at the level of 
the brain [187, 192]. On the other hand, direct in vivo measurements of EF are 
strongly sensitive to experimental procedures, resulting in measurement errors which 
can under- or overestimate the distributed EF inside the brain [46], and  compared to 
MRCDI measurements, simulations underestimate current densities on average by 
24% [252, 253]. There is therefore a strong need to improve the validity and accuracy 
of computational modeling, which should be considered in future studies. 
Furthermore, in this study we segmented the head tissues into seven major 
compartments, in line with recent studies [63, 187]. Other works have however 
highligheted the importance of including additional head tissues to improve the 
accuracy of predicted EF results. For example, subcutaneous fat and muscle tissues 
have been suggested to profoundly affect the magnitude and distribution pattern of 
induced current density in some studies [254, 255]. Other studies have however 
suggested only a small contribution of these tissues (e.g. differences in head fat 
thickness are assumed to contribute only to ~10% additional variability with respect 
to peak cortical current density  [256]). Likewise, skull compartments have been 
shown to influence the estimated EF in some studies [60, 257, 258], but suggested 
to be negligble in another study [187]. In addition, we treated all internal tissues of 
the brain as WM; other studies have however further subdivided internal brain 
tissues for the reconstructed head model (e.g 40 head compartments [259], or 20 
anatomical regions [197]). Despite increasing the cost and complexity of 
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computation, this might improve the accuracy of the estimated EF. Furthemore, brain 
tissue anisotropic conductivity, specially of WM, has been shown to influence  EF 
directionality, especially within the sulci [257], and EF magnitude [260], but again 
other studies suggested that its effects might be negligble [187, 197].  Moreover, 
there are still uncertainties related to individual tissue electrical conductivity [261, 
262], as conductivity is usually determined based on an average of a range of values 
found in the literature based on ex-vivo measurements in animal and human tissues. 
Reliable measurements of these conductivities at the level of the individual are 
difficult to obtain, and the results vary considerably between subjects [56]. Recently 
developed MR-based methods of conductivity and curent density measurements 
such as MRCDI or magnetic resonance electrical impedance tomography [252, 253, 
263, 264] might open of a window to address these uncertainities, and should be 
considered in future studies.  
In addition, due to limited MRI resolution (1mm3), image noise, and low contrast in 
some areas, automatic tissue segmentation might suffer from inherent errors, 
including discontinuities in the CSF, and unassigned/ disconnected voxels, among 
others (for detail please see [214, 265] ). In this study, we tried to correct these errors 
via two steps: 1) automatic correction (in Matlab), and 2) manual correction (via 
Simpleware, +ScanIP) by comparing the original and automatically corrected head 
tissue masks [187, 214]. Despite these, some parts of brain tissues (e.g. thin layers 
of CSF) might not have been accurately be reconstructed due to low resolution of 
conventional 1 mm3 MRI, which might then influence the measured anatomical 
factors, as well as the resulting EF simulation [46, 201, 265]. Furthermore, MRI 
studies have shown that CSF thickness changes when a subject moves from prone to 
supine position [266, 267]. This has been shown to affect the magnitude of EEG 
signals [267], is suggested also to influence cortical activity [268], and has an impact 
of about 10% on simulations of tDCS-induced EF [269]. This might be important, 
as tDCS is applied usually when subjects are in an upright position, whereas MR 
images, which are the main materials used of realistic head models, are typically 
acquired with the subject lying in a supine position. This causes concerns about the 
extent to which the individual MR-derived EF simulations represent the tDCS-
generated EF distribution in real-life, and should be considered in future studies.  
Moreover, the target population in this study was healthy young humans. However, 
the neurophysiological effects of tDCS can be affected by stimulation protocol, age, 
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gender as well as neurological and neupsychiatric disorders [113, 115, 184, 270-
273]. These confounding factors, which also affect tDCS-induced EFs, should be 
taken into consideration for the extension of the results obtained in this study to other 
populations.  Finally, we mainly focused on regional effects of tDCS, but not on 
network effects; considering these in future studies might further improve our 
understanding of intervention effects. 
5.5. Conclusions 
This study shows that individual anatomical factors (including CSF thickness and 
electrode-to-cortex distance (ECD)), significantly explain inter-individual EF 
variabilities. In addition, CSF thickness, and ECD were negatively correlated, 
whereas EFs were positively correlated with tDCS-induced physiological changes. 
It general, our study demonstrates the usefulness of computational modeling, similar 
to the one used in this study, for the prediction of EF, and physiological effects 
induced by tDCS. However, considering other relevant head tissues, anisotropic 
conductivity, as well as individual electrical conductivity, and neuronal models 
might improve modeling accuracy and potentially the predictive power for the 
neurophysiolocal effects of tDCS. In addition, the transferability of these results to 
other cortical areas, age, and patient populations should be considered in future 
studies. This study provides further insights into the dependency of neuromodulatory 
effects of tDCS from individual anatomy, and the usefulness of electrical field 








6 Study 5: Transferability of tDCS effects from the primary motor 
to the dorsolateral prefrontal cortex: a multimodal TMS-EEG 
study 
6.1. Introduction 
Neuroplasticity, an important foundation of cognitive processes such as learning and 
memory formation, is the property of the brain to adjust the strength and/or the 
efficacy of neural connections in response to environmental changes or injuries [11, 
12]. Non-invasive brain stimulation (NIBS) protocols, in humans, have been shown 
to induce and modulate brain plasticity, and thus open a window to shed light on the 
underlying brain functions [76, 181], to explore the physiological foundation of 
cognitive processes, and to improve symptoms of associated neurological and 
psychiatric disorders [17, 18]. 
One of those tools, transcranial direct current stimulation (tDCS), has been shown to 
bidirectionally induce neuroplasticity in the targeted area, by delivering weak direct 
electrical currents through the scalp via two electrodes placed on the head.  For the 
primary motor cortex, anodal tDCS, which refers to surface inward current over the 
target area, results in enhancement of cortical excitability, whereas cathodal tDCS, 
which refers to outward current over the target area, reduces it. The direction, and 
strength of effects depends on the stimulation parameters, such as polarity and 
intensity/duration [20, 96, 116].  
tDCS-induced neuroplastic after-effects have so far been most extensively 
investigated for the primary motor cortex, and less often in other cortical areas, such 
as visual, auditory and somatosensory areas [72, 73, 274]. The results obtained for 
the primary motor cortex, as indicated by transcranial magnetic stimulation (TMS)-
induced motor evoked potentials (MEP), suggest a positive association of the 
obtained excitability alterations with increased stimulation dosage within certain 
limits [20, 96]. Stimulation dosage-dependent non-linear after-effects were however 
observed when stimulation settings exceed the limits of conventional protocols [65, 
67, 68, 82, 89]. Notwithstanding, it remains unclear to what extent motor tDCS 
effects transfer to other brain regions, as the number of available studies is limited. 
Over the sensorimotor cortex, anodal tDCS increased the amplitude of 
somatosensory potentials, whereas cathodal tDCS had no effects in one study [73], 
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while another study showed excitability-diminishing effects of only cathodal tDCS  
[74]. For the effects of tDCS on visual evoked potentials, anodal tDCS enhanced, 
and cathodal tDCS reduced cortical excitability, however, the duration of the effects 
was relevantly shorter as compared to motor cortex stimulation with otherwise 
identical protocols [72]. The results of these studies show only a gradual 
comparability of stimulation effects. Taking anatomical, as well as receptor, and 
neurotransmitter distribution differences of distinct cortical areas into account,  these 
gradual differences of effects are plausible, and require direct physiological tests of 
tDCS over respective target areas [22].  
This is of critical importance, since tDCS has been probed not only to improve 
symptoms of motor-related neurological disorders [18], and/or to explore the 
physiological foundation of motor functions [22], but its neuromodulatory effects 
have been also extensively explored for the treatment of neuropsychiatric diseases 
[21], and physiological mechanisms underlying cognitive functions, including 
working memory (WM), and mood and emotional states, with the dorsolateral 
prefrontal cortex (DLPFC) as target region [32, 35, 275]. However, the 
neurophysiological effects of tDCS on this area have been much less explored. A 
recently developed multimodal neuroimaging technique, which combines TMS and 
electroencephalography (EEG), opened up a window to address modulatory effects 
of tDCS, and other NIBS techniques, on cortical excitability of different brain 
regions, as indexed by TMS-evoked potentials (TEPs) recorded from scalp EEG 
electrodes [276]. 
Few studies have employed TMS-EEG so far to evaluate tDCS effects. Anodal and 
cathodal tDCS with 1mA for 13min applied over the primary motor cortex have 
been shown to induce a bidirectional ‘anodal-enhancement cathodal-inhibition’ 
modulation of early TEP amplitudes. For the prefrontal cortex, anodal tDCS with 
1mA for 20min, applied with bipolar and high-definition tDCS (HD-tDCS), induced 
likewise an increase of local early TEP peaks, and a decrease of TMS-evoked beta 
and gamma oscillatory power over posterior EEG channels [277, 278]. In another 
study, with a newly developed electrode configuration, tDCS with 1.5mA for 14min, 
targeting the left DLPFC with the anode, and the right DLPFC with the cathode, 
however showed a reduction of late TEPs (about 120ms after the TMS pulse) over 
only the parietal cortex, accompanied by a reduction of TMS-evoked power of theta 
and gamma oscillations at the global scalp level, whereas tDCS with opposite 
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electrode positions had no effects [279]. Thus, most TMS-EEG studies so far 
indicated qualitatively comparable results of tDCS over the motor and prefrontal 
cortex, however the number of studies is scarce, and results are partially 
heterogeneous. A systematic comparative investigation of the neuroplastic effects of 
tDCS over these different brain regions is therefore required. 
In a foregoing study, we systematically explored the dosage-dependent impact of 
cathodal tDCS on motor cortex excitability, as explored by TMS-generated MEP. In 
that study, we combined different stimulation intensities (1, 2, and 3mA, electrode 
size 35 cm2), and durations (15, 20 and 30min). MEP amplitudes were reduced by 
low and high intensity protocols, whereas an excitability enhancement was observed 
after medium intensity tDCS [65]. In the present study, we aimed to explore the 
transferability of these results from the primary motor to the dorsolateral prefrontal 
cortex. In eight randomized sessions, four cathodal tDCS dosages of low, medium 
and high intensity, as well as sham stimulation were applied over the primary motor, 
and dorsolateral prefrontal cortex, with current densities at the scalp-electrode 
interface identical to our foregoing study. tDCS-induced after-effects were then 
evaluated using the TMS-EEG, and TMS-MEP approaches at the regional level for 
TMS-evoked cortical reactivity, oscillations, and MEP alterations. Based on 
previous findings, we hypothesized that all active protocols would modulate TEP 
amplitudes compared to the respective baseline and/or sham conditions. We also 
anticipated dosage-dependent nonlinear TEP and MEP amplitude modulations for 
motor cortex tDCS. Furthermore, based on anatomical, pharmacological and 
functional differences between motor and prefrontal cortex, we expected gradually 
different patterns of the neurophysiological effects of tDCS over the prefrontal 
cortex, as compared to motor cortex tDCS.  
6.2. Material and Methods 
6.2.1. Participants 
Eighteen healthy, non-smoking participants (11 males, mean age 26.61±3.56 years) 
completed the entire study. All participants were right-handed according to the 
Edinburgh handedness inventory [93] and had no history of neurological and 
psychiatric diseases, or fulfilled exclusion criteria for noninvasive electrical or 
magnetic brain stimulation [94, 95]. The study conformed to the Declaration of 
Helsinki, and was approved by the local Ethics Committee. All participants gave 
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written informed consent before starting the study, and were financially compensated 
for participation. 
 
Figure 6.1. Course of the Study. Eighteen participants were included in this complete cross-over 
single-blinded, sham-controlled study, in which eight randomized sessions with four cathodal 
tDCS dosages of low, medium, and high intensities, and sham, were applied over the stimulation 
site primary motor (M1) and dorsolateral prefrontal cortex (F3). To evaluate the neuromodulatory 
effects of tDCS, TMS-evoked cortical reactivity, and TMS-elicited MEP (only for tDCS applied 
over the primary motor cortex), were recorded before tDCS, and immediately, 30min, 60min and 
120min after tDCS. The recorded data were then evaluated at the regional level, for TMS-evoked 
potentials (TEPs), oscillations, and MEP alterations. 
6.2.2. Neuro-navigated TMS-EEG and -MEP Measures 
6.2.2.1. Transcranial Magnetic Stimulation  
Single-pulse TMS at 0.33 Hz ± 30% (random) delivered by a PowerMag magnetic 
stimulator (Mag&More,Munich, Germany) with a figure-of-eight coil (PMD70) 
which was held tangentially over the EEG cap, with the handle pointing backwards 
and laterally at 45o from the midline, were applied. For the motor cortex stimulation 
site (PMCSS), TMS pulses were first applied to determine the representational area 
of the right abductor digiti minimi (ADM) muscle, in which the largest MEPs were 
produced by a given medium TMS intensity. At this stimulation site, the resting 
motor threshold (RMT) was then determined by the TMS-Motor-Threshold-
Assessment Tool (MTAT 2.0) [280]. For the prefrontal cortex stimulation site 
(PFCSS), the TMS coil was placed over the F3 position, with the handle pointing 
backwards and laterally at 45o from the midline, to approximate the scalp location 
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overlaying the left DLPFC [277, 281, 282]. At each stimulation site, and for each 
time-point, 120 single TMS pulses were applied with a stimulation intensity of 100% 
of RMT, Figure 6.1. 
6.2.2.2. EEG Recording 
A TMS-compatible EEG system (NeurOne, BittiumCorporation, Finland) was 
used to continuously record TMS-elicited TEP at DC with a sampling frequency of 
5kHz. EEG signals were captured by a TMS compatible Ag/AgCl C-ring 64 
electrode EEG cap (EasyCap,Herrsching, Germany) according to the 10-20 
International EEG Standard1. Electrodes were online referenced and grounded to 
external electrodes placed on the forehead (above the nasion). Two additional 
electrodes were used to record horizontal and vertical eye movements (one on 
the orbital ridge centered directly below the left eye and the other one at the lateral 
junction of the upper and lower right eyelids) [283]. Impedances at all electrodes 
were kept below 5kΩ during the experiment.  
6.2.2.3. Neuronavigation 
Following the individual TMS stimulation site identification, an MR-based 3D-
neuronavigation system (PowerMAG View,Mag&More,Munich, Germany) was 
employed to store and display online the position and orientation of the TMS coil 
with respect to the participant’s head and fiducials based on an individual structural 
MRI scan, assuring accuracy and reproducibility of the stimulation outcome 
throughout the experiment [276].  
All imaging data were acquired in a 3T Philips Achieva scanner (Best, Netherlands) 
with a 32-channel head coil. Anatomical images were recorded based on T1-
weighted fast 3D gradient echo pulse sequences (repetition-time= 8179 ms, echo-
time= 3.7 ms, flip-angle= 8°, 220 slices, matrix-size= 240x240, and resolution= 
1x1x1 mm3). 
6.2.2.4. MEP Recording 
Surface EMG was recorded from the right ADM in a belly-tendon montage. The 
signals were amplified, and filtered (1000; 3 Hz–3 kHz) using D440-2 
 
1 AF3, AF4, F5, F1, F2, F4, F6, F8, FC5, FC3, FC1, FCZ, FC2, FC4, FC6, T7, C5, C1, CZ, C2, C4, C6, 




(Digitimer,WelwynGardenCity, UK), and were digitized (sampling rate: 5 kHz) 
with a micro 1401 AD converter (CED, Cambridge, UK), controlled by Signal 
Software (CED, v. 2.13). 
6.2.3. Transcranial direct current stimulation  
tDCS was applied with a constant-current battery-powered 
stimulator (neuroCare, Ilmenau, Germany), through a pair of surface rubber 
electrodes (25cm2) attached on the scalp using conductive paste (Ten20®,Weaver). 
For the motor cortex stimulation sessions, the target electrode was centered over C3, 
according to the International EEG 10-20 system, and rotated 450 towards the 
midline. For the prefrontal cortex stimulation sessions, the target electrode was 
centered over the F3 position, parallel to the midline. The anodal return electrode, 
for both stimulation targets, was located on the contralateral supraorbital region. 
Prior to electrode placement, a topical anesthetic 
cream (EMLA®, AstraZeneca, UK) was applied to the respective stimulation sites, in 
order to decrease somatosensory sensations and sufficiently blind the participants 
[97]. In eight randomized sessions, four cathodal tDCS dosage of low (for 15min), 
medium (for 20min), and high (for 20min) intensities, and sham, were applied over 
the two stimulation sites, the primary motor (M1) and dorsolateral prefrontal cortex 
(F3). We chose stimulation parameters (intensity and duration) based on the results 
of our former study [65]; but with smaller stimulation electrodes (25cm2) to sacrifice 
less EEG channels around tDCS targeted sites. Therefore, the same current densities 
at the scalp-electrode interface as in the previous study were applied for low 
(0.028mA/cm2), medium (0.057mA/cm2), and high (0.085mA/cm2) dosage tDCS. 
For sham stimulation, low dosage tDCS was delivered for 15 seconds, with a 10sec 
ramp up and down followed by 15min with 0.0mA stimulation. 
6.2.4. Experimental procedures 
The study was performed in a cross-over single-blinded sham-controlled repeated 
measures design. At the beginning of each session, participants were seated in a 
comfortable chair with head- and arm-rests. Afterwards, the topical anesthetic cream 
was applied over the scalp at the identified corresponding stimulation sites. Then the 
tDCS electrodes were attached onto the head with conductive paste, followed by the 
set-up of the EEG cap. The participant’s head was then co-registered to the 
individual head model within the neuronavigation system. Thereafter, TMS 
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stimulation sites (motor cortex representation area of the right ADM (motor hot-
spot) and F3 (prefrontal hot-spot)) were identified for motor and prefrontal 
stimulation, and stored to the neuronavigation system, to be used throughout the 
experiment. Subsequently, TMS intensity was adjusted to identify the RMT, as 
explained above. Then, for the motor cortex stimulation site, baseline cortical 
excitability was determined by applying 120 TMS pulses over the motor hot-spot, 
with simultaneous recording of MEP, and TEP. For the prefrontal stimulation site, 
baseline cortical excitability was likewise determined by applying 120 TMS pulses 
over the prefrontal hot-spot. Afterwards, the respective tDCS protocol (as outlined 
above), was applied. After intervention, cortical excitability was monitored by 
applying 120 TMS pulses immediately (POST0), 30min (POST30), 60min 
(POST60) and 120min (POST120) after tDCS, Figure 6.1. Concurrent with TEP 
recording, white noise was implemented through headphones to minimize 
contamination of the EEG signal by auditory evoked potentials, induced by the TMS-
related clicking sound [284, 285]. 
The tDCS sessions were applied in randomized order with a minimum of seven days 
between sessions to avoid carry-over effects [85].  
6.2.5. Calculations  
Offline data processing was performed with custom scripts in 
MATLAB (R2019b,Mathworks, USA), and the Fieldtrip toolbox [286].  
6.2.5.1. MEP and TEP preprocessing 
MEP amplitudes were first visually inspected to exclude MEP trials: 1) in which 
background electromyographic activity was present, and 2) with respective bad TEP 
trials (see below). Then, the individual means of peak-to-peak MEP amplitudes, 
recorded at each time-point, were separately calculated for all subjects and all 
conditions.  
TEP waveforms were first segmented into epochs around the TMS pulses (−1000 to 
1500 ms), down-sampled to 1kHz, visually inspected to remove bad trials/channels  
[287], and referenced to the average of all electrodes. Then, a time-period (−5 to 
+15ms) around each TMS pulse was removed and interpolated. Afterwards, the data 
were high-pass filtered  (1Hz; 4th − order zero − phase Butterworth) and 
preprocessed with the ‘signal-space projection with source-informed reconstruction’ 
algorithm, which has been shown to efficiently suppresses TMS-related muscle 
artifacts [288], and minimize the contribution of peripherally-evoked sensory inputs 
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to TEPs [289]. For the SSP-SIR algorithm, we formed subject-specific, realistic 
leadfield matrices, by first automatically segmenting the individual T1-weighted MRI 
images using Freesurfer software [290], which were then imported to Brainstorm 
toolboxes [291], to generate leadfields, based on the three-layer symmetric boundary 
element method via OpenMEEG [292] (tissue conductivity values (S/m): scalp = 0.33, 
skull = 0.0033 and brain = 0.33). Data were then low-pass filtered (100Hz; 4th −
order zero − phase Butterworth) following an independent component analysis 
(FastICA) to remove remaining noise components [293-296]. Finally, the 
decomposed data were filtered (lowpass: 45Hz; bandstop: 49-51Hz; 4th-order, zero-
phase Butterworth), and baseline-corrected (−100 to −50ms to the TMS onset). 
6.2.5.2. TMS-evoked Potentials- TEP  
To evaluate the local effects of tDCS, we extracted the TEP deflections from the 
averaged FC1 and CP1 electrodes (for tDCS over the motor cortex; region of 
interest (𝑅𝑂𝐼𝑚𝑜𝑡𝑜𝑟)), and from the averaged FC1 and Fz electrodes (for tDCS over 
the prefrontal cortex; 𝑅𝑂𝐼𝑝𝑟𝑒𝑓𝑟𝑜𝑛𝑡). These ROIs were selected to capture the regional 
effects of tDCS, as they are located close to the tDCS target electrode, and are distant 
from cranial muscles, to reduce the TMS-related artifacts [277, 297]. For these ROIs, 
the known TEP peaks were first identified by searching the maximum (for positive) 
or minimum (for negative) TEP deflections over the time-periods of: 20-40ms (P30), 
35-55ms (N45), 45-75ms (P60), 85-135ms (N100) and 170-230ms (P200) [276, 298-
300]. A 10ms window (±5ms) around each identified TEP peak was then averaged 
to calculate the respective TEP amplitude, and used for further statistical analysis. 
6.2.5.3. TMS-evoked Oscillations 
To test if tDCS modulated TMS-related neural oscillations, time-frequency 
representations (TFRs) of oscillatory power were calculated, for 𝑅𝑂𝐼𝑚𝑜𝑡𝑜𝑟 and 
𝑅𝑂𝐼𝑝𝑟𝑒𝑓𝑟𝑜𝑛𝑡, on single trials (Morlet wavelet; wavelet width=3.5 cycles, steps of 
1Hz between 2 and 45Hz), and then normalized relative to the respective baseline 
(−300 to −100ms) [301-303]. Finally, frequency power estimates were calculated, 
for four separate frequency bands (FBs), including of Theta (θ; 4-7Hz), Alpha (α; 8-
13Hz), Beta (β; 14-29Hz) and Gamma (γ; 30-45Hz).  
6.2.5.4. Discriminability and qualitative assessment of tDCS protocols 
After finishing each session, participants were asked to fill in a questionnaire which 
contained: 1. Guessed intensity of tDCS (none, low, medium, high) 2. Rating scales 
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for the presence and amount of visual phenomena, itching, tingling and pain during 
stimulation, and 3. Rating scales for the presence and amount of skin redness, 
headache, fatigue, concentration difficulties, nervousness and sleep problems within 
24 hours after stimulation. The side-effects were rated on a numerical scale from 
zero to five, zero representing no and five extremely strong sensations.  
6.2.6. Statistics 
All statistical analyses were performed using SPSS (IBM Corp. v.26.0), custom 
scripts in MATLAB and the Fieldtrip toolbox [286].  
6.2.6.1. Baseline measures  
At the regional level (𝑅𝑂𝐼𝑚𝑜𝑡𝑜𝑟, 𝑅𝑂𝐼𝑝𝑟𝑒𝑓𝑟𝑜𝑛𝑡𝑎𝑙), to test if baseline measures differed 
between sessions, within and or between stimulation sites, two-way repeated-
measures ANOVAs (rmANOVA) were performed, with condition (4 levels) and 
stimulation site (2 levels) as within-subject factors, and baseline of TEP peak, or 
TFRs of FB as dependent variables. In addition, two separate one-way rmANOVAs 
were performed with condition (8 levels for TMSRMT, or 4 levels for baseline MEP) 
as within-subject factor, and TMSRMT intensity, or baseline MEP as dependent 
variables, respectively. 
6.2.6.2. Regional effects of tDCS and motor-to-prefrontal transferability  
At the regional level (𝑅𝑂𝐼𝑝𝑟𝑒𝑓𝑟𝑜𝑛𝑡, 𝑅𝑂𝐼𝑚𝑜𝑡𝑜𝑟), we investigated if 1) within each 
stimulation site, the tDCS after-effects differed vs. respective sham, and baseline 
values and/or between each other, and 2) effects of the stimulation protocols differed 
between tDCS motor and prefrontal stimulation. To this end, individual means of the 
after tDCS measures: TEP peaks, TFRs of each frequency band, and MEP 
amplitudes, were first normalized (∆) to the respective individual mean baseline: 
(𝑝𝑜𝑠𝑡. 𝑡𝐷𝐶𝑆 − 𝑏𝑎𝑠𝑒𝑙𝑖𝑛𝑒) ⁄ |𝑏𝑎𝑠𝑒𝑙𝑖𝑛𝑒|. Then, three-way rmANOVAs were 
calculated with condition (4 levels), time-point (5 levels) and stimulation site (2 
levels) as within-subject factors, and each normalized TEP peak (∆P30, ∆N45, ∆P60, 
∆N100, ∆P200), TFRs of each normalized FB (∆Theta, ∆Alpha, ∆Beta, and 
∆Gamma) as dependent variable. Another two-way rmANOVA with condition (4 
levels), and time point (5 levels) as within-subject factors, and ∆MEP as dependent 
variable, was calculated to test if MEP amplitudes differed between conditions 
and/or baseline.  
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6.2.6.3. Qualitative assessment of tDCS protocols 
To identify if participants correctly guessed tDCS intensities correctly, chi-square 
tests were conducted. Side-effects during and after tDCS were analyzed by a 
repeated measure ANOVA with condition (8 levels) as within-subject factor and 
rating scores (0-5) as dependent variable. In case of significant effects, follow-up 
exploratory post-hoc paired t-tests were conducted to examine if an active session 
resulted in a significantly different sensation relative to sham. 
 
For all ANOVAs, Mauchly’s test of sphericity was conducted, and the Greenhouse-
Geisser correction was applied when necessary. The critical significance level was 
set at p ≤ 0.05. Post hoc t-tests were Bonferroni-corrected for multiple comparisons. 
 
6.3. Results 
6.3.1. Baseline measures 
Baseline measures, at the regional level (𝑅𝑂𝐼𝑚𝑜𝑡𝑜𝑟 and 𝑅𝑂𝐼𝑝𝑟𝑒𝑓𝑟𝑜𝑛𝑡𝑎𝑙), are listed in 
Table 6.1. For the baseline TEP peaks, the respective rmANOVAs showed no 
significant differences for each stimulation site, however, significant differences 
between stimulation sites were observed for P30 and N100. Post-hoc tests indicated 
a lower amplitude of P30 and N100 over the prefrontal cortex, as compared to the 
primary motor cortex. Also, for baseline TFRs of each FBs, the respective 
rmANOVAs showed no significant differences, within each stimulation site. 
However, significant differences were identified between stimulation sites for Theta 
and Alpha frequency bands, with lower power over PFCSS, as compared to PMCSS. 
No significant differences were also observed for either TMSRMT, or baseline MEP 
amplitudes, between stimulation conditions, Table 6.2.  
Table 6.1. Baseline measurements. TEP peaks, Frequency bands (FBs), MEP and TMS intensity 




















Sham 1.96 ± 0.38 -1.07 ± 0.52 1.52 ± 0.43 -5.31 ± 0.31 4.45 ± 0.64 
Low dosage 2.14 ± 0.35 -1.03 ± 0.49 0.91 ± 0.40 -5.03 ± 0.29 3.78 ± 0.55 
Medium 
dosage 
1.53 ± 0.33 -1.78 ± 0.42 1.16 ± 0.41 -5.29 ± 0.47 3.95 ± 0.67 
High dosage 2.04 ± 0.38 -1.38 ± 0.33 1.46 ± 0.33 -5.42 ± 0.31 4.23 ±0.52 





Low dosage 0.40 ± 0.26 -0.98 ± 0.26 1.38 ± 0.26 -4.05 ± 0.31 4.14 ± 0.31 
Medium 
dosage 
0.46 ± 0.24 -1.25 ± 0.29 1.44 ± 0.23 -4.22 ± 0.44 4.30 ± 0.31 
High dosage 0.44 ± 0.33 -1.57 ± 0.33 1.27 ± 0.23 -4.07 ± 0.39 4.53 ± 0.31 













Sham 2.51 ± 0.31 1.33 ± 0.10 1.44 ± 0.05 1.56 ± 0.09 
Low dosage 2.48 ± 0.19 1.26 ± 0.08 1.34 ± 0.05 1.52 ± 0.08 
Medium 
dosage 
2.47 ± 0.27 1.28 ± 0.08 1.53 ± 0.10 1.55 ± 0.08 
High dosage 2.45 ± 0.24 1.32 ± 0.12 1.45 ± 0.11 1.55 ± 0.12 
Prefrontal 
Cortex 
Sham 1.67 ± 0.11 1.03 ± 0.16 1.39 ± 0.13 1.43 ± 0.12 
Low dosage 2.04 ± 0.17 1.03 ± 0.07 1.48 ± 0.13 1.51 ± 0.11 
Medium 
dosage 
1.98 ± 0.27 1.07 ± 0.19 1.38 ± 0.13 1.42 ± 0.08 
High dosage 1.81 ± 0.12 1.14 ± 0.20 1.39 ± 0.16 1.37 ± 0.10 







Sham 57.44 ± 1.91 
Low dosage 56.86 ±1.87 
Medium 
dosage 
56.94 ± 2.06 
High dosage 58.52 ± 1.97 
Prefrontal 
Cortex 
Sham 56.22 ± 1.91 
Low dosage 57.50 ± 1.79 
Medium 
dosage 
57.16 ± 2.15 
High dosage 56.50 ± 1.95 







Sham 53.25 ± 4.98 
Low dosage 46.52 ± 4.13 
Medium 
dosage 
43.53 ± 2.49 
High dosage 52.01 ± 4.83 
 
 
Table 6.2. Results of ANOVAs conducted to evaluate baseline measurements. The ANOVAs 
showed no significant differences of baseline measures within stimulation sites; however, 
significant differences were observed for the TEP P30 and N100 between stimulation sites, and 
FBs for theta and alpha frequency bands. Asterisks indicate significant effects (p < .05), d.f. = 
degrees of freedom,  𝜂𝑝
2 = partial eta squared. 
Baseline Measures Factors d.f., 
Error 









  Condition 3, 51 0.541 0.656 0.031 
  Stimulation site 1, 17 25.815 ˂0.001* 0.603 
  Condition × Stimulation site 3, 51 0.804 0.491 0.045 
N45 
Condition 3, 51 1.291 0.288 0.071 
Stimulation site 1, 17 0.080 0.780 0.005 
Condition × Stimulation site 3, 51 0.681 0.568 0.039 
P60 
Condition 3, 51 0.363 0.780 0.021 
Stimulation site 1, 17 0.175 0.681 0.010 
Condition × Stimulation site 3, 51 0.767 0.518 0.043 
N100 
Condition 3, 51 0.212 0.888 0.012 
Stimulation site 1, 17 16.161 0.001* 0.487 
Condition × Stimulation site 3, 51 0.184 0.907 0.011 
P200 
Condition 1.970, 33.488 0.436 0.728 0.025 
Stimulation site 1, 17 0.266 0.613 0.015 






Condition 3, 45 1.048 0.381 0.065 
Stimulation site 1, 15  9.999 0.006* 0.400 




Condition 3, 48 0.215 0.886 0.013 
Stimulation site 1, 16 14.001 0.002* 0.467 




Condition 2.207, 37.516 0.119 0.905 0.007 
Stimulation site 1, 17 0.187 0.671 0.011 




Condition 3, 39 0.452 0.718 0.034 
Stimulation site 1, 13 3.439  0.086 0.209 
Condition× Stimulation site 3, 39 0.125 0.945 0.010 
TMSRMT TMSRMT Condition 3.724, 63.315 1.466 0.226 0.079 
MEP MEP Condition 3, 51 1.453 0.238 0.079 
 
6.3.2. TMS-evoked Potentials- TEPs; Regional Level 
For the ∆P30 TEP, the rmANOVA indicated significant main effects of 
condition (𝐹(3,15) = 11.798, 𝑝 < 0.001, ɳ𝑝
2 = 0.702), time-point (𝐹(4,20) =
3.131, 𝑝 = 0.038, ɳ𝑝
2 = 0.385), interactions of condition and time-point 
 (𝐹(12,60) = 2.947, 𝑝 = 0.003, ɳ𝑝
2 = 0.371), condition and stimulation site 
 (𝐹(3,15) = 6.278, 𝑝 = 0.006, ɳ𝑝
2 = 0.557), time-point and stimulation site 
 (𝐹(4,20) = 3.469, 𝑝 = 0.025, ɳ𝑝
2 = 0.412), and condition, time-point and 
stimulation site  (𝐹(12,60) = 3.143, 𝑝 = 0.037, ɳ𝑝
2 = 0.386), but no main effect of 
stimulation site Figure 6.2.D, Table 6.3. For the PMCSS, post-hoc tests comparing 
141 
 
conditions revealed a significant increase of the ∆P30 amplitude for the medium 
dosage (POST0), as compared to sham, low- and high-dosage tDCS. In addition, 
post-hoc tests comparing tDCS after-effects to baseline indicated a significant ∆P30 
amplitude reduction for high-dosage stimulation (POST0, POST30, POST60), while 
the medium dosage increased the TEP amplitude (only POST0). For the PFCSS, 
post-hoc tests comparing conditions revealed a significant reduction of the ∆P30 
amplitude for medium- (POST0, POST30) and high-dosage 
 (POST0, POST30, POST60) tDCS, in comparison with sham. Furthermore, post-
hoc tests comparing baseline with after intervention time-points showed a significant 
∆P30 amplitude reduction for medium- (POST0, POST30) and high-
dosage (POST0, POST30, POST60) tDCS. Finally, post-hoc test comparisons of 
conditions between stimulation sites indicated a significant difference for the 
medium dosages (POST0, POST30), with a larger ∆P30 amplitude over the motor 
cortex, as compared to the prefrontal cortex, Figure 6.2.D, Table 6.3. 
For the ∆N45 TEP, the rmANOVA indicated no significant effects of the main 
effects condition, stimulation site, and time-point, nor their respective interactions, 
Figure 6.2.D, Table 6.3. 
For the ∆P60 TEP, the rmANOVA resulted in a significant main effect of 
condition (𝐹(3,15) = 3.441, 𝑝 = 0.034, ɳ𝑝
2 = 0.408), and a significant interaction of 
condition and time-point (𝐹(12,43) = 3.667, 𝑝 = 0.041, ɳ𝑝
2 = 0.442), but no 
significant main effect of stimulation site,  or significances of other interactions, 
Figure 6.2.D, Table 6.3. For the PMCSS, post-hoc tests comparing conditions 
revealed a significant decrease of the ∆P60 amplitude for low- 
(POST0, POST30) and high-dosage (POST30, POST60) tDCS, as compared to 
sham. In addition, post-hoc tests comparing baseline TEPs with after affects within 
conditions showed a significant ∆P60 amplitude reduction for low- 
(POST0, POST30) and high-dosage (POST0, POST30, POST60) tDCS. For PFCSS, 
post-hoc tests comparing conditions revealed a significant reduction of the ∆P60 
amplitude for low- (only POST30) and high-dosage (POST30, POST60) tDCS, 
compared to sham. Furthermore, post-hoc tests comparing baseline with time-points 
after tDCS within conditions indicated a significant ∆P60 amplitude reduction for 
low-, medium- and high-dosage tDCS (all protocols: POST30, POST60), Figure 
6.2.D, Table 6.3. 
For the ∆N100 TEP, the the results of the rmANOVA show a significant main effect 
of time-point (𝐹(4,20) = 2.782, 𝑝 = 0.046, ɳ𝑝
2 = 0.284), and  significant 
interactions of condition and time-point (𝐹(12,84) = 3.270, 𝑝 = 0.025, ɳ𝑝
2 = 0.284), 
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and time-point and stimulation site (𝐹(4,31) = 4.021, 𝑝 = 0.040, ɳ𝑝
2 = 0.410), but 
no significant main effects of condition, stimulation site, or other respective 
interactions, Figure 6.2.D, Table 6.3. Post-hoc tests revealed a significant increase 
of the ∆N100 amplitude for low-dosage tDCS (POST0, POST30), in comparison 
with sham, and baseline, for PFCSS, Figure 6.2.D, Table 6.3. 
For the ∆P200 TEP, the rmANOVA showed no significant main effects, or 
interactions, Figure 6.2.D, Table 6.3. 
 
Table 6.3. Results of the ANOVAs conducted for tDCS-induced ∆TEP alterations. The 
statistical results indicate tDCS-induced effects for the early (∆P30 and ∆P60) and late (∆N100) 
TEP peaks, with no one-to-one transferability of tDCS effects from the motor to the prefrontal 
cortex. Asterisks indicate significant effects (where p < .05), d.f. = degrees of freedom,  𝜂𝑝
2 = partial 
eta squared. 
 Factors d.f., Error F Value p Value  𝜼𝒑
𝟐 
∆P30 
 Condition 3, 15 11.798  <0.001* 0.702 
 Time-point 4, 20 3.131     0.038* 0.385 
 Stimulation site 1, 5 4.501  0.087 0.474 
 Condition × Time-point 12, 60 2.947  0.003* 0.371 
 Condition × Stimulation site 3, 15 6.278  0.006* 0.557 
 Time-point × Stimulation site 4, 20 3.496 0.025* 0.412 
 Condition × Time-point × Stimulation site 12, 60 3.143 0.037* 0.386 
∆N45 
 Condition 3, 45 1.027     0.390     0.064 
 Time-point 4, 60 1.061     0.384 0.066 
 Stimulation site 1, 15 0.795     0.387 0.050 
 Condition × Time-point 12, 180 0.436     0.947 0.028 
 Condition × Stimulation site 3, 45 1.945     0.136 0.115 
 Time-point × Stimulation site 4, 60 0.725     0.524 0.046 
 Condition × Time-point × Stimulation site 12, 180 0.894 0.554 0.056 
∆P60 
 Condition 3, 15 3.441  0.034* 0.408 
 Time-point 4, 20 1.054 0.405 0.174 
 Stimulation site 1, 5  0.001 0.994 0.002 
 Condition × Time-point 12, 43 3.667   0.041* 0.442 
 Condition × Stimulation site 3, 15 0.560 0.740 0.138 
 Time-point × Stimulation site 4, 20 0.158 0.957 0.031 
 Condition × Time-point × Stimulation site 12, 60 0.853 0.597 0.146 
∆N100 
 Condition 3, 21 1.158 0.349 0.142 
 Time-point 4, 20 2.782   0.046* 0.284 
 Stimulation site 1, 7 1.522 0.284 0.345 
 Condition × Time-point 12, 84 3.270   0.025* 0.246 
 Condition × Stimulation site 3, 21 0.744 0.741 0.052 
 Time-point × Stimulation site 4, 31 4.021   0.040* 0.410 




 Condition 3, 33 2.095 0.120 0.160 
 Time-point 4, 44 0.913 0.465 0.077 
 Stimulation site 1, 11 0.127 0.728 0.011 
 Condition × Time-point 12, 132 1.593 0.101 0.126 
 Condition × Stimulation site 3, 33 2.729 0.199 0.060 
 Time-point × Stimulation site 4, 44 0.197 0.939 0.018 




Figure 6.2. Local neuromodulatory effects of tDCS. Cathodal tDCS dosages of low, medium, 
and high intensities, and sham, were applied over the stimulation site primary motor (M1) and 
dorsolateral prefrontal cortex (F3). The local tDCS effects were then evaluated, every 30min, 
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immediately for up to two hours after stimulation, over the 𝑅𝑂𝐼𝑚𝑜𝑡𝑜𝑟 (averaged FC1 and CP1 
electrodes) and 𝑅𝑂𝐼𝑝𝑟𝑒𝑓𝑟𝑜𝑛𝑡 (averaged FC1 and Fz electrodes). A, B) grand average across all 
subjects following sham stimulation over the left primary motor cortex (𝑅𝑂𝐼𝑚𝑜𝑡𝑜𝑟; A.1) and left 
DLPFC (𝑅𝑂𝐼𝑝𝑟𝑒𝑓𝑟𝑜𝑛𝑡; B.1), and topographic plots displaying voltage distributions across the scalp 
for each TEP peak at the respective stimulation sites (A.2, B.2); Grey bars, together with the 
horizontal lines, correspond to the latency window of TEP components, and curve shadings are 
standard error of mean (SEM). C) TMS-elicited MEPs: Low and high dosages significantly 
reduced the tDCS-induced MEP amplitudes, while a trend-wise cortico-spinal excitability 
enhancement was observed after medium dosage tDCS. Error bars represent standard error of mean 
(SEM). D) TMS-evoked potentials (∆P30, ∆N45, ∆P60, ∆N100, ∆P200): tDCS generated a 
dosage-dependent, partially non-linear modulation of TEP over the different stimulation sites, as 
shown by the amplitude alterations of early (P30 and P60) and late (N100) TEP peaks. Floating 
symbols show a significant difference of real tDCS conditions vs. sham (◆), and real tDCS vs. 
respective baseline values (*). 
6.3.3. TMS-evoked Oscillations  
For all frequency bands (∆θ, ∆α, ∆β, ∆γ), the rmANOVAs showed no significant 
effects of either the main effects condition, time-point and stimulation site, or their 
respective interactions, Table 6.4. 
 
Table 6.4. Results of the ANOVAs conducted for tDCS-induced alterations of cortical 
oscillations. The rmANOVAs showed no significant effect of tDCS at the regional level on cortical 
oscillatory activities. FB: frequency band, d.f. = degrees of freedom,  𝜂𝑝
2 = partial eta squared. 







 Condition 3, 12 0.383 0.767 0.087 
 Time-point 4, 16 2.170 0.119 0.352 
 Stimulation site 1, 4 0.049 0.835 0.012 
 Condition × Time-point 12, 48 0.902 0.552 0.184 
 Condition × Stimulation site 3, 12 1.143 0.371 0.222 
 Time-point × Stimulation site 4, 16 0.735 0.581 0.155 
 Condition × Time-point × Stimulation site 12, 48 1.287 0.257 0.243 
∆α 
 
 Condition 3, 21 1.006 0.410 0.126 
 Time-point 4, 28 1.520 0.223 0.178 
 Stimulation site 1, 7 0.847 0.388 0.108 
 Condition × Time-point 12, 48 1.543 0.125 0.181 
 Condition × Stimulation site 3, 21 1.960 0.151 0.219 
 Time-point × Stimulation site 4, 28 1.086 0.382 0.134 
 Condition × Time-point × Stimulation site 12, 84 1.142 0.339 0.140 
∆β 
 
 Condition 3, 27 1.112 0.310 0.168 
 Time-point 4, 36 1.623 0.190 0.153 
 Stimulation site 1, 9 0.167 0.692 0.018 
 Condition × Time-point 12, 108 0.697 0.752 0.072 
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 Condition × Stimulation site 3, 27 1.055 0.384 0.105 
 Time-point × Stimulation site 4, 36 0.463 0.763 0.049 
 Condition × Time-point × Stimulation site 12, 108 1.040 0.419 0.104 
∆γ 
 Condition 3, 18 2.353 0.106 0.282 
 Time-point 4, 24 1.772 0.167 0.228 
 Stimulation site 1, 6 0.031 0.21 0.852 
 Condition × Time-point 12, 72 0.666 0.778 0.100 
 Condition × Stimulation site 3, 18 2.466 0.095 0.291 
 Time-point × Stimulation site 4, 24 0.050 0.875 0.010 
 Condition × Time-point × Stimulation site 12, 72 0.661 0.783 0.099 
6.3.4. TMS-elicited MEPs 
The 2-factorial ANOVA (condition-4 levels, and time point-5 levels), conducted for 
the ∆MEP amplitudes, revealed significant main effects of tDCS condition (𝐹(3,51) =
17.853, 𝑝 < 0.001, ɳ𝑝
2 = 0.512), and time-point  (𝐹(1.992,32.748) = 10.467, 𝑝 <
0.001, ɳ𝑝
2 = 0.381), and a significant interaction (𝐹(4.893,83.186) = 7.491, 𝑝 <
0.001, ɳ𝑝
2 = 0.306). Post hoc tests comparing sham tDCS with the respective active 
conditions revealed that low-, and high-dosage tDCS significantly reduced MEP 
amplitudes (both protocols: (POST0, POST30), while a trend-wise cortico-spinal 
excitability enhancement was observed after medium-dosage cathodal tDCS (only 
POST60; p=0.067). Similar results were found by comparing after effects with 
respective baselines, Figure 6.2.C, Table 6.5.  
 
Table 6.5. Results of the ANOVA conducted for tDCS-generated alterations of TMS-elicited 
MEP. The statistical results indicate significant main effects of stimulation condition, time-point 
and the respective interaction. Asterisks indicate significant effects (p < .05), d.f. = degrees of 
freedom,  𝜂𝑝
2 = partial eta squared. 
Factors d.f., Error F Value p Value  𝜼𝒑
𝟐 
∆MEP 
 Condition 3, 51 17.853 < 0.001* 0.512 
 Time-point 1.926, 32.748 10.467 < 0.001* 0.381 
 Condition × Time-point 4.893, 83.186 7.491 < 0.001* 0.306 
 
6.3.5. Qualitative assessment of tDCS protocols 
Participants’ guesses of received stimulation intensity are shown in Table 6.6. The 
Chi-square tests indicated no significant heterogeneity for any of the tDCS dosages 
(sham: χ2=0.111, p=0.739; low-dosage: χ2=2.778, p=0.096; medium-dosage:  
χ2=1.778, p=0.182; high-dosage: χ21.000, p=0.317), which shows successful 
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blinding. Ratings of the presence and intensity of side-effects are documented in 
Table 6.7. The ANOVAs conducted for the side-effects showed also no significant 
effect either during, or 24h after stimulation (Table 6.8).  
Guessed intensity of tDCS (none, low, medium, high) 2. Rating scales for the 
presence and amount of visual phenomena 
Table 6.6. Frequency table of participants’ guesses of received stimulation intensity. In each 
session, participants were asked to guess the intensity of tDCS (none, low, medium, high). Note 
that the study included four tDCS dosages applied over two different stimulation sites. The table 






Intensity guessed by participants 






none 6 7 3 2 
Low 6 8 3 1 
Medium 3 7 5 3 
High 1 4 6 7 
Prefrontal 
Cortex 
None 6 7 4 1 
Low 6 8 4 0 
Medium 2 6 7 3 
High 2 5 5 6 
 
Table 6.7. Participant ratings of the presence and intensity of side-effects. Visual phenomena, 
itching, tingling and pain during stimulation. Skin redness, headache, fatigue, concentration 
difficulties, nervousness and sleep problems within 24 hours after stimulation. The presence and 
intensity of the side-effects were rated in a numerical scale from zero to five, zero representing no 
and five extremely strong sensations. Data are presented as mean ± SD.  
 
 






















0.33 ±  
0.68 
0.61 ±  
0.69 






























0.66 ±  
0.84  
0.50 ±  
0.51 













0.27 ±  
0.46 
0.38 ±  
0.77 
















0.27 ±  
0.95 
0.22 ±  
0.54 













0.27 ±  
0.46 
0.27 ±  
0.57 















0.66 ±  
0.76 
0.33 ±  
0.48 













0.33 ±  
0.84 
0.33 ±  
0.76 





























 Sleep Problem 
0.00 ±  
0.00 
0.05 ±  
0.23 













Table 6.8. The presence and intensity of side-effects were analyzed by one-way repeated-
measures ANOVAs. No significant effects of side-effects were identified either during or 24h 
after stimulation. d.f.= degrees of freedom.  𝜂𝑝
2 = partial eta squared. 
 Side-effects d.f., Error F Value  𝛈𝐩
𝟐 p Value 
During 
stimulation 
Visual Phenomena 7, 119 1.567 0.084 0.152 
Itching 7, 119 0.765 0.043 0.618 
Tingling 7, 119 1.780 0.095 0.098 




Redness 7, 119 0.363 0.021 0.922 
Headache 2.432, 41.342 1.157 0.064 0.332 
Fatigue 7, 119 1.560 0.084 0.154 
Concentration 3.038, 51.650 1.129 0.062 0.346 
Nervousness 3.100, 52.706 2.209 0.115 0.096 
Sleep Problem 7, 119 1.630 0.087 0.133 
 
6.4. Discussion 
In this study, we explored the dosage-dependent neuroplastic effects of cathodal 
tDCS at two targeted stimulation sites, the primary motor and dorsolateral prefrontal 
cortex. In a single-blind and sham-controlled repeated measures design, four 
cathodal tDCS dosages of low, medium, high intensity, and sham stimulation, were 
applied over the primary motor and dorsolateral prefrontal cortex. The after-effects 
were then tested by TMS-EEG and TMS-MEP techniques, at the regional level, for 
TMS-evoked cortical reactivity, oscillations, and MEP amplitude alterations. In 
general, we observed a nonlinear dosage-dependent effect of motor cortex tDCS (for 
TMS-evoked early positive TEPs, and MEPs), whereas prefrontal tDCS decreased 
almost uniformly the early positive TEP peaks. Furthermore, blinding was 
successful, and all participants tolerated tDCS well. 
tDCS over the Primary Motor Cortex: for the effects on early TEPs, the results 
showed a significant reduction of the ∆P30 amplitude for low- and high-dosage 
tDCS, as compared to baseline, but a significant enhancement of the ∆P30 amplitude 
after medium dosage tDCS, in comparison with baseline and sham stimulation 
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values. No significant effects were however found for the ∆N45 TEP at this 
stimulation site. For the ∆P60, the results showed a significant reduction after low- 
and high-dosage tDCS, as compared to baseline, and sham stimulation conditions. 
For the effects on late TEPs, no significant differences were observed for the ∆N100 
and ∆P200. In addition, the results showed no effects of tDCS on TMS-evoked 
oscillations. Furthermore, for the TMS-elicited MEPs, tDCS resulted in significant 
MEP amplitude reductions after low- and high-dosage tDCS, and a trendwise 
enhancement of MEP amplitudes after medium-dosage tDCS.  
tDCS over the Dorsolateral Prefrontal Cortex: for the effects on early TEPs, the 
results revealed a significant reduction of the ∆P30 amplitude after medium- and 
high-dosage tDCS. No significant effects were however found for the ∆N45 TEP 
peak. For the ∆P60, significant TEP amplitude reductions were observed after low-, 
medium-, and high-dosage tDCS, as compared to baseline, and sham (the latter 
however not for medium dosage tDCS). For the effects on late TEPs, the results 
showed a significant enhancement of the ∆N100 only after low-dosage tDCS, as 
compared to baseline and sham conditions. No significant differences were observed 
for the P200 amplitude. In addition, the results revealed no impact of tDCS on TMS-
evoked oscillations.  
Comparison of tDCS effects on Motor and Prefrontal Cortex excitability: for 
baseline TMS-evoked TEPs, the results show a lower amplitude of the P30 and N100 
over the prefrontal cortex, as compared to the primary motor cortex. For baseline 
TMS-evoked oscillations, significant differences were identified for theta and alpha 
frequencies, with lower power over the prefrontal, as compared to the primary motor 
cortex. In addition, the results of tDCS after-effects on early and late TEPs show a 
larger ∆P30 amplitude over the motor cortex, as compared to the prefrontal cortex, 
only for the medium dosage, in which an enhancement of the ∆P30 amplitude was 
observed for M1 stimulation. No significant differences were however observed for 
other TEP peaks. In what follows, we discuss these findings in more detail, and add 
mechanistic explanations. 
The results of local TMS-evoked TEPs for low-dosage motor cortex tDCS are in 
accordance with the only available other tDCS-TMS-EEG study, in which 
significant reductions of only early positive TEP peaks,  as compared to baseline, 
were observed after cathodal tDCS with 1mA for 13min over the primary motor 
cortex [304]. However, no sham-controlled TMS-EEG-evaluated 
neurophysiological data were so far available for different dosages of cathodal tDCS. 
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Moreover, the results of the present study are compatible with those obtained for 
other NIBS protocols. Continuous theta burst stimulation (cTBS) applied over M1, 
which reduces cortico-spinal excitability, decreased the P30 amplitude [305]. For the 
cathodal prefrontal tDCS TMS-EEG response, only one other study is available, in 
which, with a newly developed electrode configuration, bipolar tDCS, targeting 
cathodal-left and anodal-right DLPFC with 1.5 mA for 14min generated no effects 
on either TMS-evoked TEPs or oscillations. However, the electrode configuration 
and placement, as well as tDCS dosage were different, as compared to the present 
study, which might explain this disparity of outcomes. For other NIBS protocols, no 
significant effects of cTBS over F3, targeting the left DLPFC, have been reported 
for late TEP peaks (N120 and P200), and this stimulation protocol did also not alter 
oscillatory power [306]. Except for the N100 enhancement after low dosage tDCS 
over the prefrontal cortex in the present study, these results are in accordance with 
our findings. In addition, the dosage-dependent TMS-induced MEP amplitude 
reduction after low and high dosages of tDCS, together with the trend-wise 
enhancement of cortico-spinal excitability after medium dosage tDCS fit well with 
previous findings for tDCS [64, 65], and other NIBS modalities [307, 308].  
6.4.1. Proposed Mechanisms 
 Over the primary motor cortex, a significant reduction of the P30 amplitude was 
observed after low dosage motor cathodal tDCS. Several lines of indirect evidence 
suggest that early TEP peaks (≤ 30ms) might reflect excitatory neurotransmission at 
the stimulation site [309], and be a putative marker of excitability of the corticospinal 
system [310]. This assumption is supported by the fact that 1) after stimulating M1, 
motor cortical areas responded within the first 28 ms [311], 2) MEP amplitudes 
correlated with the N15/P30 complex, or the P25 amplitude [312, 313], 3), this TEP 
peak is similarly affected as MEPs by TMS intensity [314], coil angle [315], and 
paired pulse protocols [316], 4) MEP generation is suggested to depend on the 
predominance of excitatory postsynaptic potentials (EPSPs) in corticospinal 
pyramidal neurons [300], and 5) In animal models, EPSPs generated by NMDA 
receptor activation peak at ~15–40 ms, following electrical stimulation of the 
neocortex [317, 318], a time window which is similar to the P30 TEP peak. Taking 
this into account, reduction of the P30 amplitude by low dosage motor cathodal 
tDCS likely reflects the direct cathodal tDCS-induced neural excitability diminution 
at the stimulation site, which is driven by a reduction of glutamate, and NMDA 
receptor activity, and gated by reduced GABA activity [86, 100, 143]. This effect is 
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furthermore similar to the impact of this stimulation protocol on MEPs, which 
stresses the tight association of these parameters. 
Furthermore, a reduction of the P60 amplitude was observed after low dosage motor 
cathodal tDCS. This propagated positive peak (P60) is suggested to reflect a 
fluctuation between EPSP and inhibitory postsynaptic (IPSP) activities mediated by 
AMPA, NMDA, and GABA receptors in the stimulated cortical network, as shown 
by paired-pulse and pharmaco-TMS-EEG studies [300, 313, 319, 320]. Therefore, 
with the known GABA and glutamate reduction after cathodal tDCS (see above), the 
reduction of P60 after this tDCS dosage is likely caused by reduction of glutamate, 
as the effects are equivalent to the P30 peak.  
Moreover, in the current study, the N100, and later amplitudes did not change after 
low dosage cathodal motor cortex tDCS. Previous TMS-EEG studies linked the 
N100 peak to changes of local GABA-related activity [319, 321, 322], but a further 
contribution of also interhemispheric excitatory-inhibitory activity of motor 
networks or other long-range connections was also described [321, 323-325]. Taken 
this, and the known GABA and glutamate reduction after cathodal tDCS into 
account, it might be speculated that local GABA reduction, which would decrease 
this potential, would be counteracted upon by glutamate reduction-related 
enhancement of the N100, which would then result in a zero net effect of tDCS on 
the N100, in accordance with previous tDCS-TMS-EEG findings. 
In contrast to low dosage tDCS, an enhancement of the P30 amplitude was observed 
after medium dosage cathodal motor cortex tDCS. This fits well with the MEP 
results, and shows stimulation intensity-dependent non-linear effects of tDCS also 
at the intrinsic level of the motor cortex, which, based on the neurophysiological 
foundations of the P30, are likely driven by the glutamatergic system. For 
mechanisms of glutamatergic synaptic plasticity, it is known that calcium 
concentration, which involve NMDA receptors, determines the increase or decrease 
of synaptic weight, i.e. long term potentiation (LTP) and long term depression (LTD) 
[101, 121]. Low and prolonged Ca2+ influx causes LTD, a moderate increase of 
calcium influx induces no synaptic modulation, and larger calcium increases result 
in LTP [101, 121, 153]. In accordance, also for tDCS in humans, pharmacological 
and neuroimaging studies showed that a glutamatergic process involving NMDA 
receptors contributes strongly to tDCS-induced plasticity [86, 143, 167, 168]. 
Therefore, the enhancement of the P30 amplitude after medium dosage cathodal 
motor cortex stimulation reflects likely a switch from LTD- to LTP-like plasticity 
due to an enhancement of Ca2+ influx at a level sufficient for induction of LTP-like 
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plasticity. However, apart from these presumed calcium-dependent effects, 
increasing tDCS intensity might affect also neurons in deeper cortical layers [105], 
and increase also the contribution of neighbored networks to a larger degree [112, 
247]. A network effect is however unlikely. Such an impact would be more likely 
observed for the P60 amplitude, which more strongly depends on network effects 
than the P30. The P60 was however not affected by medium dose motor cortex tDCS. 
The missing effect of this intervention on the N100, and later potentials further 
support the spatial restrictedness of the stimulation effects. 
For high dosage cathodal motor tDCS, the results show again a reduction of the P30, 
and P60 amplitudes. Taken the relatedness of the P30 TEP to MEPs, together with 
the involvement of calcium channel dynamics, into account, animal studies showed 
that calcium influx beyond the LTP-inducing level again results in no or excitability-
diminishing plasticity due to counterregulatory mechanisms, which activate 
potassium channels [102]. In accordance, we have confirmed an involvement of 
calcium channel dynamics to the nonlinear high dosage tDCS-induced LTD-like 
plasticity in an MEP study in humans [326]. Therefore, high dosage motor cathodal 
tDCS reduced the P30, and also the P60 amplitude, likely by respective 
counterregulatory mechanisms. The missing effect of this intervention protocol on 
later potentials supports again the spatial restrictedness of its effects, similar to 
medium and low dosage motor cortex tDCS protocols (see above).   
Moreover, the observed pattern of tDCS effects on MEP amplitudes, with a reduction 
after low and high dosages tDCS, and enhancement after medium dosage tDCS, is 
similar to the impact of stimulation on early TEP, and thus likely caused by ssimilar 
mechanisms, as explained above.  
Over the prefrontal cortex, the results for the different tDCS dosages are, in general, 
relatively uniform, with the exception of the P30 and N100 amplitude after low 
dosage cathodal prefrontal tDCS. Based on knowledge about cathodal motor cortex 
tDCS effects (see explanation for the P30 TEP alteration obtained by low dosage 
cathodal motor tDCS), the P30 amplitude diminution observed with medium and 
high dosages of tDCS is compatible with reduced local glutamatergic activity 
induced by cathodal tDCS. The only numerical, but non-significant reduction of this 
amplitude by low-dosage tDCS might hint to an insufficient efficacy of this dosage 
to alter this potential with this prefrontal stimulation protocol. For more widespread 
effects of the stimulation, which are monitored by the P60, however also low dosage 
tDCS seemed to be efficient to alter excitability. 
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The P60 amplitude decreased significantly after low, medium and high dosage 
cathodal prefrontal tDCS. Prefrontal paired-pulse TMS-EEG studies have shown that 
the P60 amplitude is reduced by short interval cortical inhibition (SICI) protocols, 
which are mainly associated with GABA receptor activity, while this peak is 
enhanced via intra-cortical facilitation (ICF) protocols, which are attributed to 
glutamatergic-related NMDA-receptor activities. It is therefore suggested  that this 
TEP peak reflects a balance of excitatory-inhibitory mechanisms [313], similar to 
the situation in the primary motor cortex. In addition, based on the proposed 
reduction of GABA and glutamate after motor tDCS, a GABA reduction would 
enhance P60, but glutamate reduction might reduce it. Thus, taken the proposed 
mechanisms, together with the alteration pattern of this peak, into consideration, the 
contribution of glutamate is the more likely cause for the P60 reduction after low, 
medium, as well as high dosage prefrontal tDCS.  
Moreover, the results unaltered N100 and later peaks after medium and high dosage 
of stimulation, but an enhancement of N100 after low dosage prefrontal tDCS. 
Regarding mechanisms of these effects, several studies have reported that late TEPs, 
especially at periods ̴ 100ms and  ̴ 200ms, might represent similar underlying cortical 
sources, regardless of the target site following stimulation [309, 327]. In addition, over 
the left prefrontal cortex, GABA positively and glutamate negatively correlated with 
the N100 peak, as shown by magnetic resonance spectroscopy [328], suggesting that 
the N100 amplitude is linked to the balance of local inhibition-excitation. Therefore, 
with the known reduction of GABA and glutamate after cathodal tDCS, we would 
speculate that the GABA-reduction caused diminution, and glutamate-reduction 
caused enhancement of the N100 resulted in a null effect after medium and low 
dosage cathodal tDCS. For the enhancement of the N100 after low dosage tDCS, 
considering the effects of this protocol on the P60 amplitude, reduced glutamate 
seems to be the most likely cause. Therefore, it can be speculated that this specific 
low dosage tDCS is more selective for glutamate neurons, than for GABA, whereas 
with higher intensity tDCS protocols, GABA reduction would counteract the 
glutamate-reduction caused enhancement of the N100, resulting in no alterations of 
the N100 after medium and high dosage tDCS.   
In comparison with the effects of motor tDCS, early positive TEP peaks were almost 
uniformly decreased following all prefrontal tDCS dosages. This might be explained 
by anatomical cytoarchitectonic, pharmacological and functional differences of 
these two areas [329, 330], which could result in a broader range of LTD induction 
in the prefrontal cortex. From a pharmacological point of view, dopamine is  more 
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prevalent in the prefrontal cortex [331], and has been shown to strengthen cathodal 
tDCS-induced LTD-like plasticity; but converted anodal tDCS-induced LTP- to 
LTD-like plasticity [147]. Therefore, the higher amount of dopamine might have 
enhanced efficacy of cathodal tDCS-induced LTD-like plasticity relevantly in 
prefrontal areas, and prevented conversion effects into LTP-like plasticity. In 
addition, from a physical point of view, computational studies have shown that inter-
electrode distance (iED; by affecting the amount of shunting current through the 
scalp), and scalp-to-cortex distance highly influence the tDCS-induced electrical 
field (EF) [59, 60, 332]. Here, with the same tDCS dosage applied over the motor, 
and prefrontal cortex, the lower iED and higher scalp-to-cortex distance in case of 
prefrontal stimulation [236, 238] might have resulted in lower prefrontal tDCS-
induced EF over the targeted cortical area, and potentially therefore explains the 
missing effects of P30 after low dosage prefrontal tDCS, but also lack of prefrontal 
tDCS-induced plasticity conversion, compare to what was observed after increasing 
tDCS dosage over the motor cortex.  
6.4.2. Limitations and future directions 
In this study, we aimed to explore the transferability of regional effects of cathodal 
tDCS protocols from the primary motor cortex to a non-motor region. The 
investigation of whole brain effects was not within the scope of the present study, 
but will be tackled in future. In addition, we probed the neurophysiological effects 
of tDCS at the group level, but inter-individual variability has been shown to affect 
the outcome of tDCS and other NIBS protocols [43, 108]. In accordance, the data 
obtained in the present experiment show some variability, as can be seen in Figure 
6.3 and Figure 6.4. Potential contributing factors are anatomical and biophysical 
differences of individual brains, genetics, age, gender, time of day, and brain state 
[109, 114, 149]. Thus, to improve stimulation efficacy at the level of the individual, 
an important next step would now be to understand/control for individual factors 









Figure 6.3. Individual TMS-evoked cortical reactivity after low, medium and high dosage of 
cathodal tDCS over the primary motor cortex. In each graph, the green line denotes averaged 
reactivity over the FC1 and CP1 electrodes used for ROI analyses, while each yellow trace is an 
individual TEP at the ROI, and the gray lines show activity over all electrodes, averaged across all 
subjects (n = 18) at the respective time point. POST0, POST30, POST60, POST120, are the TEP 




Figure 6.4. Individual TMS-evoked cortical reactivity after low, medium and high dosage of 
cathodal tDCS over the left DLPFC. In each graph, the green line denotes the averaged reactivity 
over the FC1 and Fz electrodes used for ROI analyses, while each yellow trace is an individual 
TEP at the ROI, and the gray lines show activity over all electrodes, averaged across all subjects 
(n = 18) at the respective time point. POST0, POST30, POST60, POST120, are the TEP measures 
0min, 30min, 60min, and 120min after tDCS. 
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Furthermore, the neurophysiological data obtained in this study, which were based 
on healthy young participants, might not be one-to-one transferable to other cortical 
areas, other populations, as well as task-based motor or prefrontal tDCS applications. 
Moreover, the physiological effects of tDCS are not only determined by stimulation 
duration and intensity, but also by repetition intervals [68, 184], and electrode 
configuration [272], amongst other factors, which were beyond the scope of the 
present study, but might be important for shaping optimal stimulation protocols in 
future. Furthermore, the different effects obtained by prefrontal and motor cortex 
stimulation, as identified in this study, should be carefully evaluated in future studies, 
as it is not clear if these are due to biological differences between respective areas, 
or different current density at the cortical level, due to anatomical differences. 
Further work, including computational modeling, might help to clarify this issue.  
6.5. Conclusion 
The results of this study show modulatory effects of motor cortex tDCS on TMS-
evoked cortical reactivity, which are comparable to respective cortico-spinal 
excitability effects, measured by TMS-MEP. Low- and high-dosage motor cortex 
tDCS reduced early positive TEP peak and MEP amplitudes, whereas an amplitude 
enhancement was observed for the medium dosage of motor cortex tDCS. In 
contrast, prefrontal low-, medium- and high-dosage tDCS almost uniformly reduced 
the early positive TEP peak amplitudes. Furthermore, over both cortical areas, 
neuromodulatory effects of tDCS were not observed for late TEP peaks (except for 
low-dosage prefrontal tDCS), and TMS-evoked oscillations. The specific differences 
of the effects of tDCS might be related to physiological, anatomical and 
pharmacological differences of motor and non-motor areas. The overall results 
provide the first direct comparison of tDCS effects on different brain areas at the 
physiological level, which will further consolidate the rationale for the extension of 














7 Summary and Outlook 
In this section, we first summarize the main outcomes of the conducted studies, and 
at the end, we will provide suggestions for future research directions. 
7.1. Summary 
The main goal of this thesis was to address the current challenge regarding the 
limited neuroplastic efficacy of cathodal tDCS, aiming to empower cathodal tDCS 
outcome. To this end, from the infinite parameter space, we selected electrical 
current intensity, duration and repetition rate, and then manipulated these factors to 
test if they can increase tDCS-induced neuroplastic after-effects. We further 
addressed the Ca2+ dependency of cathodal tDCS-induced neuroplastic effects, 
aiming to explain the observed stimulation dosage-dependent nonlinearity, which 
might be another source of limited/heterogeneous efficacy. It has been moreover 
shown that the effects of tDCS are restricted by the inter-individual physical 
variability. We therefore investigated, by a computational modeling approach, 
whether and to which extent the neurophysiological outcome of tDCS, at the 
individual level, can be explained by considering individual physical factors, which 
affect the tDCS-induced electrical field and therefore potentially its neuroplastic 
effects. In addition, the target region of the aforementioned studies was the primary 
motor cortex, much less is however known for its effects over the prefrontal cortex, 
which is associated with executive functions, including working memory and 
selective attention, and an important area for clinical application of brain stimulation. 
We thus finally explored the transferability of motor cortex cathodal tDCS-induced 
neuroplasticity results to the prefrontal cortex. In what follows, we give, based on 
each study, an overview of these findings. 
Study 1: Titrating the neuroplastic effects of cathodal transcranial direct 
current stimulation (tDCS) over the primary motor cortex  
Background: clinical applications of tDCS with encouraging results have been 
reported in several pilot studies, but optimal stimulation protocols remain to be 
determined. This is also important because the efficacy and directionality of 
tDCS effects follow non-linear rules regarding neuroplastic effects for the 
stimulation parameters duration and intensity.  
Method: in this study, we systemically explored the association between tDCS, 
these parameters and induced after-effects on motor cortex excitability. 
Cathodal tDCS was applied at four different intensities (sham, 1, 2 and 3mA), 
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and three durations (15, 20 and 30mins) in 16 young healthy subjects and the 
after-effects were monitored with TMS-induced MEP until the next day 
evening after stimulation.  
Results: the statistical results conducted to disentangle the effects of tDCS 
intensity and duration show a main effect of intensity, in which 1 mA and 3 mA 
stimulation intensities induced a reduction of MEP amplitudes, but 2 mA 
resulted in an excitability enhancement. In addition, the statistical results 
conducted to compare if active stimulation effects differ from those of sham 
stimulation revealed a significant main effect of tDCS condition, in which 
stimulation with 1 mA for 15 min, and 1 mA for 30 min induced a significant 
MEP amplitude diminution, while stimulation with 2 mA for 20 min resulted 
in a significant cortico-spinal excitability enhancement. Protocols with higher 
stimulation intensity (specifically stimulation with 3 mA for 20 min) induced 
again a significant excitability diminution lasting for about one and half hour 
after stimulation, and thus were more efficient than the other protocols. 
Conclusions: our study thus provides further insights on the dependency of 
tDCS -induced neuroplasticity from specific stimulation parameters, and 
therefore delivers crucial information for future applications. 
Study 2: Probing the relevance of repeated cathodal tDCS over the primary 
motor cortex for prolongation of after-effects 
Background: tDCS has promising results in pilot studies as therapeutic 
intervention in disorders of the central nervous system, more sustained effects 
are however required for clinical application. To address this issue, one possible 
solution is the use of repeated stimulation protocols. Previous studies indicated 
the capability of extending single intervention-generated cathodal tDCS after-
effects with repeated tDCS protocols, with a superiority of relatively short 
intervals. 
Method: in this study, we thus investigated the effects of repeated stimulation 
protocols with short, and long intervals for a conventional (1mA for 15min) and 
an optimized tDCS protocol (3mA for 20min). In 16 healthy participants, we 
compared single interventions of conventional and optimized protocols with 
repeated application of these protocols with intervals of 20 min and 24 hours, 
and a sham tDCS session. tDCS-induced neuroplastic after-effects were then 




Results: the results revealed that the duration of after-effects of repeated 
conventional and optimized protocols with short intervals remained nearly 
unchanged, as compared to the respective single intervention protocols. For the 
long interval (24 h), stimulation with the conventional protocol did not 
significantly alter respective after-effects, while it reduced the efficacy of the 
optimized protocol, as compared with respective single interventions. Thus 
late-phase plasticity could not be induced by a single repetition of stimulation 
in this study, but repetition reduced the efficacy of stimulation protocols with 
higher intensities.  
Conclusions: this study provides further insights on the dependency of tDCS-
induced neuroplasticity from stimulation parameters, and therefore delivers 
crucial information for future tDCS applications.  
Study 3: Ca2+ channel dynamics explain the nonlinear neuroplasticity 
induction by cathodal transcranial direct current stimulation over the primary 
motor cortex 
Background: tDCS induces polarity-dependent neuroplasticity: with 
conventional protocols, anodal tDCS results in excitability enhancement while 
cathodal stimulation reduces excitability. However, partially non-linear 
responses are observed with increased stimulation intensity and/or duration. 
Cathodal tDCS with 2mA for 20min reverses the excitability-diminishing 
plasticity induced by stimulation with 1mA into excitation, while cathodal 
tDCS with 3mA again results in excitability diminution. Since tDCS generates 
NMDA receptor-dependent neuroplasticity, such non-linearity could be 
explained by different levels of calcium concentration changes, which have 
been demonstrated in animal models to control for the directionality of 
plasticity.  
Method: in this study, we tested the calcium dependency of non-linear cortical 
plasticity induced by cathodal tDCS in human subjects in a placebo controlled, 
double-blind and randomized design. The calcium channel blocker flunarizine 
was applied in low (2.5 mg), medium (5 mg) or high (10 mg) dosages before 
20min cathodal motor cortex tDCS with 3mA in 12 young healthy subjects. 
After-effects of stimulation were monitored with TMS-induced MEPs until 2 
hours after stimulation.  
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Results: the results show that motor cortical excitability-diminishing after-
effects of stimulation were unchanged, diminished, or converted to excitability 
enhancement with low, medium and high dosages of flunarizine.  
Conclusion: These results suggest a calcium-dependency of the directionality 
of tDCS-induced neuroplasticity, which may have relevant implications for 
future basic and clinical research. 
Study 4: A Comprehensive Study of the Association Between Individual 
Electrical Field and Anatomical Factors on the Neurophysiological Outcomes 
of tDCS: a TMS-MEP and MRI Study 
Background:  tDCS has shown promising results in basic and clinical studies. 
The known interindividual variability of the effects restrict however the 
efficacy of the technique. Recently we reported neurophysiological effects of 
tDCS applied over the primary motor cortex at the group level, based on data 
from twenty-nine participants, who received 15min of either sham, 0.5, 1.0, 1.5 
or 2.0 mA anodal, or cathodal tDCS. The neurophysiological effects were 
evaluated via changes in: 1) TMS-MEP, and 2) cerebral blood flow (CBF) 
measured by functional magnetic resonance imaging (MRI) via arterial spin 
labeling (ASL). At the group level, dosage-dependent effects of the intervention 
were obtained, which showed however interindividual variability.  
Method: In this study, we investigated the cause of the observed inter-
individual variability. To this end, for each participant, a MRI-based realistic 
head model was designed to 1) calculate anatomical factors and 2) simulate the 
tDCS- and TMS-induced electrical fields (EF). We then investigated at the 
regional level which individual anatomical factors explain the simulated EFs 
(strength and normal component). Finally, we explored which specific 
anatomical and/or EF factors predicted the neurophysiological outcomes of 
tDCS.  
Results: The results showed a significant negative correlation between 
electrode to cortex distance (ECD), and CSF thickness, and the individual EFs. 
In addition, CSF thickness, and ECD were negatively correlated, whereas EFs 
were positively correlated with tDCS-induced physiological changes.  
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Conclusion: These results provide novel insights into the dependency of the 
neuromodulatory effects of tDCS from individual physical factors. 
Study 5: Transferability of tDCS effects from the primary motor to the 
prefrontal cortex: a multimodal TMS-EEG study 
Background: Neurophysiological effects of transcranial direct current 
stimulation (tDCS) have been extensively studied over the primary motor 
cortex. Much less is however known for its effects over non-motor areas, such 
as the prefrontal cortex, which is the neuronal foundation for many high-level 
cognitive functions, and involved in neuropsychiatric disorders. 
Method: In this study eighteen healthy participants were involved in eight 
randomized sessions, in which four cathodal tDCS dosages, low, medium, and 
high, as well as sham stimulation, were applied over the primary motor and 
dorsolateral prefrontal cortex. After-effects of tDCS were evaluated via 
transcranial magnetic stimulation (TMS)-electroencephalography (EEG), and 
TMS-elicited motor evoked potentials (MEP) at the regional level, for the 
outcome parameters TMS-evoked potentials (TEP), TMS-evoked oscillations, 
and MEP amplitude alterations. 
Results: The results indicate a dosage-dependent nonlinear neurophysiological 
effect of motor cortex tDCS, which is not one-to-one transferable to prefrontal 
tDCS. Low and high dosages of motor cortex tDCS reduced early positive TEP 
peaks (P30, P60), and MEP amplitudes, while an enhancement was observed 
for medium dosage motor cortex tDCS (P30 and MEP amplitudes). In contrast, 
prefrontal low, medium and high dosage tDCS uniformly reduced the early 
positive TEP peak amplitudes. Furthermore, for both cortical areas, tDCS-
induced neuromodulatory effects were not observed for late TEP peaks (with 
the exception of low-dosage prefrontal tDCS), nor TMS-evoked oscillations. 
Conclusion: This study provides the first direct physiological comparison of 
tDCS effects applied over different brain areas, and therefore delivers crucial 
information for future tDCS applications. 
In summary, we showed that manipulating stimulation intensity and duration can 
enhance neuroplastic effects induced by cathodal tDCS over the motor cortex, but 
results also in stimulation dosage-dependent nonlinearity at the group level, with 
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relevant interindividual variability of the outcome. In addition, we showed that 
repetition with an intensified protocol might potentially decrease the after effects of 
cathodal tDCS over the motor cortex. Moreover, we showed that the nonlinear 
intensity-dependent after-effects of stimulation can be explained by calcium channel 
dynamics. Furthermore, computational approaches revealed that individual 
anatomical factors and tDCS-induced EFs can help to explain the inter-individual 
variability of tDCS effects. Finally, we showed that the observed dosage-dependent 
nonlinear neurophysiological effect of motor cortex tDCS was not one-to-one 
transferable to prefrontal tDCS. 
7.2. Outlook 
The results of the studies included in this thesis should be interpreted within the context 
of some limitations, which should be considered in future studies. First, we explored 
only the intensity, duration and repetition rate of cathodal tDCS, for the aim to 
enhance its efficacy, over only primary motor cortex. However, brain regions do not 
operate in isolation, but interact with other regions through networks. Accordingly, 
a new multifocal tDCS protocol targeting the resting state motor network, showed 
promising results for enhancing tDCS effects [272]. Therefore, a promising way of 
enhancing stimulation efficacy might be the use of multisite network-based 
stimulation, which might be considered in future studies. Second, the 
neurophysiological and computational data obtained in this thesis which were based 
on healthy young participants, might not be one-to-one transferable to task-based tDCS 
applications, and to other cortical areas as well as different age populations and patient 
groups, and should therefore be directly tested with respect to these parameters. Third, 
we showed that calcium channel dynamics are involved in the non-linear after-effects 
of high intensity cathodal motor tDCS. However, detailed mechanisms of this 
nonlinearity are largely unexplored, but might be important for the informed 
development of more efficient stimulation protocols, and should be explored in future 
studies. Fourth, we used a well-stablished computational modeling pipeline to simulate 
tDCS-induced EF, which has been shown to correlate with in-vivo intra-cranial EF 
recordings [187]. However, despite increasing sophistication of simulation techniques 
for the estimation of individual current distribution achieved by tDCS, that support the 
usefulness of individualized head models, this approach showed high sensitivity to 
modeling differences in the pipelines [46], including the addition of other relevant head 
tissues [256, 333], as well as individual head tissue electrical conductivity 
characteristics [56], leading to notable differences in the simulated tDCS-induced EF 
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that might be large enough to change the results regarding the dose distribution or 
strength in the brain. In this line, important progress has been made over the last few 
years in the field of MR-based current density imaging (MRCDI), which makes it now 
possible to reconstruct current density distributions in the human body using the weak 
current injection MRI technique [252]. This tool might be considered to improve the 
accuracy of modeling results via physical validation of simulations, which is crucial for 
the aim to adapt stimulation parameters, including electric field dose and electrode 
montage at the level of the individual to achieve inter-individually similar, and/or 
optimized neurophysiological or behavioral effects. Fifth, our results showed a strong 
correlation between individual anatomical and electrical field factors, and tDCS-
generated neurophysiological responses. An important next step would now be to test 
if modeling-based individual dosage adjustment can reduce interindividual variability, 
leading to more homogeneous and sustained effects of stimulation, across individuals. 
Finally, we, throughout the thesis, mainly focused on regional effects of tDCS, but not 
on distributed/network effects; considering these in future studies might further improve 
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MDD major depression disorder 
NIBS non-invasive brain stimulation 
tDCS transcranial direct current stimulation 
TMS transcranial magnetic stimulation 
EEG electroencephalography 
MRI magnetic resonance imaging 
MRS magnetic resonance spectroscopy 
fMRI functional magnetic resonance imaging 
ASL arterial spin label 
SICI short-interval intracortical inhibition 
ICF intracortical facilitation 
MSO maximum stimulator output  
EF electrical field 
FEM finite element method 
M1 primary motor cortex 
DLPFC dorsolateral prefrontal cortex 
CSF cerebrospinal fluid 
GM gray matter 
WM white matter 
MEP motor evoked potential 
CBF cerebral blood flow 
TEP transcranial evoked potential 
FLU flunarizine 
NMDA N-methyl-D-aspartate  
AMPA α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
ECD electrode-to-cortex distance  
ROI region of interest 
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